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Index of abbreviations and symbols 
 
abs.     absolut, dry 
Ac     acetyl 
acac     acetylacetonato 
br     broad (FTIR) 
br s     broad singulet (NMR) 
Bu     butyl 
cod     1,5-cyclooctadienyl 
Cq     quaternary carbon (NMR) 
Cy     cyclohexyl 
d     doublet (NMR) 
dd     doublet of doublets (NMR) 
ddd     doublet of a doublet of doublets (NMR) 
δ     delta (NMR shift designator) 
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MARDi    Michael addition retro-Dieckmann 
Mat.     material 
Me     methyl 
Ms     Mass spectroscopy 
MTBE     t-butylmethylether 
n-     normal 
NMR     Nuclear magnetic resonance spectroscopy 
p     total pressure 
ppm     parts per million (NMR) 
q     quartet (NMR) 
R     reaction 
RT     room temperature 
s     singlet (NMR), strong (IR) 
Start.     starting (material) 
t     reaction time, triplet (NMR) 
t     tertiary 
T     temperature 
TBDMS    tert-butyldimethylsilyl 
TEA     triethylamine 
THF     tetrahydrofuran 
TLC     thin liquid chromatography 
TMS     trimethylsilyl 
vs     very strong (IR) 
w     weak (IR) 
ν     wave number [cm-1] 
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1 Introduction 
 
Alicyclic compounds such as prostaglandins, steroids or pheromones hold a dominant 
position in organic chemistry; e.g. as natural products with important biological 
activities, others find use as perfumes or are important as antibiotics, cytotoxic agents 
and antifeedants. The terpenoids, which are perhaps the most numerous and varied 
class of organic compounds found in nature, are containing a broad variety of ring 
systems1 and have decisively influenced modern developments in synthetic organic 
chemistry. Recent years have revealed the increasingly important biological role of 
many terpenoids and the need of powerful new synthetic methods, e.g. for the 
formation of bridged or fused compounds containing rings with 5, 6, or 7 carbon 
atoms2. Several natural products like Clovene3, Pallescensin-C4, β−Barbatene5, 
Ingenane6, Taxol7, Portulal8,9 contain this kind of skeleton as depicted in Figure 1. 
 
 
Figure 1: Examples of natural products containing a multi-rings skeleton. 
 
The ingenane diterpenes comprise a structurally novel group of highly oxygenated 
tetra-cyclic diterpene esters with a broad spectrum of biological activities, ranging from 
the tumor-promoting properties10,11 of some derivatives to the powerful antileukemic 
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activity of others. Central to the novel structure of the ingenanes, which are synthesized 
by a long sequence of reactions, is the highly strained bicyclo[4.4.1]undecan-11-one 
which possesses the unusual inside-outside intrabridgehead (BC rings) stereochemical 
relationship6 (Figure 1).  
The synthesis of bridged systems of types as reported above by means of cyclization of 
cycloalkanones is performed using different reaction-types. Formation of [m.3.1] 
bridged system like 3 (Scheme 1) could be accomplished by alkylation of β-ketoester 1 
with 1,3-dibromopropane (2)12. 
 
 
 
 
 
 
Scheme 1: Formation of [m.3.1] bridged system by 1,3-dibromopropane addition. 
 
Alternatively, Mn(III)-based oxidative free-radical cyclization of unsaturated β-
ketoesters (Scheme 2) is another versatile synthetic procedure towards the synthesis of 
bicyclo[m.3.1] alkane skeletons13. For example, oxidation of cycloalkanones of type 4a 
with 2 eq. of Mn(OAc)3·2H2O and 1 eq. of Cu(OAc)2·H2O at 80 °C (Scheme 2) affords 
75 % yield of ethyl 8-oxo-bicyclo[3.2.1]oct-3-ene-1-carboxylate (5) and 15 % of ethyl 
8-oxo-bicyclo[3.2.1]oct-2-ene-1-carboxylate (6).  
 
Scheme 2: Mn(III)-based oxidative free-radical cyclization. 
 
Besides the reactions mentioned so far, a sequential Michael addition-aldol reaction 
allows the construction of the structural framework of bicyclo[3.3.1]nonane. The 
syntheses of bicyclic compounds from cycloalkanones were reported (Scheme 3): (1) 
tandem Michael addition-intramolecular aldolization of ketones with α,β−unsaturated 
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aldehydes or ketones (eq 1), (2) palladium-catalyzed reaction of cyclic β-keto esters 
with methallyl diacetate (eq 2), and (3) the annulation of β-keto thiolesters or β-keto 
sulfones (eq 3). In the previous cases, one of the two fused rings of bicycles compounds 
comes from the ring system of the starting cyclic ketones14,15.  
 
 
Scheme 3: Tandem Michael addition-intramolecular aldolization of ketones with 
α,β−unsaturated compounds. 
 
Alternatively, the formation of fused skeletons is accomplished by conjugate reduction 
by Stryker’s reagent (17) to form copper enolates followed by intramolecular aldol 
cyclization (Scheme 4), generating five and six-membered carbocycles of type 18 in 
one-pot16. 
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Scheme 4: Fused bicyclic systems synthesis by Stryker’s reagent (17). 
 
As previously described, numerous synthetic methods towards the formation of bicyclic 
system exist; however, straightforward cyclization routes often are too difficult and too 
expensive for large-scale purposes. Therefore, it is important to develop and to study 
the synthesis of bicyclic systems from simple starting materials with low costs and in 
high selectivity. 
Retrosynthetic analysis of Pallescensin-C e.g. (Scheme 5), shows a bicyclo[4.3.1] 
bridged intermediates of type 21, which could be obtained by a sequential 
hydroformylation/ aldol addition.  
 
 
Scheme 5: Retrosynthetical analysis of Pallescensin-C. 
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Some examples of tandem hydroformylation/ aldol cyclization have already been 
reported in the context of natural products or their intermediates synthesis by Eilbracht 
and Hollmann17. Then, to accomplish the synthesis of key bicycles intermediates of 
compounds depicted in Figure 1, containing 5-membered rings or larger, an application 
of this one-pot procedure reaction could be investigated (Scheme 6).  
As depicted in Scheme 6, the aim of this project is to investigate further possibilities for 
the synthesis of bicyclic systems [bridged or fused structures of type 26 or 27 
respectively] starting from unsaturated cycloalkanones of type 24 bearing side chains 
with different length. 
 
 
Scheme 6: Theoretical cyclisation of ethyl 1-alkenyl-2-oxo-cycloalkane carboxylates of 
type 23 by tandem hydroformylation/ aldol addition reaction. 
 
Reaction sequences combining hydroformylation with various subsequent 
transformations of the oxo-aldehydes in one-pot procedures are gaining growing 
interest17. Aldol reactions are often observed as side products under hydroformylation 
conditions18. Then, following earlier investigations in the tandem hydroformylation/ 
aldol addition17 different conditions are used allowing the aldol product formation 
directly under the hydroformylation conditions. The attractive aspects of 
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hydroformylation reaction are found to be its compatibility with various sensitive and 
reactive functional groups such as aldehydes, free alcohols, carboxylic acids, allyl 
halides and tosylates19,20,21,22. The hydroformylation reaction, discovered in 1938 by 
Roelen23,24 and named later by Adkins25 could be a valid synthetic approach towards the 
synthesis of complex carbon skeleton from the appropriate inexpensive starting 
materials18,26. It consists of a reaction between an olefinic double bond and synthesis gas 
(a mixture of H2 and CO) leading to linear and branched aldehydes as products which 
can be converted via reduction, oxidation or other reactions to give alcohols, carboxylic 
acids, amines or aldol condensations products (Scheme 7).  
 
 
Scheme 7: Hydroformylation reaction and transformation of the aldehyde function.  
 
The reaction is catalyzed by transition metal complexes of Rhodium, Cobalt, 
Ruthenium or others18b it can also be catalyzed by other homogeneous catalysts 
including heterogenized modifications27,28,29. 
Rhodium-catalyzed hydroformylation is one of the most prominent applications of 
homogeneous catalysis in industry35 and the generally accepted mechanism for 
rhodium-catalyzed hydroformylation was proposed by Wilkinson in 196830. Numerous 
investigation on mechanistic18f,31,32 and asymmetric/enantioselective33 aspects of 
hydroformylation are available. Moreover, chemo- and regio-stereoselectivity problems 
are involved34 and therefore metal complexes are modified by phosphorous or 
phosphine ligands35 which are able to increase the reaction performances.  
The very efficient modern rhodium-phosphine catalysts are first developed by 
Wilkinson30,36,37 and first employed by Union Carbide38,39. This kind of catalyst, 
compared to older cobalt hydroformylation catalysts, offer the advantages of enhanced 
rates, lower operating temperatures and pressures, and higher selectivity for straight-
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chain aldehydes39 in the low to medium range (5-100 bar)34 but these ligands are 
sensitive towards oxidation40. Bryant and co-workers first41 at Union Carbide Corp. 
(UCC) and successively Pruett and Smith42 observed that certain bulky phosphites lead 
to high selectivities in the rhodium-catalyzed hydroformylation of terminal and internal 
alkenes. Moreover, Van Leeuwen has reported a variety of diphosphite and 
diphosphine ligands that give high n:i regioselectivity40,43,44, Buchwald21 and Wink45 
have obtained high regioselectivities in hydroformylation of functionalized alkenes 
using rhodium diphosphite systems46. These ligands are considered too sensitive to 
hydrolysis and alcoholysis; however, phosphites are less sensitive toward oxidation 
than phosphines and they show, besides lower σ-donor capacities, better π-acceptor 
properties. The use of bulky phosphites in the rhodium-catalyzed hydroformylation has 
been a field of interest47,48,49, these ligands show a high reactivity in the 
hydroformylation of otherwise unreactive olefins50,51,52. It was noted that both the 
length of the bridge of the diphosphite41 and its steric bulk41,53 determined the preferred 
bite angle54 of the bidentate ligands stabilizing the “catalytic” species54. 
The highest selectivities are achieved using bisphenol bridges. Along these lines, in 
1988, a catalytic system derived from bis-organophosphite rhodium complex 29a, which 
gives high n:iso ratio and operates under mild conditions55, has been found to affect the 
regioselectivity in the hydrormylation of terminal olefins producing a variety of 
ω−functionalized aldehydes21. This catalyst system notably demonstrates increased 
regioselectivity, and it is tolerant of a variety of potentially reactive functional groups. 
The active hydroformylation catalyst, presumably 29a, is generated in situ, in the 
presence of the substrate, by addition of the bis-organophosphite ligand56,57 
BIPHEPHOS (29) to dicarbonylacetylacetonate rhodium at 60 °C. Then, the catalyst 
species chosen was the rhodium (I) complexes such as Rh(acac)(CO)2 (28) (Figure 2) 
modified by a diphosphite ligand such as BIPHEPHOS (29) (Figure 3).  
 
 
 
 
 
 
Figure 2: Rh(acac)(CO)2 (28) molecular structure. 
 
O O
Rh
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The diphosphite ligand BIPHEPHOS (29) (Figure 3) shows the bite angle and the steric 
bulk compatible with the Rh(acac)(CO)2 (28) structure35, and its reactive species with 
the coordination of the heteroatom to the metal centre is represented in 29a21 (Figure 
3). This system BIPHEPHOS/Rh-catalyst introduced by Union Carbide58 has proven to 
be a reliable catalyst for n-selective hydroformylation of a wide variety of different 
alkenes under mild reaction conditions21.  
 
 
Figure 3: BIPHEPHOS (29) structure and Rh-BIPHEPHOS (29a) as active species.  
 
The aldol condensation59 is one of the most important reactions in synthetic organic 
chemistry60, apparently first reported by Chiozza59a in 1856 and later by Wurtz59b and 
Perkin59c. The advantage is the construction of a relatively complex carbon skeleton 
from simple precursors.  
In a study towards the synthesis of analogs of Tromboxane A2 (TXA2)61 (Figure 4), an 
extremely potent compound which promotes the aggregation of blood platelets, via 
bicyclic ketones produced by aldol condensation, Evans and al.62 observed how the 
chemoselectivity of the intramolecular aldol addition would be influenced by an acid 
employed.  
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Figure 4: Tromboxane A2 (TXA2) molecular structure and its analog compounds 
 
In fact, the 1,5-diketone 30 is converted to bridged compound 31 (Scheme 8) on 
treatment with concentrated sulphuric acid while the use of concentrated hydrochloric 
acid, acetic acid, stannic chloride and boron trifluoride, furnished only the ”Robinson 
annulation” product 32. 
 
 
 
 
 
 
 
 
 
Scheme 8: Example of chemoselective aldol condensation under acidic conditions 
 
Gambacorta et al.63 during their studies about the Pinguisane terpenoids synthesis64, 
applied the acid catalyzed intramolecular aldol condensation by HCl. Starting from the 
6-membered cycloalkanone 33, bearing a remote aldehyde function (Scheme 9), the β-
hydroxy ketone afforded 34 as an endo-exo mixture of epimers. 
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Scheme 9: Example of acid catalyzed intramolecular aldol addition carried out on a 
cyclohexanone derivative 33.  
 
However, the fixed length of the chain to only three carbon atoms makes the Michael 
reaction a procedure useful only to the synthesis of [n.3.m] bridged compounds.  
Aldol reactions in some cases are observed under hydroformylation conditions as 
products of the oxo-aldehydes leading to higher boiling side products65. On the other 
hand, however, mixed aldol reactions of oxo-aldehydes with other carbonyl compounds 
can be used for the synthesis of new open-chained and cyclic carbon skeletons. 
Combining hydroformylation and aldol addition of the oxo aldehyde to a second 
carbonyl compound poses the usual selectivity problems of hydroformylation and of 
mixed aldol condensation with the additional problem, that the aldol step has to proceed 
under the hydroformylation conditions (Scheme 10). 
 
 
 
 
 
 
 
 
 
 
Scheme 10: General procedure of the hydroformylation reaction with subsequent aldol 
addition. 
 
Therefore, numerous efforts have been made to combine hydroformylation with a 
consecutive aldol reaction in a one-pot reaction sequence on17,66. Selective conversions 
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of this type, starting from simple olefins would allow for a convenient straightforward 
access to complex carbon skeletons.  
Thus, if converting a terminal olefin under hydroformylation conditions in the presence 
of a second carbonyl compound, first, n- and iso-selectivity of the hydroformylation 
step and second, the chemo- and regio-selectivity of the aldol condensation step has to 
be controlled. Since the metal catalyzed hydroformylation occurs under reductive 
conditions and the aldol addition step requires acid or base catalysis numerous side 
reactions are possible. 
As reported from Bergman and Heathcock67 in order that the catalyst was compatible 
under aldol reaction conditions, four important features must be incorporated into this 
catalytic process. Thus: (1) the rhodium enolate must be sufficiently nucleophilic to 
condense with aldehydes, (2) the rhodium aldolate complexes must be resistant to 
significant competing irreversible decomposition under the reaction conditions, (3) the 
rhodium-oxygen bond in the rhodium complexes must be reactive towards the organic 
enol derivatives, (4) the enol source and the aldehyde must not condense without the 
catalyst68.  
Moreover, the aldol addition combined with the hydroformylation does not proceed in 
the presence of transition metals such as rhodium in strongly coordinating solvents such 
as THF, acetonitrile or methanol. Indeed, they are able to form Lewis acid/ Lewis base 
adducts with the rhodium catalysts69, therefore apolar solvents need to be used.  
If connecting the Wilkinson30 hydroformylation studies with the Bergman and 
Heathcock67 investigations concerning the aldol reaction by means of rhodium enolate, 
the complete tandem hydroformylation/ aldol addition process could be represented as 
shown in Scheme 11. 
 
 
 
 
 
 
 
 
 
 
             Introduction 
 21
At first, the precursor catalyst complex Rh(acac)(CO)2 (28) reacts immediately with the 
BIPHEPHOS ligand (29), two CO ligands are substituted with the least sterically 
hindered phosphorus atoms40 of the ligand and the equilibrium with 29a in Scheme 11 
exists in the catalyst system. 
 
 
Scheme 11: Rhodium catalyzed tandem hydroformylation/ aldol addition of alkenes 
substrates. 
 
The second part of the process involves the n-regioselective hydroformylation catalytic 
cycle34 of the alkene substrate A (such as the cycloalkanone 24 in Scheme 6), the linear 
aldehyde of type B so formed (corresponding to the 25 in Scheme 6) undergo the 
catalytic aldol addition step. In this latter cycle, the rhodium enolate I formed67 reacts to 
the aldehyde B resulting in the formation of a rhodium aldolate III via the Zimmerman-
Traxler70 transition state II. A transfer of the hydrogen (X = H) from another enol 
compound IV results in the formation of the final adduct C (corresponding to 26 and/or 
27 in Scheme 6) and the reactive rhodium enolate I is regenerated.  
In order to reduce the multitude of selectivity problems, first studies of tandem 
hydroformylation/ aldol condensation were carried out with unsaturated ketones of type 
35 leading to cyclic products of type 37 and derivatives thereof (Scheme 12)17,66,71. 
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Scheme 12: General tandem hydroformylation/ aldol addition and condensation 
procedure. 
 
As outlined in Scheme 12 unsaturated ketones of type 35 can undergo hydroformylation 
at the olefinic double bond followed by a mixed aldol type cyclisation. According to 
earlier investigations71 in intramolecular aldol reactions of keto aldehydes 36 the ketone 
moiety usually reacts as the enolate equivalent and undergoes nucleophilic addition to 
the aldehyde function and a cyclization of type 37 is obtained. 
For a detailed study of a combination of hydroformylation and aldol addition both steps 
in a tandem procedure the β,γ-unsaturated ketone 3,3-dimethyl-4-penten-2-one (38)71 
(Scheme 13) was chosen as the substrate. 
 
 
Scheme 13: Tandem hydroformylation/ aldol condensation of 3,3-dimethyl-4-penten-2-
one (38). 
The β,γ-unsaturated ketone 38 undergoes tandem hydroformylation/ aldol 
condensation, making use of [Rh(cod)Cl]265,72 as catalyst (41) (Figure 5) and PTSA as 
cocatalyst to give the α’,β’-unsatured cyclic compound 39 which after hydrogenation 
of the double bond in α’-position generates the substituted cyclohexanone 40 (Scheme 
13).  
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Figure 5: [Rh(cod)Cl]2 (41) molecular structural.  
 
More complicated is the application of the same procedure to unsaturated carbonyl 
compounds to form bicyclic products. Here cyclic ketones with unsaturated side chains 
in various positions of the ring are required as starting materials (Scheme 14)73. 
 
 
Scheme 14: Tandem hydroformylation/ aldol cyclization on cyclic ketones with 
unsaturated side chains in various positions of the ring. 
 
If running the reaction with 3-vinyl-cyclohexanone (42) a bicyclo[4.3.0]nonane skeleton 
is generated in the ring-annulation’s step. Successively to the aldol condensation a 
double bond isomerisation to form the higher substituted enone 43 takes place. Further 
hydrogenation of the intermediate enone generates the saturated hydroindanone73 44 
(Scheme 15).  
 
 
 
 
 
 
 
Scheme 15: Tandem hydroformylation/ aldol condensation reaction starting from 3-
vinyl-cyclohexanone (42). 
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In summary, the tandem reaction of 3-vinyl substituted cycloalkanones offers an access 
to the synthesis of hydropentalene and hydroindene derivatives that represent common 
substructures in many terpenoid compounds. 
 
Annulation of six-membered rings can be achieved if starting from 3-allylsubstituted 
cycloalkanones. Hydroformylation of 45 then leads to the fused bicycles, α,β-
unsaturated ketone 46, similar to Quassinoids structure74, in satisfying yield (Scheme 
16).  
 
 
 
 
 
 
 
 
Scheme 16: Tandem hydroformylation/ aldol condensation of 3-allyl-cyclohexanone 
(45). 
 
Besides the synthesis of annulated carbocycles the method also offers an access to 
spiro-cyclic compounds. In order to obtain spiro-annulated aldol products as well, the 
sequence has to be started from allyl substituted cycloalkanones73. Indeed, the 
conversions of 2-allyl-cyclopentanone (47a), -cyclohexanone (47b) and -cyclooctanone 
(47c) give the spirocyclic β-hydroxy-ketones 48a-c in medium to good yields (Scheme 
17). The cyclisations proceed regioselectively via the keto enols of the intermediate ε-
keto aldehydes that generate the five-membered rings73. 
 
 
 
 
 
 
 
 
O O
CO/H2 (1:1) 20 bar
Rh(acac)(CO)2
BIPHEPHOS
T = 60 °C, t = 72 h
dry CH2Cl2
PTSA
(53 %)45 46
α
β
α
β
             Introduction 
 25
 
 
Scheme 17: Tandem hydroformylation/ aldol addition of 2-allyl-cycloalkanones (47a-
d). 
 
In contrast, starting with 2-allylcyclododecanone (47d) the tandem reaction does not 
lead to the spirocyclic aldol adduct in analogy to 47a-c. Here, the hydroformylation 
equally proceeds with high n-regioselectivity but the cyclization gives the bicyclo 
[9.4.1]hexadecanone derivative (49) (Scheme 17)73. 
The present research project concentrates on the conversion of 2-alkenyl-
cycloalkanones derivatives of type 50 as first model substrates (Scheme 18) and in 
further investigations the ring size, chain length and substitution pattern will be varied.  
 
Scheme 18: Theoretical pathways of tandem hydroformylation/ aldol addition reaction. 
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The unsaturated chain allows hydroformylation of the olefinic function in the terminal 
position, according to Scheme 12, and a subsequent aldol addition of the 
hydroformylation product of type 51 under the same reaction conditions with varying 
selectivity (Scheme 18).  
 
If assuming regioselective n-hydroformylation, a linear aldehyde chain as in 51 is 
generated and by the presence of the ketone functionality, an intramolecular crossed 
aldol condensation can occur in three different ways (Scheme 18). 
I) If the α-carbon, to which the aliphatic chain is attached, reacts (as enol or 
enolate) with the linear aldehyde, a second ring is formed and a spiro compound of type 
52 is obtained as previously reported in Scheme 17. 
II) If the ketone plays the role of the carbonyl function and the aldehyde is the 
methylene function, fused ring-systems of type 53 are formed (Scheme 18). 
III) If the aldehyde function reacts with its α´-carbon, a bridged bicyclic system of 
type 54 is formed as obtained if the reaction is performed starting from 2-allyl-
cyclododecanone (47d) as reported in Scheme 17. 
 
For mixed crossed aldol addition procedures, various methods of activation and 
blocking of specific positions are available and applicable to tandem hydroformylation/ 
aldol addition66,71 (Scheme 19).  
 
 
 
 
 
 
 
Scheme 19: Regio-control of tandem hydroformylation/ aldol condensation conditions. 
 
In the following several possible strategies towards selective control of 
hydroformylation/ aldol addition reactions in various directions are discussed. 
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General list types of control: 
- Blocking with removable or no-removable groups 
- Activating with electron withdrawing group (EWG) 
- Activating via enol equivalents  
 
 
• Strategy 1: removable (or no-removable) blocking group in α−position. 
 
It is possible to introduce a removable blocking group, such as an ester function, to 
avoid the cyclization in the α-position, thus two different pathways are possible leading 
to the bicyclic product of type 26 (Scheme 20, path I) cyclisation in α’-position whereas 
the fused aldol adduct of type 27 (path II) can be obtained if the tandem 
hydroformylation/ aldol condensation occurs on the keto-function. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 20: Removable blocking group in α-position. 
 
• Strategy 2: activating with EWG (electron withdrawing group) 
 
For the activation of the α’-position a model starting material is the keto ester 55. When 
inserting an activating group EWG (like COOEt) in the α’-position the reactivity of this 
carbon increases (Scheme 21). The activating group (EWG) should force the reaction 
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towards the cyclization in the α’-position to form a bicyclic compound 56 (path I) 
whereas products 57 (path II) or 58 (path III) are less favourable.  
 
Scheme 21: Activating with EWG (electron withdrawing group) in α’-position. 
 
 
• Strategy 3: activation with enol ethers. 
 
Various other methods have been developed for the directed coupling of two different 
carbonyl compounds (or carbonyl equivalents) to give a specific carbon-carbon bond 
formation between the α−C atom of one carbonyl compound component and the 
carbonyl group of the other. 
Silyl enol ethers of type 59 (Scheme 22, Y = -SiR3) are highly versatile enol derivates 
that can be regioselectively prepared from various ketones. Mukaiyama´s method using 
the trimethyl silyl enol ether of one carbonyl compound and stoichiometric amounts of 
Lewis acid, offers access to directed crossed aldol reaction75. This procedure can be 
useful to generate bicyclic compounds of type 60. 
Alternatively, instead of silylated enol ethers various other enol equivalents (including 
borane) can be used (Scheme 22, Y = -BR2). 
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Scheme 22: Activation with enol ethers.  
 
Combining all the possible pathways in Scheme 18 and the results from Scheme 16, the 
number of molecular target increases and a new application of the tandem 
hydroformylation/ aldol addition is shown in Scheme 23. Cycloalkanones of type 23, 
after introducing the unsaturated side chain in α-position, could undergo immediate 
aldol addition or condensation of the intermediate δ-keto aldehyde 25 at α´-position 
and a bicyclic-bridged compound of type 26 should be obtained (Scheme 23).  
 
Scheme 23: Preparation of tri-cyclic compounds of type 62 by tandem 
hydroformylation/ aldol addition reaction via a bicyclic product of type 26.  
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After the introduction of the new vinyl group or a longer unsaturated side chain (m = 0, 
1, 2 etc.) in β´-position of 26 to get a compound like 61, a new tandem 
hydroformylation/ aldol condensation could be applied and, as well as shown in 
Scheme 16, and the reaction should yield a condensed tricyclic compound of type 62 
(Scheme 23).  
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2 Theoretical part 
2.1 Preparation of starting materials 
 The appropriate precursor compounds with which to begin a study of methods of 
sequential hydroformylation/ aldol addition as depicted in Scheme 6 can be synthesized 
via a variety of methods. Thus, those compounds of type 24 can be synthesized starting 
from cycloalkanones of type 23 (R = COOEt) by introducing in α-position an allylic or 
homoallylic unsaturated side chain (Scheme 24). 
 
 
Scheme 24: General strategy for sequential hydroformylation/ aldol addition. 
 
 
a. Synthesis of ethyl 2-oxo-cycloalkane carboxylates (65c-e) 
While the cyclic β-ketoesters of type 23 with 5- and 6-membered rings (Scheme 24, 65a 
with n = 0 and 65b with n = 1) are commercially available, the preparation of the larger 
ones (65c-e, n = 2, 3 and 4) could be accomplished under mild conditions, through the 
ring expansion of cycloalkanones via W. L. Mock’s procedure76 as show in Scheme 25. 
These investigations furnish an excellent method to obtain homologated cycloalkanones 
by BF3·OEt2 catalyzed77,78 alkyl diazoacetate79 insertion into a carbonyl-alkyl bond80. 
Aliphatic diazoalkanes react with carbonyl compounds by virtue of their nucleophilic 
properties, forming homologous carbonyl compounds by elimination of nitrogen. In the 
case of cycloalkanones this procedure leads to the formation of cycloalkanones which 
are ring enlarged by one C-atom. Using the general procedure reported by H.-J. Liu81, 
the reaction of cyclohexanone (63a), cycloheptanone (63b) or cyclooctanone (63c) in 
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the presence of BF3·OEt2 and ethyl diazoacetate (64), proceeded selectively in high 
yields as shown in Table 1.  
 
 
 
 
 
 
 
Scheme 25: Preparation of ethyl 2-oxo-cycloalkane carboxylates (65c-e) by ring 
expansion reaction.  
 
Table 1: Preparation of ethyl 2-oxo-cycloalkane carboxylates (65c-e)a 
Reaction m Starting Mat. Product n Yields (%) 
R 1 1 63a 65c 2 74 
R 2 2 63b 65d 3 98 
R 3 3 63c 65e 4 91 
a) The smaller ones 5-, and 6-membered β-keto ester rings labeled as 65a,b are commercially available. 
 
 
b. Preparation of ethyl 1-allyl-2-oxo-cycloalkane carboxylates (4a-e) 
 
Ethyl 1-alkenyl 2-oxo-cycloalkane carboxylates of type 24 (Scheme 24, R = COOEt, m 
= 1; n = 0-4) can be obtained by alkylation of the corresponding cycloalkanones 65a-e 
(from Scheme 25) in the presence of 1 eq. of NaH82,83 and 1 eq. of allylbromide (66) as 
alkylating agent (Scheme 26). The β-ketoesters 65a-e react smoothly, furnishing the 
unsaturated derivatives 4a-e in high yield (over 90 %) with exception of the reaction 
carried out starting from ethyl 2-oxo-cycloheptane carboxylate (65c) which is converted 
into compound 4c in about 80 % yield (Table 2, R 6). 
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Scheme 26: Synthesis of ethyl 1-allyl-2-oxo-cycloalkane carboxylates (4a-e). 
 
Table 2: Allylation in α position of ethyl 2-oxo-cycloalkane carboxylates (65a-e) 
Reaction n Starting Mat. Product Yields (%) 
 
R 4 
0 65a 4a 93 
R 5 1 65b 4b 91 
R 6 2 65c 4c 80 
R 7 3 65d 4d 96 
R 8 4 65e 4e 92 
 
 
c. Preparation of ethyl 1-(but-3-enyl)-2-oxo-cycloalkane carboxylates (68a-c,e) 
Proceeding with the preparation of starting materials that could be used in one-pot 
reactions, compounds of type 24 bearing an homoallylic side chain in α-position 
(Scheme 24, R = COOEt, m = 2) are prepared. The alkylation reaction is performed 
starting from 65a-c,e (n = 0-2,4) and in the presence of t-BuOK as base with catalytic 
amounts of KI84,85 and addition of 4-bromo-1-butene (67). The reaction proceeds with 
formation of ethyl 1-(but-3-enyl)-2-oxo-cycloalkane carboxylates 68a-c,e (Scheme 27) 
in good yields with exception of the reaction carried out with ethyl 2-oxo-cycloheptane 
carboxylate (65e) which is converted into compound in 68e in 47 % yield (Table 3, R 
12). 
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Scheme 27: Synthesis of ethyl 1-(but-3-enyl)-2-oxo-cycloalkane carboxylates (68a-c,e) 
 
Table 3: Synthesis of ethyl 1-(but-3-enyl)-2-oxo-cycloalkane carboxylates (68a-c,e) 
Reaction n Starting Mat. Product Yields (%) 
R 9 0 65a 68a 85 
R 10 1 65b 68b 85 
R 11 2 65c 68c 81 
R 12 4 65e 68e 47 
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2.2 Stepwise hydroformylation/ aldol addition under acidic 
conditions 
2.2.1 Introduction 
 Taking into account the aldol condensation results obtained from Evans et al.62 
under acidic conditions as depicted in Scheme 8, studies were performed in order to 
find out how the reaction parameters (co-catalyst, solvent, temperature, reaction time) 
could influence the chemoselectivity of the intramolecular aldol addition86,87 of 
compounds of type 24 (Scheme 28, 4a-c and 68a-c). 
Intramolecular aldol addition will be investigated in the presence of both strong mineral 
acids (H2SO4 and HCl). As depicted in the Scheme 28 two different intramolecular 
aldol additions, due to the presence of two sites of enolization, could be possible: one 
resulting from the attack of the ketoester enolate on the aldehyde (26, path I), while the 
second one, the aldol adduct of type 69 is formed from the aldehyde-enolate with 
reversed chemoselectivity (path II). 
 
Scheme 28: Chemoselectivity in the intramolecular aldol addition of keto-aldehydes of 
type 24. 
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a Preparation of ethyl 2-oxo-(n-oxo-alkenyl)cycloalkane carboxylates (n = 4, 5). 
 
The first logical step is to perform the hydroformylation reaction of unsaturated β-
ketoesters 4a-c and 68a-c under regiocontrol in the presence of BIPHEPHOS (29) as 
ligand. 
As it has been observed that the hydroformylation could be performed under mild 
conditions when the ligand BIPHEPHOS (29) is employed21, hydroformylation 
reactions are carried out in the presence of 4 % mol of ligand and 1 % mol of 
Rh(acac)(CO)2 (28), using 20 bar of CO/ H2, 60 °C for three days (Scheme 29). All 
results are compiled in Table 4. 
 
 
Scheme 29: Hydroformylation of ethyl 1-alkenyl-2-oxo-cycloalkane carboxylates 4a-c 
and 68a-c. 
 
Table 4: Hydroformylation of unsaturated β-ketoester (4a-c and 68a-c) 
Reaction m n Starting Mat. Product Yields (%) 
R 13 1 0 4a 70a 82 
R 14 1 1 4b 70b 98 
R 15 1 2 4c 70c 97 
R 16 2 0 68a 71a 61 
R 17 2 1 68b 71b 35 
R 18 2 2 68c 71c 40 
Conditions: 1 % mol - Rh(acac)(CO)2, 4 % mol - BIPHEPHOS, dry DCM, T = 60 °C, t = 72 h. 
 
In contrast to the results obtained in hydroformylation of ethyl 2-allyl-cycloalkane 
carboxylates (4a-c) (Table 4, R 13-15) the compounds 68a-c, with a longer side chain, 
when hydroformylated under the same reactions conditions, react with lower yields to 
form compounds 71a-c (Table 4, R 16-18). 
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2.2.2 Intramolecular aldol addition of ethyl 2-oxo-1-(n-oxo-butyl)cycloalkane 
carboxylates (n = 4, 5). 
 
a. Aldol addition tests on ethyl 2-oxo-1-(4-oxo-butyl)-cycloalkane carboxylates 
 (70a-c) 
As alluded to in the introduction, several parameters could influence the 
chemoselectivity of the aldol addition. Then, the intramolecular aldol addition of the 
1,6 dicarbonyl compound 70a-c has been carried out under acidic conditions (H2SO462 
and HCl63) using DCM and dioxane as solvent (Scheme 30). All investigations are 
listed in Table 5. 
 
 
Scheme 30: Intramolecular aldol condensations of ethyl 2-oxo-1-(4-oxo-butyl)-
cycloalkane carboxylates 70a-c under acidic conditions. 
 
When ethyl 2-oxo-1-(4-oxo-butyl)-cycloalkane carboxylates (70a-c) are treated under 
acidic conditions at room temperature, no aldol addition products like 73a-c are 
observed (Scheme 30). From the results in Table 5, it can be assumed that the 
chemoselectivity of the reaction should be influenced by the ring size. Indeed, the 
replacement of seven-membered 70c by five-, six-membered ring such as 70a,b leads 
to conversions into the fused aldol compounds 72a,b involving an intramolecular aldol 
condensation. 
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Table 5: Intramolecular aldol condensations of compounds 70a-c under acidic 
conditions  
aReact. n Starting Mat. Acid Solvent Product Yields (%) 
R 19 0 70a HCl DCM 72a 99 
R 20 0 70a H2SO4 DCM 72a 99 
R 21 0 70a HCl dioxane 72a 61 
R 22 0 70a H2SO4 dioxane 72a 99 
R 23b 0 70a PTSA DCM 72a 99 
R 24 1 70b HCl DCM 72b 99 
R 25 1 70b H2SO4 DCM 72b 98 
R 26 1 70b HCl dioxane 72b 52 
R 27 1 70b H2SO4 dioxane 72b 98 
R 28b 1 70b PTSA DCM 72b 97 
R 29 2 70c HCl DCM 70c -- 
R 30 2 70c HCl dioxane 70c -- 
a) Unless otherwise noted, all reactions are performed at room temperature for a period of 24 h; b) T = 60 °C, t = 72 
h. 
 
As summarized in Table 5, keto-aldehydes 70a,b in the presence of different acids and 
solvents, undergo aldol condensation to form the corresponding fused aldol adducts 
72a,b in good to excellent yield. Strong mineral acids H2SO4 and HCl as well as 
PTSA25,71 could satisfactorily be employed in DCM or dioxane. 
If, however HCl in dioxane (R 21 and R 26) at room temperature for 24 hours are used 
in the reaction, the aldol adducts are obtained in lower yield, whereas the corresponding 
reactions in the presence of H2SO4 in dioxane proceeds with high yields (R 22 and R 
27). 
From these results it can be concluded that while the chemoselectivity of the reaction is 
neither affected by the polarity of the acids, nor the temperature or reaction time, lower 
yield are observed by changing of the acid (H2SO4 and HCl) and solvent (dioxane vs. 
DCM). 
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b. Attempts of aldol addition on ethyl 2-oxo-1-(5-oxo-pentyl)cycloalkane 
 carboxylates (71a-c) 
 
Proceeding with 1,7-ketoaldehyde of type 71a-c (Scheme 29) the reactions are 
performed under the same conditions as described above. Failure of the aldol addition 
promoted by acid catalysis is observed (Scheme 31).  
 
 
Scheme 31: Attempted intramolecular aldol addition of ethyl 2-oxo-1-(5-oxo-
pentyl)cycloalkane carboxylates (71a-c). 
 
 
Finally, an investigation of the starting material 71c in dichloromethane at 60 °C for 72 
hours in the presence of HCl (Table 6, R 35) results, once again, in failure of the aldol 
addition.  
 
Table 6: Attempts of aldol cyclization of ethyl 2-oxo-1-(5-oxo-pentyl)cycloalkane 
carboxylates (71a-c) 
aReaction n Starting Mat. Acid Product 
R 31 0 71a HCl Start. Mat. 
R 32 0 71a H2SO4 Start. Mat. 
R 33 1 71b HCl Start. Mat. 
R 34 1 71b H2SO4 Start. Mat. 
R 35b 2 71c HCl Start. Mat. 
a) Unless otherwise noted, all reactions are performed at room temperature in DCM for a period of 24 h; b) T = 60 
°C, t = 72 h. 
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Several interesting conclusion can be drawn from the results reported above. Under 
acidic conditions only the allyl ketoaldehydes 70a,b reacted to give only the 
corresponding fused bicyclic products 72a,b when 5- and 6-membered ring compounds 
are used (Scheme 30).  
However, while the step-wise reactions subsequent to the generation of the aldehyde 
have been performed in the presence of strong mineral acids such as H2SO4 and HCl, 
these catalysts are too aggressive for performing the reaction in an autoclave.  
Then, according the results observed above, the PTSA in amounts ranging 5-10 mol % 
is the suitable catalyst in DCM for accomplishing these reactions in a one-pot 
hydroformylation/ aldol addition.  
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2.3 One-pot tandem hydroformylation/ aldol addition  
2.3.1 Tandem hydroformylation/ aldol addition of ethyl 1-alkenyl-2-oxo-
cycloalkane carboxylates 
 
a. Use of ethyl 1-allyl-2-oxo-cycloalkane carboxylates (4a-e) 
 Earlier investigations concerning the acid catalyzed tandem hydroformylation/ 
aldol condensation under harsh conditions73 of 3,3-dimethyl-4-penten-2-one (38) 
(Scheme 13) and under milder conditions73 of 3-allyl-cyclohexanone (45) (Scheme 16), 
suggest that using the same latter reaction conditions, even monocycles like ethyl 1-
allyl-2-oxo-cycloalkane carboxylates 4a-e could form the aldol adducts of type 26 
and/or 27 (Scheme 6). Thus, the compounds 4a-e are hydroformylated with 
Rh(acac)(CO)2 (28) as catalyst88,89,90,91,92 (1 mol %), BIPHEPHOS (29) as ligand21,91 (4 
mol %) in the presence of PTSA as co-catalyst71,25 (5 mol %), under 20 bar of syn-gas 
pressure (CO/H2 in a ratio of 1:1), temperatures around 60 °C for 3 days (Scheme 32).  
 However, in order to verify the possible cyclization under basic conditions, the 
six-membered compound 4b was submitted to the similar reaction conditions by 
replacing PTSA with DBU as co-catalyst. 
 
 
Scheme 32: Attempts of tandem hydroformylation/ aldol addition on ethyl 1-allyl-2-
oxo-cycloalkane carboxylates (4a-e) under acidic or basic conditions. 
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The results, obtained when the ethyl 1-allyl-2-oxo-cycloalkane carboxylates (4a-e) were 
submitted to the tandem hydroformylation/ aldol addition conditions, are shown in Table 
7. The one-pot hydroformylation/ aldol addition procedure carried out on 5-, 6-
membered compounds 4a,b proceeds with aldol condensation, derived from enolate of 
aldehyde on the ketone, resulting in a fused bicycle formation like 72a,b (Scheme 32). 
Moreover, while the ethyl 1-allyl-2-oxo-cyclopentane carboxylate 4a is found to yield 
the 72a (n = 0) as the only product (Table 7, R 36), the compound 72b (n = 1) is 
accompanied by small amounts of the subsequently hydrogenated system 76b (Table 7, 
R 37). In contrast to the previous results, the size of the cycloalkanone ring seems to 
have a significant effect on the chemoselectivity of the reaction. Then, the same reaction 
conditions applied on the larger 7-, 8-, 9-membered compounds 4c-e gave exclusively 
the n-products of hydroformylation 70c-e (Scheme 32) and none of the aldol adducts of 
type 73 or 72 is detected (Table 7, R 38-40). Anyway, branched aldehydes of type 77 
and double bond hydrogenated compound of type 78 have never detected (Scheme 32). 
Finally, to the results obtained when PTSA was used, the reaction of the 6-membered 
compound 4b carried out in the presence of DBU (5 % mol) as co-catalyst, forms a 
mixture of linear aldehyde 70b accompanied by small amounts of the fused bicycle 72b 
in a ratio of 11:1 (Table 7, R 41). 
 
Table 7: One-pot reaction conditions applied on ethyl 1-allyl-2-oxo-cycloalkane 
carboxylates (4a-e) 
Reaction n Starting Mat. Products Yields (%) 
R 36a 0 4a 72a -- 65 
R 37a 1 4b 72b (3)c 76b (1)c 79d 
R 38a 2 4c 70c -- 98 
R 39a 3 4d 70d -- 37 
R 40a 4 4e 70e -- 40 
R 41b 1 4b 72b (1)c 70b (11)c 98d 
a) 1 mol % - Rh(acac)(CO)2, 4 mol % - BIPHEPHOS, 5 mol % - PTSA, dry DCM, T = 60 °C, t = 72 h; b) 1 mol % - 
Rh(acac)(CO)2, 4 mol % - BIPHEPHOS, 5 mol % - DBU, dry DCM, T = 60 °C, t = 72 h; c) ratio by 1H-NMR 
analysis; d) calculated by GC-analysis. 
 
Again, as observed in the step-wise procedure, the different outcome of these reactions 
could be explained by the ring forming Baldwin’s rules93. Appling these rules on the 5-, 
and 6-membered cycloalkanones 4a,b, both the intramolecular aldol addition via 7-enol-
endo-exo-trig annulation in α’-position to give compounds 73a,b (deriving from the 
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keto-enolate) and the 5-enol-exo-exo-trig condensation at the ketone moiety to furnish 
compounds 72a,b (deriving from the aldehyde-enolate) can occur (Scheme 32). 
Nevertheless from the results reported above, the formation of 72a,b appears to be 
favored under these conditions. This chemoselectivity could be explained if considering 
besides the Baldwin’s rules93a,b also the Bürgi-Dunitz trajectory theory94. In fact, it could 
be supposed that the aldehyde enolate intermediate of the compounds 4a,b is able to 
attack the ketone with a preferred angle of approach about 109° (Figure 6). 
 
 
Figure 6 : Mechanism of 5-enol-exo-exo-trig intramolecular aldol condensation on 5-, 6-
membered compounds 4a (n = 0) and 4b (n = 1) respectively. 
 
The absence of intramolecular aldol condensation regarding the larger rings 4c-e could 
be due to the conformation of the rings. In fact, if the 7-, 8-, 9-membered rings are 
considered, a combination of angle strain (Baeyer strain)95,96 and bond opposition strain 
(Pitzer strain)95,96 with cross ring interaction (transannular strain) lead to a disfavored 
conformation for the favored angle of approach.  
In order to test the suitability of the one-pot procedure, further sequential 
hydroformylation/ aldol addition investigations will be also carried out on 
cycloalkanones bearing a longer side chain. 
 
 
b. Use of ethyl 1-(but-3-enyl)-2-oxo-cycloalkane carboxylates (68a-c,e) 
To provide further information about the role of ring size and tethers under the same 
previous tandem hydroformylation/ aldol addition conditions (Scheme 32) 
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cycloalkanones bearing a longer side chain used so far, such as ethyl 1-(but-3-enyl)-2-
oxo-cycloalkane carboxylates (68a-c,e), were examined (Scheme 33). 
 
 
Scheme 33: Attempts of tandem hydroformylation/ aldol addition on ethyl 1-(but-3-
enyl)-2-oxo-cycloalkane carboxylates (68a-c,e). 
 
Table 8: Tandem hydroformylation/ aldol cyclization applied on ethyl 1-(but-3-enyl)-2-
oxo-cycloalkane carboxylates (68a-c,e) 
Reaction n Start. Mat. Products Yields (%) 
R 42 0 68a 71a (5)a 79a (1)a 78 
R 43 1 68b 71b (33)a 79b (1)a 86 
R 44 2 68c 71c -- 40 
R 45 4 68e 71e -- 26 
Reaction conditions: 1 mol % - Rh(acac)(CO)2, 4 mol % - BIPHEPHOS, 5 mol % - PTSA, dry DCM, T = 60 °C, t = 
72 h; a) ratio by 1H-NMR analysis. 
 
As listed in Table 8 (R 42-43) the ethyl 1-(but-3-enyl)-2-oxo-cyclopentane-, -hexane 
carboxylates (68a and 68b respectively) react under tandem hydroformylation/ aldol 
addition conditions to form a mixture of linear aldehyde products 71a and 71b 
accompanied by small amounts of the corresponding branched aldehydic compounds 
79a and 79b. The reaction occurred exclusively with formation of linear aldehyde 
derivatives 71c,e when seven-, and nine-membered cyclic compounds 68c,e respectively 
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are used (Table 8, R 44-45). It seems that the regioselectivity of the hydroformylation 
process is directly dependent on the size of the cycloalkanone. 
These results show that both the 6-enol-exo-exo-trig annulations like 75 (condensation 
at keto group) and the 8-enol-endo-exo-trig as 74 are disfavored. Besides the Baldwin’s 
rules93a,b and the Bürgi-Dunitz trajectory theory94, the activation energy for ring closure 
should be considered. The strain energy involved in the formation of the bridged or 
fused rings should be a critical factor in this annulation due to the length of the chain. As 
the chain length increases the probability of the chain approaching the cycloalkanone 
decreases (negative entropy due to less freedom of internal rotation around the single 
bonds of the chain backbone when the open-chain precursor is converted into the ring 
shaped transition state95,97. Moreover the results could be explained, if bond opposition 
forces due to imperfect staggering (Pitzer strain95,96), deformation of ring bond angles 
(Baeyer strain95,96) and transannular strain due to repulsive interactions between atoms 
across the ring when they are forced close to each other95 are considered.  
 
In conclusion, all the results obtained under tandem hydroformylation/ aldol addition 
conditions can be collected in Table 9.  
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Scheme 34: Ethyl 1-alkenyl-2-oxo-cycloalkane carboxylates (4a-e and 68a-c,e) under 
tandem hydroformylation/ aldol addition conditions. 
 
 
 
 
 
 
 
 
 
Table 9: Main results by sequential hydroformylation/ aldol addition conditions 
carried out on ethyl 1-alkenyl-2-oxo-cycloalkane carboxylates (4a-e and 68a-c,e). 
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( ) = Yield; a) Including amounts of the corresponding hydrogenated compound 76b; b) Including amounts of the 
corresponding branched aldehydes 79a (m = 2; n = 0) and 79b (m = 2; n = 1) respectively. 
 
• Although bicyclic compounds of type 73 (Scheme 32) or 74 (Scheme 33) have 
never been observed, the tandem hydroformylation/ aldol addition acid catalyzed by 
PTSA is an efficient method to transform 5-, 6-membered allyl cycloalkanones like 4a,b 
directly into the corresponding bicyclic pentalene or indene skeletons 72a,b respectively 
(Scheme 32). 
• The larger 7-, 8-, 9-membered allyl cycloalkanones 4c-e gave linear aldehydes 
70c-e (m = 1; n = 2-4) as main products (Scheme 32). 
• No cyclization has been observed regardless the ring size when homoallylated 
compounds of type 68 are used. Only linear aldehydes 71a-c,e and traces of branched 
ones 79a (m = 2; n = 0) and 79b (m = 2; n = 1) have been detected (Scheme 33). 
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2.4 Study of the substituent effects in the 2-oxo-2-alkenyl-
cycloalkanes under sequential hydroformylation/ aldol 
addition reactions 
2.4.1 Introduction 
 As the unsaturated β-ketoesters with 5-, 6-membered rings of type 55 (4a with 
R1 = COOEt, R2 = H, m = 1; n = 0 and 4b with R1 = COOEt, R2 = H, m = 1; n = 1) via 
sequential hydroformylation/ aldol addition afford the fused aldol adducts 72a,b, 
further studies are performed for the construction of bridged system of type 56 (Scheme 
35). Investigations are conducted in order to find out how the aldol reaction succeeding 
hydroformylation is influenced by the presence of further substituents in the 
unsaturated ketones of type 55. 
 
 
Scheme 35: Possible pathway in tandem hydroformylation/ aldol addition of activated 
cycloalkanones of type 55. 
 
Thus, it could be expected that kinetic or thermodynamic control should be effective if:  
 
• the α’-position reactivity could be increased by replacing R2 with an activating 
group such as ester, CN etc., 
• steric influence in the α’-position is lowed by using substituents such as a 
methyl group or hydrogen. 
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2.4.2 Tandem hydroformylation/ aldol addition investigations with diethyl 1-
alkenyl-2-oxo-cycloalkane-1,3-dicarboxylates. 
 
In the context of compounds useful in the formation of bridged systems of type 56, the 
compound with which to begin is the 1,3-dicarboxylate of type 55 where the α´-
position  is activated by introducing an electron-withdrawing function such as an ester 
(Scheme 35). In this way, the enolate of a 1,3-dicarbonyl derivative should be more 
reactive towards the intramolecular cyclization under the tandem hydroformylation/ 
aldol addition reaction conditions. 
 
a. Preparation of the diethyl 1-alkenyl-2-oxo-cycloalkane dicarboxylates 
 (83b,c and 84). 
The preparation of unsaturated ketones bearing an ester function in α´-position is 
conducted using the procedure reported by Marshall et al.98 in which starting materials 
are added to a refluxing mixture of NaH and diethylcarbonate (82) in dry THF. Thus, 
starting from the allylated compounds 4b (n = 1) and 4c (n = 2) and the homoallylated 
7-membered ring compound 68c, after distillation, corresponding 1,3-dicarboxylates 
83b,c and 84 (Scheme 36) are obtained in good yields as compiled in Table 10. 
 
 
Scheme 36: Synthesis of diethyl 1-alkenyl-2-oxo-cycloalkane-1,3-dicarboxylates 83b,c 
and 84. 
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Table 10: Preparation of diethyl 1-alkenyl-2-oxo-cycloalkane-1,3-dicarboxylates 
83b,c and 84c 
Reaction m n Starting Mat. Product dra Yields (%) 
R 46 1 1 4b 83b 1:1 90 
R 47 1 2 4c 83c 1:1 82 
R 48 2 2 68c 84 -- 83 
a) Calculated by NMR analysis. 
 
 
b. Reactivity of diethyl 1-alkenyl-2-oxo-cycloalkane-1,3-dicarboxylates (83b,c 
 and 84c) under tandem hydroformylation/ aldol addition reaction 
 conditions. 
Preliminary investigations are conducted starting from the substituted six-membered 
ring compound 83b (Scheme 37, m = 1, n = 1) subjected to the sequential 
hydroformylation/ aldol conditions under mild conditions (CO/H2 20 bar, 60 °C for 72 
h) in the presence of 1 mol % of Rh(acac)(CO)2 (28) catalyst and 4 mol % of p-TsOH. 
An interesting feature emerged from the analysis of this result as shown in Scheme 37 
(Table 11, R 49). A cyclization in α’-position to form the bicyclo[3.3.1]octane ring 
system 85 is resulting from the attack of the enolate of the ketoester to the iso-aldehyde 
which is formed in spite of the presence of the BIPHEPHOS (29) ligand. Moreover, 
loss of the ester group in α-position is observed.  
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Scheme 37: Attempt of tandem hydroformylation/ aldol addition of diethyl 1-alkenyl-2-
oxo-cycloalkane dicarboxylates (83b,c and 84).  
 
Table 11: Tandem hydrformylation/ aldol addition of diethyl 1-alkenyl-2-oxo-
cycloalkane dicarboxylates (83b,c and 68c) 
Reaction m n Starting Mat. Product Yields (%) 
R 49 1 1 83b 85 -- 37 
R 50 1 2 83c 88 (5)a 89 (1)a 98 
R 51 2 2 84 90 (2)a 91 (1)a 90 
Reaction conditions: 1 mol % - Rh(acac)(CO)2, 4 mol % - BIPHEPHOS, 5 mol % - PTSA, dry DCM, T = 60 °C, t = 
72 h; a) calculated by 1H-NMR analysis. 
 
Proceeding the investigations by using larger rings, the allylated ketoester 83c (Scheme 
37, m = 1, n = 2) is also considered. As it has previously been observed the unsaturated 
mono-ketoester 4c (Scheme 32) when submitted to tandem hydroformylation/ aldol 
addition conditions, the 83c is not observed to react to the aldol adduct and only the n-
aldehyde is isolated.  
In contrast to the results previously reported about bicycles like 85, the 1,3-
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observed by 1H-NMR and no aldol adduct of type 86 is detected (Scheme 37). Again, 
in spite of the presence of BIPHEPHOS (29), the loss of regioselectivity of the 
hydroformylation reaction is observed. As the mixture of the aldehydes 88 and 89 is 
isolated in excellent yields, the failure to observe the intramolecular aldol adducts is 
again explained in terms of ring-size influence, as reported in the reaction of β-
ketoester 4c (Scheme 32). Under the mild conditions applied for compound 83c, the 
ketoester 84c reacts with a moderate regioselectivity with 2:1 preference for the n-
product 90 as listed in Table 11 (R 51). According with the results above, no 
cyclization is observed.  
 
 
2.4.3 Tandem hydroformylation/ aldol addition investigations with ethyl 3-allyl-
3-methyl-2-oxo-cyclohexane carboxylate (93) and 2-allyl-2-methyl-
cyclohexanone (92). 
 
Proceeding with investigations to find out how the substitution pattern in unsaturated 
cycloalkanones could influence the sequential hydroformylation/ aldol addition, 
systems of type 55 (Scheme 35) such as the 2-allyl-2-methyl-cyclohexanone (92) and 
the ethyl 3-allyl-3-methyl-2-oxo-cyclohexane carboxylate (93), are tested (Figure 7). 
The compound 92 is employed in order to suppress the electronic or sterical effect of 
the ester nearby the allyl chain; thus, a methyl group is installed in α-position. 
Furthermore as in the previous case (Scheme 37) an ester function in α’-position could 
be introduced like 93 (Figure 7). 
 
 
 
 
 
 
 
Figure 7: 2-allyl-2-methyl-cyclohexanone (92) and ethyl 3-allyl-3-methyl-2-oxo-
cyclohexane carboxylate (93). 
OO
α αα´ α´
O
O
92 93
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a. Synthesis of 2-allyl-2-methyl-cyclohexanone (92) 
While the alkylation reaction of β-ketoesters is easily performed without any further 
activation of the carbonyl group, the alkylation at the more hindered α-site of 
unsymmetrical cycloalkanones such as the 2-methyl-cyclohexanone (94) could require 
the generation of enolates as intermediates. Silyl enol ethers99 are introduced as 
precursors of specific enolates. They have several advantages over other enol 
derivatives, not the least being the ease with which specific silyl enol ethers can be 
prepared from unsymmetrical ketones100,101. Making use of quoted procedures 
recommended by House and co-workers100 for the preparation of the silyl-enol ether 
under kinetic control, the compound 96 is selectively formed from 94 by using first 
lithium diisopropyl-amide102, to generate the lithium enolate, and then O-silylating with 
chlorotrimethylsilane (95). Moreover as indicated by Fleming and Paterson103, high 
conversion and regioselectivity can be achieved into the lithium enolate formation if the 
reaction is carried out at -78 °C. Thus, in only 2 h the silyl enol ether 96 is obtained in 
85 % of yield (whereas the 'thermodynamic' silyl-enol ethers is formed after 5 days)103 
using TMSCl (95) and LDA as base104 (Scheme 38, R 52).  
 
 
Scheme 38: Synthesis of 2-allyl-2-methyl-cyclohexanone (92). 
 
The alkylation on more substituted α-position takes place if the silyl enol ether 96 is 
treated with allylbromide 66 as alkylating agent and t-BuOK105. The reaction proceeds 
via alkali-enolates104 (R 53) which can be easily generated from 96 by cleavage of the 
oxygen-silicon bond with alkali-potassium enolate (Scheme 38). Thus, the alkylated 
product 2-allyl-2-methylcyclohexanone (92) is synthesized in 89 % yields.  
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b. Preparation ethyl 3-allyl-3-methyl-2-oxo-cyclohexane carboxylate (93) 
As previously described, the electron-withdrawing ester function could be introduced in 
α’-position of the 2-allyl-2-methyl-cyclohexanone (92) via a procedure analogously 
performed for the preparation of 1,3-dicarboxylates as depicted in Scheme 37. Then, 
ethyl 3-allyl-3-methyl-2-oxo-cyclohexane carboxylate (93) is synthesized in 85 % yield 
by adding on 92 of diethylcarbonate (82) and NaH as base98 (Scheme 39, R 54). 
 
 
Scheme 39: Synthesis of ethyl 3-allyl-3-methyl-2-oxo-cyclohexane carboxylate (93).  
 
 
c. Tandem hydroformylation/ aldol addition of ethyl 3-allyl-3-methyl-2-oxo-
 cyclohexane carboxylate (93) 
Starting with the ethyl 3-allyl-3-methyl-2-oxo-cyclohexane carboxylate  (93) bearing a 
α-allyl substituent the sequential hydroformylation/ aldol addition is carried out in the 
presence of p-TsOH under mild conditions of 20 bar, 60 °C and for 3 days (Scheme 
40). The reaction proceeds with formation of three products 97, 99 and 100 in a ratio of 
7.2:1:5 (detected by 1H-NMR analysis) respectively, where, the major component is the 
bridged compound 97 isolated in 32 % yield (R 55). 
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Scheme 40: Tandem hydroformylation/ aldol addition of ethyl 3-allyl-3-methyl-2-oxo-
cyclohexane carboxylate (93). 
 
In analogy to the one-pot hydroformylation/ aldol addition of 1,3-di-ester 83b (Scheme 
37), predominately the iso-isomer ethyl-3-methyl-3-(2-methyl-3-oxo-propyl)-2-oxo-
cyclohexane carboxylate (98) is generated, which could readily undergo cyclization to 
form ethyl 2-hydroxy-3,5-dimethyl-9-oxo-bicyclo[3.3.1]nonane-1-carboxylate (97) 
(Scheme 40). Once again, in the presence of ester function in α’-position the formation 
of iso-aldehyde could be explained if considering the kinetics and energetics of the 
hydroformylation sequence. As side products the fused bicyclic adducts ethyl-3-formyl-
7a-methyl-2,4,5,6,7,7a-hexahydro-1H-indene-4-carboxylate (99) and ethyl-3-formyl-
7a-methyl octahydro-1H-indene-4-carboxylate (100), resulting from the reaction of n-
aldehyde, are detected.  
For the formation of branched aldehyde 98 (Scheme 40) as predominant intermediate 
the insertion step should be considered as reversible, dependent on reaction conditions. 
A potential scheme showing the competition between the backward reaction and the 
complexation of CO reaction is shown in Scheme 41. At low temperatures and 
sufficiently high pressures the formation of 2-alkyl species from 1-alkenes 93 (Scheme 
40) or 83b (Scheme 37) can also be irreversible. The barriers for the backwards reaction 
(β-elimination) and forward reaction (CO complexation) drawn at about the same height 
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indicate the competition between the two steps. β-elimination may lead to 2-alkene, 
which forms a less stable complex than 1-alkene (not shown).  
Clearly, energy differences are very small and entropy and concentrations will have 
large influence on the actual kinetics106. 
 
Scheme 41: Reversible migratory insertion of alkenes to 2-alkyl-rhodium species. 
 
d. Tandem hydroformylation/ aldol addition of 2-allyl-2-methyl-
 cyclohexanone (92). 
If the 2-allyl-2-methyl-cyclohexanone (92) is investigated the reaction proceeds 
exclusively with n-selectivity leading to 3a-methyl-3,3a,4,5,6,7-hexahydro-2H-indene-
1-carbaldehyde (101) in 93 % yield (Scheme 42, R 56). 
 
 
 
 
 
 
 
Scheme 42: Tandem hydroformylation/ aldol addition of 2-allyl-2-methyl-
cyclohexanone (92). 
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Again, according to the results observed with unsaturated β-ketoesters 4a,b (Scheme 
32), an aldol condensation on the ketone function occurs resulting in the formation of 
the “kinetic” aldol adduct regardless the functional group (ester or methyl groups) in 
the α-position. 
 
 
2.4.4 Tandem hydroformylation/ aldol addition of ethyl 3-alkenyl 2-oxo-
 cyclohexane carboxylates. 
 
As previously reported a low tendency of the α´-position to the intramolecular 
condensation is observed when the substituent R2 = H (Scheme 32 and Scheme 40). On 
the other hand, activating groups such as an ester function installed in such position, 
resulting in the formation of iso-product. All attempts to influence the chemoselectivity 
of the aldol addition by introduction of activating or blocking groups (Me, COOEt) in 
α- or α’-position, towards the synthesis of bicyclic compounds of type 56 (Scheme 35) 
failed. Further studies in order to find out if the substituents in α-position combined 
with the α’-position one could influence the outcomes of the reaction have been 
conducted. Then, in absence of such blocking group, β-ketoester of type 55 (R1 = H, R1 
= COOEt, Scheme 35) bearing an olefinic chain in α-position seems to be the available 
starting material. 
 
2.4.5 Preparation of ethyl 3-alkenyl-2-oxo-cyclohexane carboxylates. 
 
Hauser and al.107 reported that treatment of β-ketoesters with 2 eq. of a strong base 
followed by the appropriate alkylating agent108 furnished the alkylation of the more 
reactive enolate. Following this procedure starting from 65b, the 1,3-dianion generated 
by LDA109 could readily react with alkylating agents (Scheme 43) such as allylbromide 
(66) or homoallybromide (67). According to the results compiled in Table 12 (R 57), 
the ethyl 3-allyl-2-oxo-cyclohexane carboxylate (102) is obtained in high yield, 
whereas the reaction to form the corresponding homoallyl product 103 proceeds with 
considerably lower yields (24 %) (R 58). 
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Scheme 43: Synthesis of ethyl 3-alkenyl-2-oxo-cyclohexane carboxylates (102 and 
103). 
 
Table 12: Synthesis of ethyl 3-alkenyl-2-oxo-cyclohexane carboxylates (102b and 103b)  
Reaction Starting Mat. Length chain (m) Product dra Yields (%) 
R 57 65b 66 (m = 1) 102 2.5:1 82 
R 58 65b 67 (m = 2) 103 3:1 24 
a) By NMR analysis. 
 
a. Tandem hydroformylation/ aldol addition of ethyl 3-allyl-2-oxo-
 cyclohexane carboxylate (102) 
Beginning with compound 102 the tandem hydroformylation/ aldol addition is 
performed under mild conditions (CO/H2 20 bar, 60 °C for 3 days) (Scheme 44, R 59). 
The reaction proceeds through an aldol addition resulting in the formation of 
inseparable mixture of spiro compound 104, the fused aldol adducts like 105 and its 
hydrogenated derivative 106 are observed in a ratio of 20:3.2:1 as determined by NMR. 
 
 
Scheme 44: Tandem hydroformylation/ aldol addition on ethyl 3-allyl-2-oxo-
cyclohexane carboxylate (102). 
 
OO
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dry THF
α αα´ α´EtOOCBr
+ (   )m
(   )m
65b 66 (m = 1) 102 (m = 1)
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α
OHC
O
A: CO/H2 20 bar (1:1), Rh(acac)(CO)2, BIPHEPHOS, PTSA, dry CH2Cl2, T = 60 °C, t = 72 h
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Several interesting conclusion could be drawn from the results depicted in Scheme 44. 
Cycloalkanones bearing an ester function in α’-position and monosubstituted in α-
position with an olefinic chain undergo intramolecular aldol addition to give the spiro 
compound 104. As side products, minor amounts of fused compounds 105 and 106 are 
observed. Then, according to Hollmann’s results73, the α-position appears to be the 
most reactive if such site of the cycloalkanone is monosubstituted. Moreover, in 
contrast to the results obtained with the unsaturated 1,3-diester cycloalkanone 83b 
(Scheme 37) and unsaturated α’-ester cycloalkanone 93 (Scheme 40), where only the 
aldol adduct is formed by the iso-isomer, regiocontrolled reaction towards the 
formation of n-aldehyde is accomplished. 
 
 
b. Tandem hydroformylation/ aldol addition on ethyl 3-(but-3-enyl)-2-oxo-
 cyclohexane carboxylate (103) 
 
Continuing these investigations ethyl 3-(but-3-enyl)-2-oxo-cyclohexane carboxylate 
(103) is hydroformylated in the presence of p-TsOH under mild conditions in a yield of 
40 %. According to the latter results, the aldol addition occurs in α-position, resulting 
in the formation of ethyl 7-hydroxy-1-oxo-spiro[5.5]undecan-2-carboxylate (107). The 
formation of the spiro-compound 107 is accompanied by the linear aldehyde 108 as a 
mixture in a ratio of 1:1 (Scheme 45, R 60). 
 
Scheme 45: Tandem hydroformylation/ aldol addition on ethyl 3-(but-3-enyl)-2-oxo-
cyclohexane carboxylate (103). 
 
All the most significant results obtained under tandem hydroformylation/ aldol addition 
conditions are compiled in Table 13: 
 
CO/H2 1:1 (10/10 bar)
PTSA
dry CH2Cl2
Rh(acac)(CO)2
BIPHEPHOS
T = 60 °C
t = 72 h
O
αα´
O
αα´
OH
O
αα´
OHC
EtOOC EtOOC EtOOC
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Table 13: Summary of tandem hydroformylation/ aldol addition results  
R2 = H R2 = COOEt 
R1 
m n 
Starting 
material 
Product m n 
Starting 
material 
Product 
0 
1 
COOEt
O
(   )n
72a (65 %) 
72b (79 %)a 
1 
O
HO
EtOOC
 
85 (37 %) 
2 
3 
1 
4 
O
COOEt
(   )n
4a-e O
COOEt
O
(   )n
70c-d 
1 
2 
O
COOEtEtOOC
(   )n
83b,c 
 O
EtOOC
COOEt
O
 
88 (98 %) 
0 
1 
2 
C
O
O
E
t 
2 
4 
O
COOEt
(   )n
68a-c,e 
O
COOEt O
(   )n
71a-c,e 
2 2 
O
EtOOC
COOEt
84 
O
EtOOC
COOEt
O
 
90 (90 %) 
Me 1 1 
O
92 
O
 
101 (93 %) 
1 1 
O
EtOOC
 
93 
O
HO
EtOOC
 
97 (32 %) 
1 
H 1 
0 
1 
3 
O
(   )n
47a-cc 
O
OH(   )n  
48a (71%)c 
48b (51 %)c 
48c (61 %)c 
2 
1 
O
EtOOC (   )m
 
102 
103 
O
EtOOC
OH
(   )m
 
104 (45 %) 
107 (40 %) 
( ) = Yield; a) Including amounts of the corresponding hydrogenated compound 76b; b) Including amounts of the 
corresponding branched aldehydes 79a (m = 2; n = 0) and 79b (m = 2; n = 1) respectively; c) C. Hollmann results73. 
CO/H2 20 bar (1:1)
PTSA, dry CH2Cl2
Rh(acac)(CO)2
BIPHEPHOS
T = 60 °C, t = 72 h
O
αα´
R1
R2 (   )m
(   )n
55
(28)
(29)
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As it can be seen from Table 13 the results obtained under sequential hydroformylation/ 
aldol addition conditions could be ordered with regard to the substituent in α’- position: 
 
1. When in α’- position R2 = H: 
 
• Fused aldol bicycles 72a,b are formed when five-, six-membered rings bearing 
an allyl side chain are used, whereas larger rings proceed with high n-
regioselectivity in the hydroformylation step, towards the formation of n-
aldehydes 70c,d.  
• Increasing the chain length, no aldol adduct is observed regardless of the ring 
size; only linear aldehydes are isolated 71a-c,e.  
• Less bulky substituent in α-position such as a methyl group does not influence 
the chemoselectivity of the aldol reaction and again a fused aldol product like 
101 is formed if 2-allyl-2-methyl-cyclohexanone is used. 
• Cycloalkanones mono-substituted in α-position (Scheme 17), react through an 
aldol addition resulting in the formation of spiro-compounds 48a-c.  
 
 
2. When in α’-position R2 = COOEt: 
 
• As the bridged bicyclo[3.3.1]nonane systems 85 and 97, are formed regardless 
of the substituent in α-position (CH3, COOEt) of the six-membered ring used; a 
loss of regioselectivity is observed in the hydroformylation step.  
• No aldol adduct is formed starting from larger rings, instead, only linear 
aldehyde derivatives 88 and 90 are obtained.  
• Spiro compounds 104 and 107 are formed if monosubstituted α-position 
cycloalkanones are converted73.  
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2.5 Attempts of sequential hydroformylation/ Mukaiyama 
aldol addition of silyl enol ethers 
2.5.1 Introduction 
As it has been concluded from the results reported in the last section and depicted in 
Scheme 46, the sequential hydroformylation and acid–catalyzed aldol addition appears 
to be an effective method towards the preparation of fused aldol adducts like 72a,b and 
101 (Schemes 32 and 42) or bicycles such as 85 (Scheme 37) and 97 (Scheme 40). On 
the other hand, the procedure has proved to be less useful when the construction of 
bicyclic alkanones of type 56 is required. Therefore, investigations have to be 
conducted by performing an alternative activation of the carbonyl group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 46: Cyclization obtained by tandem hydroformylation/ aldol addition.  
 
House and Mukaiyama published a general method to accomplish cross-aldol additions 
starting from silyl enol ethers of various carbonyl compounds, which react with 
aldehydes and ketones in the presence of titanium tetrachloride under mild conditions. 
Such silyl enol ethers possess significant nucleophilic character owing to electron 
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donation to the alkene π-system derived from resonance interaction with the oxygen ion 
pairs110,111 and a high degree of chemoselectivity112 could be achieved. Silyl enol ethers 
on one hand are reported to be stable against hydroformylation conditions20 and 
directed aldol addition113 can be catalyzed by a large number of transition metal 
complexes71. Rhodium (I) complex catalyzed reactions of enol-silanes III and 
aldehydes A, are investigated by Matsuda88,114,115, Reetz69 and Heathcock67; the latter 
showed in detail the catalytic mechanism using a rhodium complex (Scheme 47). 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 47: Catalytic cyclic in the Rh-catalyzed aldol addition. 
 
The aldehyde A reacts with the rhodium enolate I giving the rhodium aldolate II, 
successively through silyl transfer from the enolsilane III the final adduct B is formed. 
Following these observations, Eilbracht et al.66 accomplished an intramolecular aldol 
addition of unsaturated silyl enol ethers under hydroformylation conditions in a one-pot 
procedure catalyzed by a rhodium (I) complex (Scheme 48). Sequential 
hydroformylation and intramolecular aldol addition of silyl enol ethers of type 109 
bearing remote olefinic functionalities give β-silyloxy substituted cyclic ketones of type 
111 (Scheme 48).  
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Scheme 48: Tandem hydroformylation/ Mukaiyama aldol reaction of silyl enol ethers. 
 
In previous investigations using [Rh(cod)Cl]2 (41) as catalyst66, starting from 
unsaturated silyl enol ethers of type 112 six-membered rings of type 113, as depicted in 
Scheme 49, by converting only one of the two different double bonds are obtained.  
 
 
 
 
 
 
Scheme 49: Silyl enol ether in intramolecular aldol addition.  
 
The overall procedure described above can be used for completely different substrates 
such as the unsaturated enol silane 114 to give naphthol derivatives 115 and 116 
(Scheme 50). In this case the intermediate product undergoes desilylation and 
dehydration followed by tautomerisation of the enone form to the more stable 
derivatives 115 and 116. 
 
 
Scheme 50: Intramolecular aldol addition of trimethylsilyl enol ether 114.  
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To investigate this procedure a number of enolsilane of cycloalkanones of type 24 (4a,b 
with R = COOEt; m = 1; n = 0, 1; or 68a-c with R = COOEt; m = 2; n = 0, 1, 2) were 
used to study the one-pot hydroformylation/ aldol addition have been prepared and 
exposed to the hydroformylation conditions (Scheme 51). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 51: Tandem hydroformylation/ aldol addition of silyl enol ether compounds of 
type 117. 
 
 
2.5.2 Attempts of rhodium-catalyzed Mukaiyama aldol addition 
a. Preparation of TMSilyl enol ethers of ethyl 1-allyl-2-oxo-cycloalkane 
 carboxylates (4a,b) 
Denmark’s investigations116 showed the high efficiency of the aldol addition chemistry 
of trichlorosilyl enolates and trimethylsilyl enolates derived from ketones. They are 
effective aldol reagents in the absence of additives, reacting with aldehydes at ambient 
temperature to provide high yields of aldol adduct. A general preparative method for 
the synthesis of silyl enol ethers involved preliminary treatment of ketones with bases 
of sufficient strength to convert the ketones completely into their enolate anions. 
Subsequent reaction of the enolate anion(s) with excess of trimethylsilyl chloride 
produces the O-silylated product. The preparation of enolates of unsymmetrical ketones 
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of type 117 (Scheme 51) could be achieved by controlling the reaction conditions. 
House and co-workers100 report silyl-enol ethers, under kinetic control, are very 
selectively formed from ketones by using first lithium diisopropylamide to generate the 
lithium enolate and then O-silylating with chlorotrimethylsilane. Paterson and al.103 
found that the method could be improved by generating the lithium enolate at -78 °C 
and by avoiding the aqueous work-up giving high yields and regioselectivities. House 
et al. found that silyl enol ethers, under thermodynamic control, are best prepared by 
equilibrating the mixture of silyl enolates formed by treating the ketone with 
triethylamine and chlorotrimethylsilane in dimethylformamide. The equilibration is 
done simply by heating the reaction mixture under reflux for hours or days. 
Following these observations and taking into account the investigations proposed here, 
applying House’s procedure100 silyl enol ethers 120a,b (Scheme 52) of type 117 
(Scheme 51) are synthesized in the presence of trialkylsilane such as chloro 
trimethylsilane (TMSCl) (95) under kinetic control at -78 °C for 4 hours. The results 
are listed in Table 14.  
 
 
 
 
 
 
 
Scheme 52: Preparation of trimethylsilyl enol ethers 120a,b from ethyl 1-allyl-2-oxo-
cycloalkane carboxylates (4a,b). 
 
Table 14: Preparation of trimethylsilyl enol ethers 120a,b 
Reaction n Starting Mat. Product Yields % 
R 61 0 4a 120a 96 
R 62 1 4b 120b 91 
 
Both the compounds are obtained in high yield after filtration of LiCl salts through a 
short pad of neutral alumina (R 61 and R 62). 
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b Hydroformylation of α´,β- unsaturated silyl enol ethers (120a,b) 
In order to evaluate the behavior of these silyl enol ethers towards the Mukaiyama aldol 
addition, the compounds 120a,b are subjected to the standard conditions, previously 
optimized66 (Scheme 49 and 50). The reactions are carried out in the presence of 
[Rh(cod)Cl]2117 (41) as catalyst species under 80 bar of syn-gas pressure CO/H2 (1:1) at 
90 °C for 3 days (Scheme 53). After filtration on a short pad of alumina, which is used 
as standard neutral work up which can avoid any type of decomposition such as 
desilylation or retro-aldol reaction, the crude reaction mixture is analyzed. In contrast to 
the preliminary results upon these conditions, the aldol addition does not take place and 
a mixture of linear aldehydes 70a,b and branched ones 77a,b is obtained in high yield 
(Table 15, R 63 and R 64). 
 
 
Scheme 53: Tandem hydroformylation/ Mukaiyama addition on 120a,b. 
 
Table 15: Tandem hydrofromylation/ aldol addition of silyl enol ethers 120a,b 
Reaction n Starting Mat. Product Yields % 
R 63 0 120a 70a (22)a 77a (1)a 95 
R 64 1 120b 70b (8)a 77b (1)a 90 
Conditions: 1 % - mol [Rh(cod)Cl]2, DCM, T = 90 °C, t = 72 h a) by 1H-NMR analysis. 
 
The results show that the trimethylsilyl enol ether is too labile under these 
hydroformylation conditions and consequentially the formation of rhodium enolate 
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cannot take place. The King and Iqbal118 infrared spectroscopic investigations on the 
alkylrhodium tetracarbonyl derivatives could be useful to explain the loss of the 
TMSilyl group: here at elevated pressures the [Rh(CO)2Cl2] and the ethene, HCl is 
formed (Scheme 54).  
 
 
 
Scheme 54: King and Iqbal investigations on the alkylrhodium tetracarbonyl 
derivatives. 
 
Similarly, [Rh(cod)Cl]2 (41) under the sequential hydroformylation/ Mukaiyama 
addition conditions could generate the tetracarbonylrhodium hydride (123) (Scheme 
55) species with formation of HCl, as well as the previous [Rh(CO)2Cl2], which is able 
to remove the trimethylsilyloxy function.  
 
 
 
 
Scheme 55: Generation of the tetracarbonylrhodium hydride (123). 
 
From these observations, it could be concluded that a preparation of more stable silyl 
enol ether or the change of the catalyst species has to be accomplished. 
 
 
b. Preparation of TBDMSilyl enol ethers of ethyl 1-alkenyl-2-oxo-cycloalkane 
 carboxylates (125a-c and 126a,b) 
To overcome the problems described above, more stable silyl ethers119 such as tert-
butyldimethylsilyl enol ethers are found to be more stable to hydrolysis than 
trimethylsilyl enol ethers by a rate factor of 104 and they are compatible with a much 
wider range of reagents used in organic synthesis. Therefore, under the conditions 
applied for the preparation of TMSilyl-enol the reactions of compounds 4a-c with 
chloro tert-butyldimethlysilane (124) (TBDMSCl) proceeds with good yields (Scheme 
56) into the silyl compounds 125a,c (Table 16, R 65-67). Besides these allyl silyl-enol 
[Rh(CO)2Cl]2 + 4CO + 2H2 + 2C2H4 2C2H5Rh(CO)4 + 2HCl
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41
CO
-(cod)
[Rh(CO)2Cl]2 -HCl HRh(CO)4
122 123
                    Results and Discussion 
 68
ethers, homoallyl cycloalkanones 68a,b were used to form the corresponding 
TBDMSilyl enol ethers 126a,b in high yields (Table 16, R 68-69). 
 
 
 
 
 
 
 
 
Scheme 56: Preparation of tert-butyldimethylsilyl enol ethers from ethyl 1-alkenyl-2-
oxo-cycloalkane carboxylates (4a-c) and (68a,b). 
 
Table 16: Preparation of tert-butyldimethylsilyl enol ethers 125a-c and 126a,b 
Reaction m n Starting Mat. Product Yields % 
R 65 1 0 4a 125a 90 
R 66 1 1 4b 125b 73 
R 67 1 2 4c 125c 85 
R 68 2 0 68a 126a 98 
R 69 2 1 68b 126b 96 
 
 
c. Attempts of tandem hydroformylation/ Mukaiyama aldol addition of 
 allylated TBDMSilyl enol ethers (125a-c) 
All these silyl enol ethers 125a-c and 126a,b (from Scheme 56) have to be 
hydroformylated under standard conditions to evaluate the behavior of these 
compounds towards the Mukaiyama aldol addition. 
Similar results to TMSilyl-enol ethers (Scheme 53) are observed upon filtration of the 
crude reaction mixture through a small pad of alumina. Indeed, if compounds 125a-c 
(Scheme 57) are treated with 1 mol % of [Rh(cod)Cl]2 under 80 bar of CO/H2 at 90 °C 
for 2 days. Only a mixture of linear aldehyde 127a,b and branched isomers 128a,b is 
obtained in high yield (Table 17, R 70 and 71), whereas the reaction starting from 
compound 125c proceeds with high regioselectivity towards the n-aldehyde 127c but 
LDA
TBDMSCl (124)
dry THF
O
(   )n
α´ α
OTBDMS
(   )n
α´ αCOOEt COOEt
4a-c 125a-c(m = 1, n = 0-2) (m = 1, n = 0-2)
68a,b 126a,b(m = 2, n = 0,1) (m = 2, n = 0,1)
(  )m(  )m
                    Results and Discussion 
 69
with drastically lower yield (Table 17, R 72). Again no Mukaiyama aldol adducts 
(129a-c) are obtained but here the TBDMSilyl function is maintained whereas the TMS 
group is lost as shown in Scheme 53. 
 
 
Scheme 57: Tandem hydroformylation/ Mukaiyama cyclization of TBDMSilyl enol 
ethers 125a-c. 
 
Table 17: Tandem hydroformylation/ Mukaiyama addition of silyl enol ethers 125a-c 
Reaction n Starting Mat. Product Yields % 
R 70 0 125a 127a (1.2)a 128a (1)a 94 
R 71 1 125b 127b (1.5)a 128b (1)a 92 
R 72 2 125c 127c -- 23 
Reaction conditions: 1 % - mol [Rh(cod)Cl]2, CO/H2 80 bar (1:1), dry DCM, T = 90 °C, t = 72 h; a) by 1H-NMR 
analysis. 
 
 
d. Attempt of tandem hydroformylation/ Mukaiyama aldol addition of 
 homoallylated TBDMSilyl enol ethers (126a,b).  
Upon the previous reaction conditions, the homoallylated TBDMSilyl enol ethers 
126a,b with 5 and 6 membered ring are tested. Although a more stable silyloxy 
function is employed under these reaction conditions, again no Mukaiyama aldol 
adduct products like 132a,b are detected. The 126a,b do not undergo aldol addition and 
again a mixture of n-aldehydes 130a,b and iso-isomers 131a,b of the remote double 
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bond is generated in the hydroformylation step (Scheme 58). The results are 
summarized in Table 18. 
 
 
Scheme 58: Attempted tandem hydroformylation/ aldol addition, under Mukaiyama 
conditions, of compounds 126a,b. 
 
Table 18: Attempted tandem hydroformylation/ aldol addition of compounds 126a,b 
under Mukaiyama conditions  
Reaction n Starting Mat. Product Yields % 
R 73 0 126a 130a (7)a 131a (1)a 75 
R 74 1 126b 130b (4.5)a 131b (1)a 85 
Reaction conditions: 1 % - mol [Rh(cod)Cl]2, CO/H2 80 bar (1:1), dry DCM, T = 90 °C, t = 72 h; a) 1H-NMR 
analysis. 
 
Based on all these negative results, the cyclization via silyl-enol ether should be 
performed via stepwise procedure by the use of Lewis acids120.  
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2.5.3 Enol ethers in the stepwise hydroformylation/ aldol cyclization under 
Mukaiyama conditions 
As mentioned in the introduction, Mukaiyama115,121 and shortly thereafter House122, 
published a general method to accomplish cross-aldol addition starting from silyl enol 
ethers of various carbonyl compounds which could react with aldehydes and ketones in 
the presence of titanium tetrachloride under mild conditions. Titanium tetrachloride is 
found to generate the active eletrophilic species as results of its strong interaction with 
carbonyl compounds, and the complex thus formed would react easily even with 
relatively weak carbon nucleophiles (such as enol ethers)123. 
 
 
 
 
 
Scheme 59: Aldol addition in the presence of TiCl4. 
 
As depicted in Scheme 59, the aldol reaction between silyl enol ether of acetophenone 
134 and benzaldehyde 133 in the presence of titanium(IV)tetrachloride afforded the 
aldol product 135 in high yields115,121. Further studies of this reaction reveal a number of 
advantages over conventional methods. First, it not only gives a variety of aldol adducts 
in high yield but also a regioselective aldol adduct when the silyl enol ether of an 
unsymmetrical ketone is used. That is, the aldol reaction proceeds with retention of the 
regiochemical integrity of the starting silyl enol ethers to afford the corresponding aldol 
regiospecifically. Starting silyl enol ethers 136 can be conventionally prepared 
regioselectively under kinetical or thermodynamical control. Second, functional group 
selectivity is observed i.e. reactions with aldehydes proceeds at -78 °C whereas those 
with ketones proceed at elevated temperatures (ca 0 °C). Chemoselectivity is observed 
with acceptors having two different kinds of carbonyl function, for example aldehyde 
and ketone or ester, in the same molecule. 
Ketoester 136 and silyl enol ether 137 give the hydroxyketoester 138 as sole product124 
(Scheme 60). 
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Scheme 60: Chemoselectivity of aldol addition when keto esters of type 136 and TiCl4 
are used. 
 
A direct aldol reaction between two ketones affords thermodynamically unfavourable 
aldols in high yields due to of stabilization of the aldol adducts intramolecular chelation 
of type 142 with titanium (Scheme 61). 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 61: The step-wise Mukaiyama aldol addition reaction of enolsilanes of type 139 
with aldehydes or ketones. 
 
From mechanistic aspects, silyl enol ethers of type 139 could readily attack a carbonyl 
compound like 140 activated by titanium tetrachloride in a nucleophilic fashion to form 
trimethylsilyl chloride and an intermediate chelate of type 142. Hydrolysis of this 
intermediate should then afford aldol of type 143. Despite its remarkable power as a 
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method for carbon-carbon bond formation, the level and sense of its stereoselectivity 
often vary. The syn/anti ratio for the aldol products 146 and/or 147 (Scheme 62) is 
affected by the stereochemistry of the aldehyde and silyl enolate, and the character of 
the Lewis acid catalyst125. However the stereochemical observations have been 
rationalized by considering an acyclic transition state126. 
 
 
Scheme 62: Lewis acid-catalyzed aldol reaction of silicon enolates. 
 
 
a. Preparation of ethyl 2-(tert-butyl-dimethyl-silanyloxy)-1-(4-oxo-butyl)-
 cyclohex-2-ene-carboxylate (127b) 
For initial investigations on the formation of bridged systems, the hydroformylation of 
the unsaturated silyl enol ether 125b is performed with a catalytic amount of 
Rh(acac)(CO)2 (28) in CH2Cl2 under 20 bar of CO/H2 at 60 °C. The regioselectivity of 
the reaction is successfully achieved by use of 5 mol % of BIPHEPHOS (29) giving 
exclusively the n-aldehyde 127b in 88 % of yield (Scheme 63, R 75). 
 
 
 
 
 
 
 
 
Scheme 63: Synthesis of ethyl 2-(tert-butyl-dimethyl-silanyloxy)-1-(4-oxo-butyl)-
cyclohex-2-ene-carboxylate (127b). 
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b. Intramolecular aldol addition catalyzed by TiCl4: synthesis of ethyl 5-
 hydroxy-10-oxo-bicyclo[4.3.1]decane-1-carboxylate (73b) 
As stated in the introduction under mild conditions (TiCl4, DCM at room temperature) 
cross-aldol addition could be performed in good yields121,127. According to these 
observations, the reaction on 127b compound proceeds with retention of regiochemical 
integrity of the starting silyl enol ethers121 to afford the corresponding crossed aldol 
73b in 73 % yield (Scheme 64). 
 
 
 
 
 
 
 
Scheme 64: Synthesis of ethyl 5-hydroxy-10-oxo-bicyclo[4.3.1]decane-1-carboxylate 
(73b). 
 
The different outcome of the attempts to perform one-pot hydroformylation/ 
Mukaiyama aldol additions could be explained according to the Bouillon’s 
investigations128. Indeed, in the intramolecular aldol reaction of silyl enol ether of type 
127b (Scheme 64), the Lewis acid could catalyze the reaction decreasing the 
intermediate energetic barrier.  
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2.6 Sequential enolboration/ hydroformylation/ aldol 
addition reactions 
2.6.1 Introduction 
 Efforts towards the synthesis of bridged bicycles of type 56 with various ring 
sizes (Scheme 46) via intramolecular regio- and chemoselective aldol processes 
followed by a regioselective n-hydroformylation in a one-pot reaction failed although 
silyl enol ethers via Mukaiyama conditions were employed (previous chapter). Thus, 
continuing the investigations of C–C bond forming reactions under the conditions of 
Rh-catalysed hydroformylation, other methods starting with activated enolates will be 
considered. 
Boron enolates are highly versatile intermediates in organic synthesis129 and because of 
their high reactivity they are used as important intermediates in organic synthesis130,131. 
Direct generation of these species from carbonyl compounds could be useful for 
expanding the synthetic utility of boron enolates–mediated aldol reaction. One of the 
methodologies towards the preparation of boron enolates involves the reaction of 
ketones with a suitable organoboron derivative, R2BX in the presence of a suitable 
tertiary amine (Scheme 65). It has been thought that increasing the Lewis acidity of 
boron by introducing an excellent leaving group on the boron would result in an 
increase in acidity of the carbonyl compounds by coordination of a carbonyl group to 
the boron compound. The corresponding boron enolate would be formed by abstraction 
of the α-proton of the carbonyl compound with a weak base such as a tertiary amine of 
variable steric requirements. Ganesanet et al.132 in a study of the effects of amine, 
solvent, concentration, temperature and other reaction parameters controlling the 
enolate geometry observed the interaction of tertiary amines of variable steric 
requirements with R2BX such as dicyclohexylchloroborane (cy-hex)2BC1 (159) (Figure 
8). The results suggest that the smaller amines coordinate strongly with (cy-hex)2BC1 
while the more bulky amines do not. These amines have also been examined for the 
enolboration in order to understand the effect of the steric requirements of the amine on 
the enolate geometry. While the smaller amines favor formation of E(O)-boron enolate, 
the more hindered amines favor formation of the isomeric Z(O)-boron enolate. 
Triethylamine could be chosen as one of the best amines in terms of yield and 
selectivity. In addition, Evans133 has systematically studied the aldol stereoselection of 
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boron enolates and established that Z(O)-boron enolates give syn aldols and E(O)-boron 
enolates give anti aldols stereoselectively (Scheme 65). 
 
 
 
 
 
 
 
 
Scheme 65: Aldol stereoselection of boron enolates. 
 
The boron enolate-mediated aldol addition proceeds via a more rigid chair-like six-
membered transition state than those of alkali metal enolate, because of a shorter bond 
length between boron and oxygen (Scheme 66). That is, dialkylboron enolates have 
relatively short metal-ligand and metal-oxygen bonds, which are suited to maximizing 
1,3-diaxal (R3-L) interaction syn the transition state. This facilitates the formation of 
more stable transition state (150 and 153), where R3 occupies a pseudo equatorial 
position, when vinyloxyboranes (148 and 152) react with aldehydes to afford aldol 
adducts (151 and 154). 
 
Scheme 66: Stereoselection aldol addition of Z(O) or E(O)-boron enolates and 
aldehydes. 
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Keränen’s previous investigations134 concerning the sequential enolboration/ 
hydroformylation/ aldol addition (Scheme 67) with unsaturated ketoesters suggest that 
the (cy-hex)2BC1 (159) (Figure 8) is a an effective enolborane132,135 precursor and 
triethylamine (TEA)132 is a good tertiary amine in the boron enolates formation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 67: Synthesis of 6- and 7-membered ring carbocycles 156 and 158 from 
ketoesters 155 and 157. 
 
The generation of 6- and 7-membered ring carbocycles like 156 and 158 was attempted 
by applying the ketoesters 155 and 157. In the case of 155, the desired cyclization 
product ethyl 6-hydroxy-1,3,3-trimethyl-2-oxo-cyclohexane carboxylate (156) was 
obtained in 82 % isolated yield as a 2.5:1 mixture of diastereoisomers. Another 
encouraging result was obtained when ketoester 157 if subjected to the same conditions, 
resulting in the formation of the 7-membered ring of methyl 2-hydroxy-1-methyl-7-
oxocycloheptane carboxylate (158) as the sole product in 89 % yield as a 6:1 mixture of 
diastereoisomers (Scheme 67). Notably, the boron enolate tolerates the 
hydroformylation conditions and reacts immediately with the aldehyde group, thus 
preventing unwanted side reactions. 
Moreover, when ligands are required to accomplish a regioselective hydroformylation 
reaction, the process tends to favor the use of the diphosphine XANTPHOS 
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(160)44,136,40 (Figure 8) as bidentate ligand to afford the n-aldehyde allowing higher 
temperatures than those tolerated by BIPHEPHOS (29).  
 
 
 
 
 
 
Figure 8: (cy-hex)2BC1 (159) and XANTPHOS (160) molecular structures. 
 
The suitability of this method to form functionalized β-hydroxycycloalkanones bearing 
α-quaternary centres in high yields and good diastereoselectivities is particularly 
attractive in the synthesis of some natural cyclic compounds. Thus, unsaturated 
cycloalkanones of type 161 (Scheme 68) undergo tandem hydroformylation/ aldol 
addition via in situ generated boron enolates in the presence of 1 mol % of 
Rh(acac)(CO)2 (28), 1.8 mol % XANTPHOS (160), (cy-hex)2BCl/ TEA in DCM134.  
 
 
Scheme 68: Boron enolates of 2-allyl-cyclohexanone derivatives of type 161 towards 
the formation of bridged compounds of type 163. 
 
 
a. Conversion of ethyl 1-allyl-2-oxo-cyclohexane carboxylate (4b)  
Starting to test the methodology on the unsaturated cycloalkanones, the ethyl 1-allyl-2-
oxo-cyclohexanone carboxylate (4b) boron enolate is in situ generated smoothly by 
treating of cycloalkanone with NEt3 as base, and (cy-hex)2BCl at 0°C, under argon 
atmosphere (Scheme 69, R 77). After approximately 40 minutes Rh-catalyst is added 
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and the reaction is carried out under 80 bar of CO/ H2 (1:1) for 24 hours at 90°C. The 
oxidative work-up137 of crude mixture, consistent of boron chelate and ammonium salts 
and working under neutral conditions, aldol adducts are isolated. The regulation of the 
pH by using a pH 7 phosphate buffer is necessary to avoid the retro-aldol products. The 
results showed in a different chemoselectivity observed when the same starting 
materials undergo one-pot hydroformylation/ aldol addition under acidic conditions 
(Scheme 32). A mixture of bridged bicycle 73b and trace of fused unsaturated bicycle 
72b is obtained.  
 
Scheme 69: Tandem hydroformylation/ aldol addition via in situ generated boron enol 
ether of ethyl 1-allyl-2-oxo-cyclohexanone carboxylate (4b). 
 
In contrast with the results observed under tandem hydroformylation and acid-catalyzed 
aldol addition where the fused bridged compound 72b is the only product (Scheme 32), 
a bridged system 73b in the aldol addition is observed. The result confirmed the highly 
efficient formation of the enol borane of compound 4b to activate the α’-position in 
absence of any auxiliary activating group.  
 
 
b. Conversion of 2-allyl-2-methyl-cyclohexanone (92) 
Proceeding with unsaturated cycloalkanones, the 2-allyl-2-methyl-cyclohexanone (92) 
is investigated (Scheme 70, R 78). When exposing 92 to the previous reaction 
conditions, the compound reacts through an aldol addition resulting in the formation of 
bridged β-hydroxy ketone 164 (as main product) and 101 in a ratio of 9:1. While via 
sequential hydroformylation/ aldol addition acid catalyzed (Scheme 42) the formation 
of the compound 101 was observed as the sole product, under these conditions a 
reverse of chemoselectivity is obtained.  
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Scheme 70: Tandem hydroformylation/ aldol addition via in situ generated borane-enol 
ether of 2-allyl-2-methyl-cyclohexanone (92). 
 
 
c.  Conversion of ethyl 3-allyl-3-methyl-2-oxo-cyclohexane carboxylate (93)  
Next, the generation of bridged system was attempted with the conversion of ethyl 3-
allyl-3-methyl-2-oxo-cyclohexane carboxylate (93) (Scheme 71, R 79). When subjected 
to the reaction sequence, bridged β-hydroxy ketone 97 as the sole product in 46 % yield 
is obtained.  
As it can be observed, as well as under one-pot acid catalyzed reaction (Scheme 40) 
once again the regioselectivity of the hydroformylation is influenced of the presence of 
ester function in α’-position and the formation of 6-membered ring is favored.  
 
Scheme 71: Tandem hydroformylation/aldol addition via in situ generated borane-enol 
ether of ethyl 3-allyl-3-methyl-2-oxo-cyclohexane carboxylate (93). 
 
Thus, the one-pot enolboration/ hydroformylation/aldol addition reaction demonstrate 
its utility in the regio- and chemoselective synthesis of bridged bicyclic compounds 
bearing functionalised substituents starting from easily available cyclolakanones.  
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2.7 Tricyclic compound via Michael addition/ aldol 
reactions 
2.7.1 Introduction 
 
Many diverse and biologically important natural products like Taxol (Figure 1 or 
Scheme 72) embody the bicyclo[5.3.1]undecane ring system as the core carbocyclic 
sub-unit7. As reported in the last sections in Scheme 32 and Scheme 33, and 
summarized here in Scheme 72 (eq. 1), every attempt to accomplish the formation of 
bicycles like 73a-e (m = 0; n = 0-4) or 74a-c,e (m = 1; n = 0-4) failed if the sequential 
hydroformylation/ aldol addition was performed starting from cycloalkanones bearing 
an allylic or homoallylic side chain.  
 
Scheme 72: A new approach to the synthesis of bicyclic[x.3.1] compounds of type 167. 
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Alternatively, by analyzing the bond formations needed to construct the desired bridged 
system, it can be seen that the bicyclo[x.3.1]cycloalkanone systems of type 167 
(Scheme 72, eq. 2) similar to 73b (m = 0, n = 1) or 74b (m = 1, n = 1) could be 
accomplished by tandem hydroformylation/ aldol addition of cycloalkanones of type 
165 if an unsaturated two-carbon atoms chain is added. The introduction of the required 
vinyl chain is proposed via several ways, among those, if considering the reactivity of 
vinyl sulfoxide with certain nucleophiles giving the Michael-adducts138 and their 
thermal decomposition to give olefins139, this reaction could be applied to the 
introduction of the vinyl group into the β-ketoester140,141. These methods are of limited 
scope in terms of the active methylene compounds applicable. Another limitation is that 
they provide only ethenylated products not blocking the α-position. It is expected that 
such compounds can readily isomerizes to the thermodynamically stable conjugated 
enone. 
In order to circumvent these limitations, the preparation of 2-vinyl-cycloalkanones 
could be accomplished in the preparation of 1,2 divinyl cycloalkanols142. In fact, α-
chloro-cycloalkanones could react with vinylmagnesium chloride143,144 affording 
chlorohydrin which undergo 1,2-migration of the vinyl group smoothly to afford the 2-
vinylcycloalkanone when its magnesium salts is heated143,144,145,146,147. 
Recently, Yamaguchi et al.148 developed an ethenylation reaction of cyclic ketones and 
β-dicarbonyl compounds with trimethylsilylethyne in the presence of GaCl316. The 
reaction converts silyl enol ethers to α-ethenylated products in one-step. This novel 
ethenylation reaction has a wide applicability and provides not only ketones with a 
quaternary α-carbon but also enolizable products. A limitation of the method, however, 
is that cyclic ketones with relatively small ring sizes such as cyclohexanones and 
cycloheptanones give considerable amounts of the conjugated α-enones. Alternatively, 
Kanematsu’s149 procedure could be considered using the reaction between 
sulfonylallene and enammines of cyclic ketones but the vinyl cycloalkanones 
derivatives are present in low yields. Although this method could be a valid alternative 
vinylation method, costs and safety considerations discourage their use for large-scale 
synthesis. Finally, Nishino’s method150 seems to be the best one, but many steps are 
necessary to introduce the vinyl chain starting from an α-chloro cycloalkanone. On the 
other hand, the 1,5-dicarbonyl compounds of type 169 (Scheme 73) could also be 
obtained from straightforward routes, in fact, they can be synthesized starting from 
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cycloalkanones of type 171 or its derivates by a Michael reaction employing the α,β-
unsaturated aldehydes70 of type 170. 
 
Scheme 73: Synthesis of bridged compounds via Michael reaction.  
 
Traditionally, Michael addition reactions of β-keto esters are catalyzed by very strong 
bases such as alkali metal alkoxides. Several undesirable side reactions can be caused 
by these strongly basic catalysts151,152 including rearrangements, secondary 
condensations, isomerizations, polymerizations, double additions and 
transesterifications. 
In order to circumvent strongly alkaline conditions several alternative methods have 
been developed in recent years153,154,155,156 that make use of weak Brønsted bases (e.g. 
Barium hydroxide, alkali metal fluorides) or some Lewis acids catalyzing the Michael 
addition reaction, albeit not always with satisfactory efficiency157. 
 
 
2.7.2 Synthesis of bicyclo[m.3.1]alkane systems via stepwise Michael addition/ 
aldol cyclization under acidic conditions (m = 2-5) 
 
a. Conversion of ethyl 2-oxo-cycloalkane carboxylate in the presence of 
 acrolein 
To begin the route, the Michael addition is conducted following the procedure reported 
by Kanaguchi et al.158 in which acrolein (172) (Scheme 74) is added to a solution of 
ethyl 2-oxo-cycloalkane carboxylates 65a-d and TEA in DMF at room temperature to 
give the Michael adducts 173a-d as listed in Table 19.  
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Scheme 74: Synthesis of ethyl 2-oxo-1-(3-oxo-propyl)-cycloalkane carboxylates (173a-
d).  
 
 
All reactions proceed with high yield of the 1,5-ketoaldehyde 173a-d which are readily 
ready to be employed in the aldol addition reaction. 
 
 
b. Intramolecular aldol cyclization of ethyl 2-oxo-1-(3-oxo-propyl)-
 cycloalkane carboxylate (173a-d) 
On the base of the results observed in intramolecular aldol addition acid or base – 
catalyzed of 1,6 keto-aldehyde 70a-c (Scheme 30), attempts to utilize these reaction 
conditions methodology to convert the Michael adducts 173a-d (Scheme 75) into β-
hydroxy bicyclic compounds of type 167 (Scheme 72, eq. 2) have been conducted. All 
results are listed in Table 20. When the 5-, 6-membered ring compounds 173a,b 
(Scheme 75) are treated with HCl in dioxane63, the results reveal the formation of 
bicyclic compounds 174a,b in good yields. As expected the aldol addition proceeds 
Table 19: Synthesis of ethyl 2-oxo-1-(3-oxo-propyl)-cycloalkane carboxylates 
(173a-d) 
Reaction n Starting Mat. Product Yields (%) 
R 80 0 65a 173a 90 
R 81 1 65b 173b 50 
R 82 2 65c 173c 68 
R 83 3 65d 173d 75 
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with low degree of diastereoselectivity as the aldol adducts are obtained as mixtures of 
two diastereoisomers. 
 
 
 
 
 
 
 
Scheme 75: Preparation of bicyclo[m.3.1] compounds (m = 2-5) of 173a-d under acidic 
conditions.  
 
Table 20: Intramolecular aldol addition of the compounds 173a-d 
Reaction n Starting Mat. Product dra Yields (%) 
R 84 0 173a 174a 3.8:1 78 
R 85 1 173b 174b 1.6:1 87 
R 86 2 173c 174c 5.4:1 55 
R 87 3 173d 174d 4:1 62 
a) Calculated by NMR-analysis 
 
Tests of these conditions on larger cycloalkanones 173c-d (R 86-R 87) were carried out 
under the same mild reaction conditions. In contrast to the latter results, lower yields 
are observed. 
Following the interest in tandem reactions which combine multiple transformations in 
an efficient one-pot procedure in order to move in the direction of β-hydroxy 
cycloalkanones of type 167 (Scheme 72, eq. 2), an one-pot Michael-aldol addition 
under basic conditions will be investigated. 
 
 
2.7.3 One-pot Michael addition/ aldol cyclization under basic conditions. 
In the course of the study on the stereoselective synthesis of the naturally occurring 
Prelog-Djerassi lactone, Rodriguez et al.159 found a very useful base-catalyzed 
diastereoselective three centre Michael addition of chiral β-ketoester (175) to α,β-
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unsaturated carbonyl compounds of type 176 (Scheme 76). In addition to these results, 
they described a mild and general one-pot high yield preparations of synthetically 
valuable β-hydroxy bicyclo[3.2.1]octanones of type 177 by a slight modification of 
their initial conditions for the Michael addition160. Furthermore, bicyclic derivatives are 
involved as intermediates in the ring expansion of cyclopentanones to seven-membered 
ring161 such as compound 178. The one-pot condensation-cyclization takes place under 
very mild conditions with α, β-unsaturated aldehydes of type 176 in acetone at room 
temperature in the presence of 1.5 eq. of K2CO3. Moreover, if compound 177 is treated 
with K2CO3 in the presence of MeOH or EtOH, they smoothly undergo retro-
Dieckmann reaction162, to the corresponding substituted cycloheptane derivatives 
178163. 
 
 
Scheme 76: Base-catalyzed two-carbons ring expansion of cyclopentanone (175). 
 
In 1997, Filippini et al.164 reported a base-induced anionic sequence involving five 
different reactions starting from the 5-membered ring compound of type 175 by 
replacing acetone with MeOH or EtOH (Scheme 76). The overall transformation named 
“MARDi cascade” involved a Michael addition, an intramolecular aldol addition, a 
retro-Dieckmann reaction followed by dehydration, and chemoselective ester 
saponification. The results are the facile one-pot diastereoselective formation of highly 
functionalized and synthetically valuable cycloheptanes 178 (Scheme 76). 
In contrast to these results, if the reaction is performed starting with cyclododecanone 1 
under same reaction conditions (Scheme 77), bicycle compound 179 is obtained165 
while the expected opened-bridge ring product 180 is not observed. 
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Scheme 77: M.A.R.Di reaction on ethyl 2-oxo-cyclododecanone carboxylate (1). 
 
In order to find out how the DBU-EtOH could influence the reaction on membered rings 
larger than cyclopentanone, investigations starting from 6-membered rings are 
performed in the presence of α,β-unsaturated enals and base such as 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) in EtOH166.  
 
 
2.7.4 Preparation of bicyclo[m.3.1]compounds derivatives under acidic 
conditions via one-pot procedure (m = 3-5). 
The sequential Michael addition intramolecular aldolization between 1 eq. of β-
ketoesters 65b-d (with 6-, 7-, 8-membered rings) with 1 eq. of acrolein (172) are 
carried out in the presence of DBU as base in EtOH at room temperature (Scheme 78).  
According to the results observed with ethyl 2-oxo-cyclododecanone carboxylate (1), 
the reactions proceed through a sequential Michael addition/ intramolecular aldol 
reaction resulting in the formation β-hydroxy bicycles 174b-d in high yield as 
summarized in Table 21 (R 88-90).  
Proceeding into investigations, crotonic aldehyde (181) is employed as Michael 
acceptor (Scheme 78). Thus, 6- and 7-membered rings 65b,c react in EtOH under 
Michael addition/ aldol condition to give the aldol adducts 182b,c as a mixture of 
diastereoisomers in high yields (Table 21, R 91-92). 
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Scheme 78: One-pot Michael addition intramolecular aldol cyclization wth acrolein 
(172) and crotonic aldehyde (181). 
 
Table 21: One-pot Michael addition intramolecular aldol cyclization by DBU 
Reaction n Starting Mat. R Product dra Yields (%) 
R 88 1 65b H 174b 1:1 96 
R 89 2 65c H 174c 5:1 78 
R 90 3 65d H 174d 4:1 76 
R 91 1 65b CH3 182b 8.3:3.6:1.5:1 86 
R 92 2 65c CH3 182c 9:4.7:2:2:1.7:1 80 
a) by 1H-NMR analysis 
 
From all these results it can be concluded that good to excellent yields of 
bicycles[3.3.1] and [4.3.1] compounds 182b and 182c respectively (R 91-R 92) are 
obtained regardless the nature of α,β-unsaturated enals (172 or 181) and ring sizes. No 
M.A.R.Di cascade reaction is detected as observed in 5-membered ring164 (Scheme 76). 
With the aim to combine the rapid preparation of bridged system 174b-d (Scheme 78) 
via one-pot Michael addition with the proven method of ring closure offered by tandem 
hydroformylation/ aldol addition and enolboration/ hydroformylation/ aldol addition the 
β-hydroxy bicyclic substrates are chosen as starting materials in the preparation of 
tricycle compounds. 
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2.7.5 Preparation of tricyclic compounds via bridged bicyclic systems 
2.7.5.1 Introduction 
 
The last part of this work is to establish a general route towards the formation of 
bridged and fused tricyclic compounds of type 186 or 189 (Scheme 79) combining all 
the observed results concerning the sequential hydroformylation/ aldol addition or 
Michael addition/ aldol reactions. This required the synthesis of more complicated 
substrates than those prepared previously that allow the closure of a three or four 
carbon atoms aldehydic chain introduced in α’-position, which could be added by a 
number of methods. 
 
Scheme 79: Hypothetical approach towards the synthesis of multi-ring systems. 
 
First of all, bicyclo[3.3.1]alkanone compound of type 183, such as 174b (Scheme 75), 
is considered as standard starting material to the synthesis of tricyclic compounds with 
m = n = p = 1. The introduction of this necessary aldehydic chain could be 
accomplished via two different ways. First, oxidation of β-hydroxy bicycle resulting 
into the formation of 1,3-diketone of type 184 which may increase the acidity of α’-
position needed to construct the bridged compound of type 185 via a further Michael 
addition/ aldol reaction instead of a vinylic chain addition followed by a one-pot Rh-
catalyzed cyclization (Scheme 79, path I). A different strategy towards the synthesis of 
tricyclic compounds could be carried out to obtain fused aldol adducts of type 189 by 
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installing a vinyl or allyl group via Sakurai reaction167,168 which could later undergo a 
tandem hydroformylation/ aldol addition acid-catalyzed (Scheme 79, path II). 
 
2.7.5.2 Tricyclic bridged compounds of type 186 (Scheme 79, path I) 
As illustrated in Scheme 78, the first strategy pursed in the construction of tricyclic 
systems involves the synthesis of 1,3-diketone of type 184. To accomplish this in a 
straightforward fashion, Swern oxidation169,170,171,172 could be performed starting from 
the β-hydroxy bicycle 174b (Table 21, R 89), and the ethyl 4,9-dioxo-
bicyclo[3.3.1]nonane-1-carboxylate (190) is obtained in 82 % of yield (Scheme 80, R 
93). This compound 190 is then subjected to Michael addition with acrolein in the 
presence of TEA and work-up under acidic conditions to afford the corresponding 
inseparable mixture of keto aldehyde 191 and β-hydroxy tricycle 192 (Scheme 80, R 
94). Thus, in attempting to perform the aldol addition, the crude mixture is treated with 
an aqueous solution of HCl and stirred for 24h. The tricyclic compound 192 as a 
mixture of four diastereoisomers is observed, accounted for by the disappearance of 
aldehyde in the NMR of the crude mixture and simultaneously the presence of those 
typical signals belonging to the alcohol function (Scheme 80, R 95). 
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Scheme 80: Preparation of bridged tricyclic compound 192.  
 
 
 
2.7.5.3 Tricyclic fused compounds of type 189 (Scheme 79, path II) 
 
In order to move further in the direction of fused tricyclic systems of type 189 (Scheme 
79), compounds of type 188 bearing the required unsaturated chain in β’-position could 
be directly obtained from α,β-unsaturated ketone of type 187 by the Sakurai 
reaction167,168,173, 75c and consequently by tandem hydroformylation/ aldol addition. 
Proceeding from β-hydroxy bicycle 174b, the preparation of unsaturated ketoester 193 
(Scheme 81) could be performed under dehydration conditions using 
cerium(III)chloride heptahydrate in combination with sodium iodide174. Unfortunately, 
this attempt to carry out the reaction towards the preparation of compound 193 resulted 
in recovering of starting material (R 96). 
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Scheme 81: Attempt condensation in the presence of CeCl3. 
 
A different approach to this compound 193 will be investigated under both acidic and 
basic conditions. The ketoaldehyde 173b is treated with DBU in EtOH affording an 
intractable crude mixture (Scheme 82, R 97).  
Alternatively, starting again from 173b the reaction is performed by BF3·OEt2141 in abs. 
DCM. An intramolecular aldol addition is observed to takes place and the bridged 
system 174b in isolated in 87 % yields (Scheme 82, R 98), however, in according to the 
Bredt’s rules175, the intramolecular aldol condensation of 173b to generate 193 is 
disfavored. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 82: Attempted intramolecular aldol condensation of 173b under basic or acidic 
conditions.  
 
It could be concluded that the use of sequential Michael addition/ aldol reaction gave a 
preliminary interesting results towards the construction of tricyclic compounds of type 
186 (Scheme 79, n = m = p = 1) such as 192 (Scheme 80). In contrast, the combination 
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of Michael addition/ aldol reaction with tandem hydroformylation/ aldol addition is not 
successful for obtaining fused tricyclic compounds of type 189 due to the failure of the 
intramolecular aldol condensation via 187 and 188 intermediates (Scheme 79) as shown 
in Scheme 81 and 82.  
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3 Summary 
 
Aim of the present investigations was to find out valid synthetically strategies to get 
bicyclic skeletons of natural products via one-pot tandem hydroformylation/ aldol 
addition starting from common and commercially available compounds. Many natural 
compounds have a framework similar to the spiro-cicylic compounds of type 48a-c, 
fused rings 195 or bridged rings 56 and often they have a policyclic skeleton (Scheme 
83). Following previous investigations reported by C. Hollmann73 (Schemes 15, 16 and 
17), tandem hydroformylation/ aldol addition are applied on cycloalkanones of type 55 
bearing unsaturated side chains and various different substituents R1 and R2 (Scheme 
83). 
 
Scheme 83: Synthesis of skeletons of some natural products by tandem 
hydroformylation/ aldol condensation. 
 
Investigations concerning the acid catalyzed tandem hydroformylation/ aldol 
condensation under acidic conditions carried out on the ethyl 1-allyl-2-oxo-cycloalkane 
carboxylates 4a-e show chemoselectively fused bicyclic compounds like 72a,b when 
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the compounds with a 5- or 6-membered ring (4a and 4b respectively) are used 
(Scheme 84).  
In contrast to the above results, the same reaction conditions applied on the larger 7-, 8-
, 9-membered compounds 4c-e gave exclusively the n-products of hydroformylation 
70c-e. 
 
 
Scheme 84: Synthesis of fused rings 72a,b from 5-, 6-membered cycloalkanones 4a,b. 
 
Cycloalkanones bearing longer side chains such as ethyl 1-(but-3-enyl)-2-oxo-
cycloalkane carboxylates (68a-c,e) (Scheme 85), react under tandem hydroformylation/ 
aldol addition to form mixtures of linear aldehyde products 71a-c,e accompanied by 
small amounts of branched aldehyde compounds. 
 
 
 
 
 
 
 
 
 
 
Scheme 85: Attempts of cyclizations from homoallyl cycloalkanones 68a-c,e. 
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As the unsaturated β-ketoesters with 5-, 6-membered rings 4a,b via sequential 
hydroformylation/ aldol addition are able to afford the fused aldol adducts 72a,b, 
further studies were performed using cycloalkanones which would allow the 
construction of bridged system of type 56 (Scheme 83). The installation of substituents 
R1 and R2 with different electronic or steric effects furnished a valid method to control 
the regio- and chemoselectivity of the intramolecular cyclization.  
First, the compound 83b with a 6-membered ring submitted to tandem 
hydroformylation/ aldol addition furnished the bicylic compounds 85 by the cyclization 
of the branched aldehyde intermediate (Scheme 86). In contrast to the results reported 
above, the 1,3-dicarboxylate 83c reacted to give the hydroformylated products 88 as a 
mixture of n-iso-aldehydes and no aldol adducts are detected. Proceeding with the 
homologated ketoester 84, the sequential hydroformylation/ aldol addition furnished 
again a mixture of n-iso-aldehydes 90 (Scheme 86).  
 
 
Scheme 86: Synthesis of bridged bicyclic[3.3.1] skeleton by tandem hydroformylation/ 
aldol addition. 
 
Fused bicycle compound of type 195 (Scheme 83) is also obtained when the 2-allyl-2-
methyl-cyclohexanone (92) is used. The reaction proceeds exclusively with n-
selectivity leading to 7a-methyl-2,4,5,6,7,7a-hexahydro-1H-indene-3-carboxylate (101) 
in 93 % yield (Scheme 87). Again, due to steric hindrance of ester function and in 
analogy to the one-pot of 83b, the bridged compound 97, from the branched aldehyde 
intermediate, is formed when the cycloalkanone 93 is used.  
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Scheme 87: Synthesis of fused and bridged bicyclic skeletones from substituted 
cycloalkanones 92 and 93. 
 
Cycloalkanones bearing an ester function next to the ketone moiety and the olefinic 
chain in opposite side like the allylic 102 and homoallylic 103 with 6-membered ring 
(Scheme 88), undergo intramolecular aldol addition to give the spiro compounds such 
as 104, as main products of a mixture containing the fused aldol adducts and the 
product 107. 
 
 
Scheme 88: Synthesis of spiro-cyclo skeletons 104 and 107.  
 
Although the tandem hydroformylation/ aldol addition of unsaturated ketoesters are 
able to furnish different cyclization fashion, as an alternative method, silyl enol ethers 
like 120a,b, 125a-c and 126a,b were investigated (Scheme 89). In contrast to the 
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previous results, no cyclization takes place but only a mixture of linear and branched 
aldehyde is observed. 
 
 
Scheme 89: Attempts of cyclization by tandem hydroformylation/ Mukaiyama aldol 
addition. 
 
Finally, proceeding with unsaturated cycloalkanones an enolboration/ 
hydroformylation/ aldol addition is performed. In contrast to the results observed under 
tandem hydroformylation/ aldol addition acid-catalyzed conditions, where the fused 
bridged compounds 72a,b are the major products (Scheme 84), a reverse of 
chemoselectivity of the aldol addition is observed under these reaction conditions. 
Indeed, starting from 4b and 92 compounds, the reactions proceed with high 
chemoselectivity and the bridged systems 73b and 164 are generated respectively 
(Scheme 90). The result confirmed the highly efficient formation of the enol borane of 
unsaturated cycloalkanones in absence of any auxiliary activating group.  
On the other hand, when ethyl 3-allyl-3-methyl-2-oxo-cyclohexane carboxylate (93) is 
subjected to this reaction, bridged β-hydroxy ketone 97, as the sole product in 46 % 
yield, is obtained.  
As can be observed, once again the regioselectivity of the hydroformylation is 
influenced of the presence of ester function (R2 = COOEt) and the formation of the 6-
membered ring is favored (Scheme 90).  
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Scheme 90: Synthesis of bridged bicyclic skeletones by enolboration/ 
hydroformylation/ aldol addition of 4b, 92 and 93. 
 
Proceeding with the studies towards the construction the bridged skeletons of type 56 
(Scheme 83), one-pot Michael addition/ intramolecular aldol reaction was carried out 
adding acrolein or crotonic aldehyde to a solution of 65b-d (6-, 7-, 8-membered rings) 
in the presence of catalytic amount of DBU. Under these conditions both bridged 
compounds like 174b-d or 182b,c are obtained as a mixture of diastereoisomers 
(Scheme 91). Mild reaction conditions together with excellent yields turns out the 
DBU-ethanol mediated Michael addition reaction as an important and superior 
alternative to the classic base catalysis and other methods, since both side-reactions and 
subsequent reactions under strong basic conditions are avoided.  
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Scheme 91: Synthesis of bridged bicyclic skeletons via Michael addition/ aldol 
cyclization. 
 
Ultimate goal of this work was the efforts towards the formation of tricyclic systems of 
type 186 or 189 (Scheme 92) by performing the sequential hydroformylation/ aldol 
addition two or more times.  
 
 
Scheme 92: Plan towards the synthesis of tri-cyclic compounds of type 186. 
 
From these results while sequential Michael addition/ aldol reaction gave preliminary 
interesting results towards the construction of tricyclic compounds of type 186 
combined with the tandem hydroformylation/ aldol addition (path I), attempts for 
obtaining fused tricyclic compounds of type 189 failed (path II) (Scheme 92). 
 
Further investigations towards the synthesis of polycyclic compounds and about their 
stereochemistry will be involved in next projects. 
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4 Experimental part 
4.1 General aspects 
 
Reagent, solvents and synthesized catalyst  
 
All reagents were purchased from commercial sources and were used withouth further 
purification unless otherwise stated. THF and Et2O were distilled over sodium metal 
and benzophenone, while CH2Cl2 and triethylamine were distilled over CaH2.  
The [Rh(cod)Cl]2 catalyst used in hydroformylation was prepared via the method of 
Crabtree72, while the Rh(CO)2(acac) hydroformylation catalyst and RhCl·3H2O were 
donated by Degussa AG, Düsseldorf. 
 
Spectroscopic and analytical methods 
 
1H and 13C NMR spectra were recorded on Bruker DRX 400, 500 instruments. CDC13 
was used as the solvent, and both proton and carbon spectra were referenced to CDCl3 
(δ 7.25 and δ 77.00). The assignment of the signals in most cases is based on H,H-, 
C,H- und long range C,H-correlation spectroscopy. All 1D-NMR spectra were Fourier 
transformed using Bruker WINNMR software and plotted using the ACDLABS 
SpecMan software suite. IR spectra were acquired using Nicolet Impact 400 D using 
neat compounds or thin films in CDCl3 between KBr. High resolution analytical mass 
spectra HR-FABMS and HR-EIMS were recorded on JEOLJMS-SX 102 A and 
Finnigan MS 8200 spectrometers, respectively.  
 
Chromatographic/ purification methods 
 
Analytical gas chromatography was carried out on a Fisons 8130 gas chromatograph 
with 25 m CP-sil-5(CB) capillaries. Detection was accomplished via a flame-ionization 
detector. TLC was performed exclusively on aluminum-backed Merck F254 silica gel 60 
plates, with the appropriate running solvents. Column chromatography was performed 
using gel silica 60 (size 0.063-0.200 nm). Filtration subsequent to hydroformylation in 
order to remove residue were performed with Merck alumina, neutral activity. 
                Experimental part 
 102
Working methods 
 
Reactions are performed in normal laboratory glassware with round glass joints, and 
reactions requiring an inert atmosphere were run under positive pressure of argon. 
Pressure reactions have been carried in autoclaves (250 ml, type A, PTFE-insert) from 
Berghof, Eningen, Germany, and similar autoclaves (70 ml, stainless steel). 
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4.2 One-pot sequential hydroformylation/ aldol addition on 
ethyl 1-alkenyl-2-oxo-cycloalkane carboxylates 
4.2.1 Preparation of starting materials 
a. Preparation of ethyl 2-oxo-cycloalkane carboxylates (65c-e)81 
 
R 1: Synthesis of ethyl 2-oxo-cycloheptane carboxylate (65c)81 
 
To a solution of cyclohexanone (63a) (2.0 g, 20.0 mmol) in dry Et2O at 0 °C are added 
4.23 g (30.0 mmol) of a solution BF3·OEt2 (1M in cyclohexane) in 15 ml dry Et2O. A 
solution of ethyl diazoacetate (64) (3.4 g, 30.0 mmol) in 10 ml dry Et2O is then added 
over a period of 15 min. and the resulting solution is stirred at room temperature under 
an argon atmosphere. After 24 h, the mixture is cooled to 0 °C and neutralized with 
saturated aqueous solution of NaHCO3. The resulting mixture is extracted with 
chloroform (3 x 20 ml). The combined extracts are washed with a saturated solution of 
NaCl, dried over anhydrous MgSO4, filtered, and concentrated in vacuum. Purification 
by bulb-to-bulb distillation (T = 80 °C, P = 6 x 10-2 mbar) gave 2.72 g (14.7 mmol, 74 
% yield) of ethyl 2-oxo-cycloheptane carboxylate81 (65c) (C10H16O3, 184.232 g/mol) as 
a colorless oil. 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 
184 (M+, 52), 156 (99), 138 (75), 110 (75), 82 (90), 
55 (65). IR (KBr-Film): ν  [cm-1] = 2890 (s), 2926 (s), 
2852 (m), 1744 (s), 1707 (s), 1639 (s). 1H-NMR (400 
MHz, CDCl3): δ [ppm] = 1.21 (t, 3H, 3J = 7.03 Hz, 
CH3-11), 1.38 (m, 2H), 1.56 (m, 1H), 1.79 (m, 3H), 
2.03 (m, 1H), 2.37 (m, 1H), 2.54 (m, 2H), 3.48 (dd, 
1H, 3J = 10.3 Hz, 3J = 4.02 Hz, CH-1), 4.14 (q, 2H, 3J = 7.03 Hz, CH2-10). 13C-NMR 
(100 MHz, CDCl3): δ [ppm] = 14.0 (CH3, C-11), 24.3, 27.5, 27.9, 29.5, 43.0 (CH2-
3/4/5/6/7), 58.8 (CH, C-1), 60.9 (CH2, C-10), 170.5 (CO, C-8), 208.9 (CO, C-2). 
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R 2: Synthesis81 of ethyl 2-oxo-cyclooctane carboxylate (65d)  
Amounts: 37.9 g  (267.0 mmol)  BF3·OEt2 
  20.0 g  (178.0 mmol)  cycloheptanone (63b) 
  30.43 g (267.0 mmol)  ethyl diazoacetate (64) 
  100 ml     abs. Et2O 
Procedure: Analogously to R 1. 
Work-up: The combined extracts are washed with brine, dried over anhydrous 
MgSO4, filtered, and concentrated in vacuum. Purification by bulb-to-bulb distillation 
(T = 70 °C, P = 2 x 10-2 mbar) furnished 34.53 g (174.0 mmol, 98 % yield) of ethyl 2-
oxo-cyclo-octane carboxylate183 (65d) (C11H18O3, 198.259 g/mol) as a colorless oil. 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 198 (M+, 48), 152 (56), 124 (98), 
96 (62), 55 (42). IR (KBr-Film): ν  [cm-1] = 2979 
(s), 2929 (s), 2856 (s), 1747 (s), 1705 (s), 1644 (s). 
1H-NMR (400 MHz, CDCl3): δ [ppm] = 1.26 (t, 
3H, 3J = 7.03 Hz, CH3-12), 1.40-1.50 (m, 5H), 1.68 
(m, 2H), 1.85 (m, 1H), 2.07 (m, 1H), 2.35 (m, 3H), 
3.50 (m, 1H), 4.18 (q, 2H, 3J = 7.03 Hz, CH2-11). 
13C-NMR (100 MHz, CDCl3): δ [ppm] = 14.2 
(CH3, C-12), 23.7, 25.9, 26.5, 28.6, 29.8, 32.2 (CH2-3/4/5/6/7/8), 56.9 (CH, C-1), 60.0 
(CH2, C-11), 175.9 (CO, C-9), 212.2 (CO, C-2). 
 
 
R 3: Synthesis81 of ethyl 2-oxo-cyclononane carboxylate (65e)  
Amounts: 33.6 g  (237.0 mmol)  BF3·OEt2 
  20.0 g  (158.0 mmol)  cyclo-octanone (63c) 
  27.0 g  (237.0 mmol)  ethyl diazoacetate (64) 
  100 ml     abs. Et2O 
Procedure: Analogously to R 1. 
Work-up: The combined extracts are washed with brine, dried, and concentrated in 
vacuum. Purification by bulb-to-bulb distillation T = 70 °C, P = 2.3 x 10-2 mbar, gave 
30.32 g (142.8 mmol, 91 % yield) of ethyl 2-oxo-cyclononane carboxylate76 (65e) 
(C12H20O3, 212.285 g/mol) as a colorless oil. 
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Spectroscopic data: GC-MS (EI, 70 eV): m/z 
(%) = 212 (10), 183 (16), 166 (38), 138 (98), 
110 (45), 55 (45). IR (KBr-film): ν  [cm-1] = 
2930 (s), 2873 (s), 2856 (m), 1746 (s), 1708 (s), 
1641 (s). 1H-NMR (400 MHz, CDCl3): δ [ppm] 
= 1.16 (t, 3H, 3J = 7.03 Hz, CH3-13), 1.44 (m, 
4H), 1.64 (m, 2H), 1.81 (m, 2H), 2.02 (m, 2H), 
2.27 (m, 2H), 2.51 (m, 2H), 3.55 (dd, 1H, 3J = 
8.03 Hz, 3J = 6.27 Hz, CH-1), 4.05 (q, 2H, 3J = 7.03 Hz, CH2-12). 13C-NMR (100 
MHz, CDCl3): δ [ppm] = 13.9 (CH3, C-13), 23.7, 24.2, 24.3, 24.8, 25.7, 26.9, 42.2 
(CH2, C-3/4/5/6/7/8/9), 58.6 (CH, C-1), 61.0 (CH2, C-12), 175.7 (CO, C-10), 211.6 
(CO, C-2). 
 
 
b. Preparation of ethyl 1-allyl-2-oxo-cycloalkane carboxylates (4a-e)  
 
R 4: Synthesis82 of ethyl 1-allyl-2-oxo-cyclopentane carboxylate (4a)  
To an ice-cooled solution of ethyl 2-oxo-cyclopentane carboxylate (65a) (10.0 g, 64.0 
mmol) in dry THF (100 ml) NaH is added (2.56 g, 64.0 mmol, 60 % dispersion in 
mineral oil). Allyl bromide (66) (7.62 g, 64.0 mmol) in 20 ml of dry THF is added over 
a period of 1 h, and the mixture is stirred overnight (12 h) at r.t. The reaction mixture is 
diluted with Et2O (60 ml), washed with H2O (3 x 20 ml), dried over anhydrous MgSO4, 
filtered, and concentrated in vacuum. The residue is distilled bulb-to-bulb (T = 40 °C, 
7.0 x 10-2 mbar) to give 11.6 g (59.11 mmol, 93 %) of ethyl 1-allyl-2-oxo-cyclopentane 
carboxylate83 (4a) (C11H16O3, 196.243 g/mol) as a colorless oil. 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 197 (M++1, 100), 168 (30), 123 
(30), 105 (25), 94 (38), 55 (12). IR (KBr-film): ν  [cm-1] 
= 3078 (m), 2979 (s), 2908 (s), 1751 (s), 1727 (s), 1640 
(s), 1465 (s), 1390 (s), 1295 (s), 958 (s), 860 (s). 1H-
NMR (400 MHz, CDCl3): δ [ppm] = 1.21 (t, 3H, 3J = 
7.03 Hz, CH3-12), 1.84-2.02 (m, 3H), 2.15-2.43 (m, 
4H), 2.65 (m, 1H), 4.13 (q, 2H, 3J = 7.03 Hz, CH2-11), 
5.06 (ddd, 2H, 3J = 17.82 Hz, 3J = 10.79 Hz, 3J = 7.03 Hz, CH2-8), 5.7 (dddd, 1H, 3J = 
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17.82 Hz, 3J = 10.54 Hz, 3J = 7.28 Hz, 3J = 7.28 Hz, CH-7). 13C-NMR (100 MHz, 
CDCl3): δ [ppm] = 14.0 (CH3, C-12), 19.4, 32.1, 37.7, 38.0 (CH2, C-3/4/5/6), 59.8 (Cq, 
C-1), 61.4 (CH2, C-11), 120.0 (CH2, C-8), 132.9 (CH, C-7), 170.8 (CO, C-9), 214.6 
(CO, C-2). 
 
 
R 5: Synthesis82 of ethyl 1-allyl-2-oxo-cyclohexane carboxylate (4b)  
Amounts: 10.0 g  (58.0 mmol) ethyl 2-oxo-cyclohexane carboxylate (65b) 
  2.32 g  (58.0 mmol) NaH (60 % dispersion in mineral oil) 
  6.96 g  (58.0 mmol) allyl bromide (66) 
  100 ml    dry THF  
Procedure: Analogously to R 4. 
Work-up: The combined organic layer is dried over anhydrous MgSO4, filtered, 
and concentrated in vacuum. 11.1 g (52.7 mmol, 91 % yield) of ethyl 1-allyl-2-oxo-
cyclohexane carboxylate83 (4b) (C12H18O3, 210.270 g/mol) are isolated by bulb-to-bulb 
distillation (T = 50 °C, 7.0 x 10-2 mbar) as a colorless oil. 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) 
= 211 (M++1, 100), 210 (10), 137 (55), 119 (87), 
108 (30), 55 (10). IR (KBr-film):  ν  [cm-1] = 3077 
(m), 2979 (s), 2941 (s), 2866 (s), 1746 (s), 1726 (s), 
1639 (s), 1463 (s), 1387 (s), 1282 (s), 918 (s). 1H-
NMR (400 MHz, CDCl3): δ [ppm] = 1.19 (t, 3H, 3J 
= 7.03 Hz, CH3-13), 1.14-1.36 (m, 1H), 1.54-1.73 
(m, 3H), 1.93-1.98 (m, 1H), 2.24-2.30 (m, 1H), 2.37-2.44 (m, 3H), 2.52-2.57 (m, 1H), 
4.12 (q, 2H, 3J = 7.03 Hz, CH2-12), 4.96 (ddd, 2H, 3J = 14.56 Hz, 2J = 3.01 Hz, 4J = 
0.75 Hz, CH2-9), 5.66 (dddd, 1H, 3J = 17.32 Hz, 3J = 14.81 Hz, 3J = 7.78 Hz, 3J = 7.28 
Hz, CH-8). 13C-NMR (100 MHz, CDCl3): δ [ppm] = 14.1 (CH3, C-13), 22.3, 27.4, 
35.6, 39.2, 41.0 (CH2, C-3/4/5/6/7), 60.7 (Cq, C-1), 61.1 (CH2, C-12), 118.1 (CH2, C-
9), 133.2 (CH, C-8), 171.3 (CO, C-10), 207.4 (CO, C-2). 
 
 
R 6: Synthesis82 of ethyl 1-allyl-2-oxo-cycloheptane carboxylate (4c)  
Amounts: 1.0 g  (5.4 mmol) ethyl 2-oxo-cycloheptane carboxylate (65c) 
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  216.0 mg (5.4 mmol) NaH (60 % dispersion in mineral oil) 
  710.0 mg (6.0 mmol) allyl bromide (66) 
  30 ml    dry THF  
Procedure: Analogously to R 4. 
Work-up: The combined organic phases are dried over anhydrous MgSO4, filtered, 
and concentrated in vacuum. 0.964 g (4.30 mmol, 80 %) of ethyl 1-allyl-2-oxo-
cycloheptane carboxylate83 (4c) (C13H20O3, 224.296 g/mol) are isolated by bulb-to-bulb 
distillation (T = 80 °C, 4.5 x 10-2 mbar) as a colorless oil. 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 183 (13), 179 (10), 151 (22), 55 
(18). IR (KBr-film): ν  [cm-1] = 3077 (m), 2979 (s), 2861 (s), 1736 (s), 1711 (s), 1639 
(s), 1455 (s), 1389 (s), 1293 (s), 938 (s), 859 (s). 1H-NMR (400 MHz, CDCl3): δ [ppm] 
= 1.21 (t, 3H, 3J = 7.23 Hz, CH3-14), 1.33-1.41 (m, 
1H), 1.53-1.60 (m, 3H), 1.63-1.78 (m, 3H), 2.04-2.09 
(m, 1H), 2.27-2.32 (m, 1H), 2.39-2.44 (m, 1H), 2.59-
2.64 (m, 1H), 2.68-2.72 (m, 1H), 4.13 (q, 2H, 3J = 
7.23 Hz, CH2-13), 5.03 (dd, 2H, 3J = 16.46 Hz, 3J = 
10.72 Hz, CH2-10), 5.68 (ddd, 1H, 3J = 17.45 Hz, 3J = 
10.47 Hz, 3J = 6.98 Hz, CH-9). 13C-NMR (100 MHz, 
CDCl3): δ [ppm] = 14.0 (CH3, C-14), 24.5, 25.5, 29.8, 32.0, 39.6, 42.0 (CH2, C-
3/4/5/6/7/8), 60.7 (Cq, C-1), 61.1 (CH2, C-13), 118.5 (CH2, C-10), 133.5 (CH, C-9), 
171.9 (CO, C-11), 209.0 (CO, C-2). 
 
 
R 7: Synthesis82 of ethyl 1-allyl-2-oxo-cyclooctane carboxylate (4d)  
Amounts: 2.0 g  (20.0 mmol) ethyl 2-oxo-cyclooctane carboxylate (65d) 
  0.4 g  (20.0 mmol) NaH (60 % dispersion in mineral oil) 
  1.2 g  (20.0 mmol) allyl bromide (66) 
  100 ml    dry THF  
Procedure: Analogously to R 4. 
Work-up: The combined organic phases are dried over anhydrous MgSO4, filtered, 
and concentrated in vacuum. 4.56 g (19.2 mmol, 96 %) of ethyl 1-allyl-2-oxo-
cyclooctane carboxylate83 (4d) (C14H22O3, 238.323 g/mol) are obtained after 
purification by bulb-to-bulb distillation (T = 80 °C, 4.5 x 10-2 mbar) as a colorless oil. 
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Spectroscopic data: 1H-NMR (400 MHz, 
CDCl3): δ [ppm] = 1.08 (t, 3H, 3J = 7.2 Hz, CH3-
15), 1.2-1.3 (m, 6H), 1.49-1.52 (m, 1H), 1.70-1.82 
(m, 2H), 2.02-2.12 (m, 2H), 2.20-2.26 (m, 1H), 
2.52-2.66 (m, 2H), 4.02 (q, 2H, 3J = 7.28 Hz, CH2-
14), 4.9 (dd, 2H, 3Jtrans = 17.07 Hz, 3Jcis = 10.04 
Hz, CH2-11), 5.50 (ddd, 1H, 3J = 16.82 Hz, 3J = 
10.04 Hz, 3J = 6.53 Hz, CH-10). 13C-NMR (100 MHz, CDCl3): δ [ppm] = 13.8 
(CH3,C-15), 19.1, 22.4, 23.1, 24.3, 25.0, 35.6 (CH2, C-3/4/5/6/7/8/9), 60.7 (CH2, C-14), 
63.8 (Cq, C-1), 118.0 (CH2, C-11), 133.0 (CH, C-10), 171.2 (CO, C-12), 209.7 (CO, C-
2). 
 
 
R 8: Synthesis82 of ethyl 1-allyl-2-oxo-cyclononane carboxylate (4e)  
Amounts: 4.0 g  (18.0 mmol) ethyl 2-oxo-cyclononane carboxylate (65e) 
  0.72 g  (18.0 mmol) NaH (60 % dispersion in mineral oil) 
  2.16 g  (18.0 mmol) allyl bromide (66) 
  100 ml    dry THF  
Procedure: Analogously to R 4. 
Work-up: The combined organic phases are dried over anhydrous MgSO4, filtered, 
and concentrated in vacuum. 4.08 g (16.0 mmol, 92 % yield) of ethyl 1-allyl-2-oxo-
cyclononane carboxylate (4e) (C15H24O3, 252.349 g/mol) are isolated by bulb-to-bulb 
distillation (T = 80 °C, 4.5 x 10-2 mbar) as a colorless oil. 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 253 (M++1, 8), 223 (10), 207 
(24), 179 (88), 137 (38), 95 (98), 67 (100), 55 (30). 
IR (KBr-film): ν  [cm-1] = 3077 (m), 2927 (s), 2874 
(s), 2853 (s), 1739 (s), 1708 (s) 1640 (s), 1559 (s), 
1455 (m), 1388 (s), 1295 (s), 955 (s), 832 (s). 1H-
NMR (400 MHz, CDCl3): δ [ppm] = 1.19 (t, 3H, 3J 
= 7.03 Hz, CH3-16), 1.49 (m, 2H), 1.61-1.72 (m, 
4H), 1.79-1.84 (m, 2H), 1.89-2.02 (m, 3H), 2.09-
2.15 (m, 1H), 2.20-2.24 (m, 2H), 2.45 (m, 1H), 2.68 
(m, 1H), 4.12 (q, 2H, 3J = 7.03 Hz, CH2-15), 4.90 (dd, 1H, 3Jcis = 10.29 Hz, 2J = 1.25 
Hz, CH2-12), 4.98 (dd, 1H, 3Jtrans = 17.07 Hz, 2Jgem = 1.25 Hz, CH2-12), 5.77 (ddd, 1H, 
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3J = 17.07 Hz, 3J = 10.29 Hz, 3J = 6.53 Hz, CH-11). 13C-NMR (100 MHz, CDCl3): δ 
[ppm] = 14.0 (CH3, C-16), 23.1, 24.1, 25.4, 28.3, 28.8, 29.2, 30.0, 38.5, (CH2, C-
3/4/5/6/7/8/9/10), 61.1 (CH2, C-15), 61.9 (Cq, C-1), 114.7 (CH2, C-12), 138.0 (CH, C-
11), 171.7 (CO, C-13), 212.3 (CO, C-2). 
 
 
c. Synthesis of ethyl 1-(but-3-enyl)-2-oxo-cycloalkane carboxylates (68a-c,e) 
 
R 9: Synthesis84 of ethyl 1-(but-3-enyl)-2-oxo-cyclopentane carboxylate (68a)  
To a stirred mixture of ethyl 2-oxo-cyclopentane carboxylate (65a) (2.0 g, 12.0 mmol) 
and potassium t-butoxide in t-butanol (14.1 ml, 1.0 M), potassium iodide (0.12 g, 0.77 
mmol) and 4-brom-1-butene (67) (2.02 g, 15.0 mol) are added. After being stirred 
under argon at room temperature for 2 h, the reaction mixture is gently refluxed for 24 
hours. The cooled reaction mixture is treated with water (30 ml), extracted with Et2O (3 
x 20 ml), dried over anhydrous MgSO4, filtered, and concentrated in vacuum. The 
residue is distilled bulb-to-bulb (T = 60 °C, 5.0 x 10-2 mbar) giving 2.22 g (10.55 
mmol, 85 % yield) of ethyl 1-(but-3-enyl)-2-oxo-cyclopentane carboxylate176 (68a) 
(C12H18O3, 210.270 g/mol) as a colorless oil. 
Spectroscopic data: 1H-NMR (500 MHz, CDCl3): δ [ppm] = 1.17 (t, 3H, 3J = 7.23 Hz, 
CH3-13), 1.37-1.40 (m, 1H), 1.57-1.62 (m, 1H), 
1.83-1.97 (m, 5H), 2.15-2.23 (m, 1H), 2.32-2.37 
(m, 1H), 2.46-2.49 (m, 1H), 4.09 (q, 2H, 3J = 
7.23 Hz, CH2-12), 4.89 (dd, 1H, 3Jcis = 10.72 Hz, 
CH-9a), 4.96 (dd, 1H, 3Jtrans = 17.2 Hz, CH-9b), 
5.71 (dddd, 1H, 3J = 16.46 Hz, 3J = 10.22 Hz, 3J 
= 7.73 Hz, 3J = 6.48 Hz, CH-8). 13C-NMR (125 
MHz, CDCl3): δ [ppm] = 13.9 (CH3, C-13), 19.5, 
29.0, 32.7, 32.8, 37.7 (CH2, C-3/4/5/6/7), 60.0 
(Cq, C-1), 61.2 (CH2, C-12), 114.9 (CH2, C-9), 
137.5 (CH, C-8), 170.7 (CO, C-10), 214.5 (CO, C-2). 
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R 10: Synthesis84 of ethyl 1-(but-3-enyl)-2-oxo-cyclohexane carboxylate (68b)  
Amounts: 2.0 g  (11.7 mmol) ethyl 2-oxo-cyclohexane carboxylate (65b) 
  1.44 g  (12.8 mmol) potassium t-butoxide (in t-BuOH) 
  0.117 g (0.71 mmol) potassium iodide  
  1.9 g  (14.0 mmol) 4-brom-1-butene (67) 
  50 ml    t-BuOH 
Procedure: Analogously to R 9. 
Work-up: The combined organic phases are dried over anhydrous MgSO4, filtered, 
and concentrated in vacuum. 2.23 g (9.94 mmol, 85 
% yield) of ethyl 1-(but-3-enyl)-2-oxo-cyclohexane 
carboxylate84 (68b) (C13H20O3, 224.296 g/mol) are 
isolated by bulb-to-bulb distillation (T = 60 °C, 5.0 x 
10-2 mbar) as a colorless oil. 
Spectroscopic data: 1H-NMR (400 MHz, CDCl3): δ 
[ppm] = 1.16 (t, 3H, 3J = 7.28 Hz, CH3-14), 1.31-1.38 
(m, 1H), 1.50-1.66 (m, 5H), 1.83-1.93 (m, 3H), 2.33-
2.43 (m, 3H), 4.10 (q, 2H, 3J = 7.28 Hz, CH2-13), 
4.82 (d, 1H, 3J = 10.04 Hz, CH-10a), 4.90 (dd, 1H, 3J = 17.07 Hz, 2J = 1.25 Hz, CH-
10b), 5.68 (ddd, 1H, 3J = 16.56 Hz, 3J = 10.54 Hz, 3J = 6.27 Hz, CH-9). 13C-NMR (100 
MHz, CDCl3): δ [ppm] = 13.8 (CH3, C-14), 22.3, 27.4, 28.3, 33.6, 35.9, 40.8 (CH2, C-
3/4/5/6/7/8), 60.3 (Cq, C-1), 60.9 (CH2, C-13), 114.4 (CH2, C-10), 137.8 (CH, C-9), 
171.6 (CO, C-11), 207.4 (CO, C-2). 
 
 
R 11: Synthesis84 of ethyl 1-(but-3-enyl)-2-oxo-cycloheptane carboxylate (68c)  
Amounts: 1.00 g  (4.4 mmol) ethyl 2-oxo-cycloheptane carboxylate (65c) 
  540.0 mg (4.4 mmol) potassium t-butoxide (in t-BuOH) 
  44.0 mg (0.26 mmol) potassium iodide  
  710.0 mg (5.28 mmol) 4-brom-1-butene (67) 
  50 ml     t-BuOH 
Procedure: Analogously to R 9. 
Work-up: The combined organic phases are dried over anhydrous MgSO4, filtered, 
and concentrated in vacuum. 850.0 mg (3.56 mmol, 81 % yield) of ethyl 1-(but-3-enyl)-
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2-oxo-cycloheptane carboxylate177 (68c) are isolated by bulb-to-bulb distillation (T = 
60 °C, 5.0 x 10-2 mbar) (C14H22O3, 238.323 g/mol) as a colorless oil. 
Spectroscopic data: IR (KBr-film): ν  [cm-1] = 3077 (m), 2977 (s), 2860 (s), 1736 (s), 
1708 (s), 1640 (s), 1454 (s), 1389 (s), 1298 (s), 941 
(s), 859 (s). 1H-NMR (400 MHz, CDCl3): δ [ppm] = 
1.20 (t, 3H, 3J = 7.03 Hz, CH3-15), 1.56-1.70 (m, 8H), 
1.94-2.13 (m, 4H), 2.42-2.45 (m, 1H), 2.52-2.61 (m, 
1H), 4.13 (q, 2H, 3J = 7.03 Hz, CH2-14), 4.87 (d, 1H, 
3J = 10.29 Hz, CH-11a), 4.95 (dd, 1H, 3J = 17.32 Hz, 
2J = 1.51 Hz, CH-11b), 5.69 (ddd, 1H, 3J = 16.82 Hz, 
3J = 10.29 Hz, 3J = 6.27 Hz, CH-10). 13C-NMR (100 
MHz, CDCl3): δ [ppm] = 14.0 (CH3, C-15), 24.7, 
25.4, 28.8, 29.8, 32.8, 34.5, 41.9 (CH2, C-3/4/5/6/7/8/9), 60.9 (CH2, C-14), 62.4 (Cq, C-
1), 114.6 (CH2, C-11), 137.9 (CH, C-10), 172.3 (CO, C-12), 209.2 (CO, C-2). 
 
 
R 12: Synthesis84 of ethyl 1-(but-3-enyl)-2-oxo-cyclononane carboxylate (68e)  
Amounts: 5.0 g  (23.0 mmol) ethyl 2-oxo-cyclononane carboxylate (65e) 
  3.13 g  (28.0 mmol) potassium t-butoxide (in t-butanol) 
  238.0 mg (1.43 mmol) potassium iodide  
  3.78 g  (28.0 mmol) 4-brom-1-butene (67) 
  50 ml     t-butanol 
Procedure: Analogously to R 9. 
Work-up: The combined organic phases are dried over anhydrous MgSO4, filtered, 
and concentrated in vacuum. 2.913 g (10.0 mmol, 47 % yield) of ethyl 1-(but-3-enyl)-
2-oxo-cyclononane carboxylate (68e) (C16H26O3, 266.376 g/mol) are isolated by bulb-
to-bulb distillation (T = 60 °C, 5.0 x 10-2 mbar) as a 
colorless oil. 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) 
= 266 (M+, 4), 225 (34), 212 (30), 193 (6), 138 (21), 
81 (77), 67 (75), 55 (92). High Resolution Mass: 
Calculated: 266.1882 Found: 266.1887. IR (KBr-
film): ν  [cm-1] = 3075 (w), 2929 (vs), 2873 (s), 2854 
(s), 1737 (s), 1708 (vs), 1641 (m), 1477 (m), 1467 
O
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(s), 1446 (s), 1195 (s), 1130 (s), 1031 (m), 912 (m). 1H-NMR (400 MHz, CDCl3): δ 
[ppm] = 1.17 (t, 3H, 3J = 7.03 Hz, CH3-17), 1.25-1.41 (m, 8H), 1.61-1.68 (m, 2H), 
1.76-2.24 (m, 7H), 2.63-2.71 (m, 1H), 4.10 (q, 2H, 3J = 7.03 Hz, CH2-16), 4.92 (ddd, 
2H, 3Jtrans = 17.07 Hz, 3Jcis = 10.04 Hz, Jgem = 1.51 Hz, CH2-13), 5.77 (ddd, 1H, 3J = 
16.56 Hz, 3J = 10.04 Hz, 3J = 6.27 Hz, CH-12). 13C-NMR (100 MHz, CDCl3): δ [ppm] 
= 13.9 (CH3, C-17), 19.7, 23.0, 23.5, 24.5, 24.9, 27.3, 28.5, 30.2, 37.4 (CH2, C-
3/4/5/6/7/8/9/10/11), 60.9 (CH2, C-16), 63.5 (Cq, C-1), 114.6 (CH2, C-13), 137.6 (CH, 
C-12), 172.1 (CO, C-14), 210.5 (CO, C-2). 
 
 
4.3 Stepwise hydroformylation/ intramolecular aldol addition of 
ethyl 1-alkenyl-2-oxo-cycloalkane carboxylates 
4.3.1 First step: hydroformylation reactions 
a. Ethyl 1-allyl-2-oxo-cycloalkane carboxylates (4a-c) as starting materials 
 
R 13: Synthesis of ethyl 2-oxo-1-(4-oxo-butyl)cyclopentane carboxylate (70a) 
A solution of ethyl 1-allyl-2-oxo-cyclopentane carboxylate (4a) (2.0 g, 10.0 mmol), 
313.6 mg (5 mol %) of BIPHEPHOS (29), and [Rh(acac)(CO)2] (28) (1 mol %) in 
anhydrous dichloromethane (20 ml) is placed in an autoclave. After flushing with argon 
the reactor is pressurized with 10 bar carbon monoxide and 10 bar hydrogen, the 
mixture is magnetically stirred and heated to 60 °C for 3 days. Then the autoclave is 
allowed to cool to room temperature. After expanding the syngas, the remaining 
solution is filtered through alumina N (III) using MTBE as eluent. The solvent is 
removed evaporation and the residue is analyzed by gas chromatography. The product 
of the reaction mixture is separated by bulb-to-bulb distillation (T = 85 °C, P = 5 x 10-2 
mbar) and 1.853 g (8.2 mmol, 82 % yield) of ethyl 2-oxo-1-(4-oxo-pentyl)cyclopentane 
carboxylate178 (70a) (C12H18O4, 226.269 g/mol) are obtained. 
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Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 
226 (1), 198 (8), 196 (48), 156 (92), 152 (62), 79 (98), 
55 (25). IR (KBr-film): ν  [cm-1] = 2963 (s), 2832 (s), 
2725 (w), 1749 (s), 1723 (s), 1450 (m). 1H-NMR (500 
MHz, CDCl3): δ [ppm] = 1.21 (t, 3H, 3J = 7.23 Hz, 
CH3-13), 1.50-1.68 (m, 3H), 1.86-2.01 (m, 4H), 2.22 
(m, 1H), 2.35-2.50 (m, 4H), 4.12 (q, 2H, 3J = 7.23 Hz, 
CH2-12), 9.7 (br t, 1H, 3J = 1.50 Hz, CHO-9). 13C-
NMR (125 MHz, CDCl3): δ [ppm] = 14.0 (CH3, C-
13), 17.4, 19.5, 32.7, 33.0, 37.8, 43.8 (CH2-3/4/5/6/7/8), 60.1 (Cq, C-1), 61.4 (CH2, C-
12), 170.8 (CO, C-10), 201.7 (CO, C-9), 214.6 (CO, C-2). 
 
 
R 14: Synthesis of ethyl 2-oxo-1-(4-oxo-butyl)cyclohexane carboxylate (70b) 
Amounts: 2.0 g  (9.5 mmol) ethyl 1-allyl-2-oxo-cyclohexane  
      carboxylate (4b) 
  24.0 mg (1.0 % mol) [Rh(acac)(CO)2] (28) 
  313.0 mg (5.0 % mol) BIPHEPHOS (29) 
  20 ml     dry DCM 
Procedure: Analogously toR 13; 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h. 
Work-up: After expanding the syngas, the remaining solution is filtered through 
alumina N (III) using MTBE as eluent. The solvent is removed and the residue is 
analyzed by gas-chromatography giving 2.32 g (9.3 mmol, 98 % yield) of ethyl 2-oxo-
1-(4-oxo-butyl)cyclohexane carboxylate (70b)178 
(C13H20O4, 240.296 g/mol).  
Spectroscopic data: 1H-NMR (500 MHz, CDCl3): δ 
[ppm] = 1.19 (t, 3H, 3J = 7.23 Hz, CH3-14), 1.39-
1.95 (m, 10H), 2.36-2.47 (m, 4H), 4.15 (q, 2H, 3J = 
7.23 Hz, CH2-13), 9.68 (br s, 1H, 3J = 1.50 Hz, 
CHO-10). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 
14.0 (CH3, C-14), 16.9, 22.4, 27.4, 33.9, 35.90, 40.9, 
43.8 (CH2-3/4/5/6/7/8/9), 60.5 (Cq, C-1), 61.1 (CH2, C-13), 171.6 (CO, C-11), 201.8 
(CO, C-10), 207.6 (CO, C-2). 
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R 15: Synthesis of ethyl 2-oxo-1-(4-oxo-butyl)cycloheptane carboxylate (70c) 
Amounts: 4.0 g  (17.8 mmol) ethyl 1-allyl-2-oxo-cycloheptane  
      carboxylate (4c) 
  46.0 mg (1.0 % mol) [Rh(acac)(CO)2] (28) 
  550.0 mg (5.0 % mol) BIPHEPHOS (29) 
  20 ml     dry DCM 
Procedure: Analogously to R 13, 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h. 
Work-up: After expanding the syngas, the remaining solution is filtered through 
alumina N (III) using MTBE as eluent. The solvent is removed and 4.38 g (17.2 mmol, 
97 % yield) of ethyl 2-oxo-1-(4-oxo-butyl)cycloheptane carboxylate (70c) (C14H22O4, 
254.3221 g/mol) are obtained as a colorless single product without any further 
purification. 
Spectroscopic data: of 70c: GC-MS (EI, 70 eV): m/z (%) = 254 (2), 209 (10), 181 (8), 
109 (12), 95 (33), 81 (39), 67 (56), 55 (55). IR 
(KBr-film): ν  [cm-1] = 3428 (m), 2935 (vs), 2863 
(s), 2721 (m), 1727 (vs), 1712 (vs), 1455 (s), 1455 
(s), 1446 (s), 1224 (s), 1176 (s), 1151 (s), 970 (m). 
1H-NMR (500 MHz, CDCl3): δ [ppm] = 1.19 (t, 
3H, 3J = 7.23 Hz, CH3-15), 1.35 (m, 2H), 1.51-1.54 
(m, 6H), 1.68 (m, 2H), 1.89 (m, 1H), 2.06-2.11 (m, 
1H), 2.36-2.42 (m, 3H), 2.56-2.61 (m, 1H), 4.14 (q, 
2H, 3J = 7.23 Hz, CH2-14), 9.68 (br t, 1H, 3J = 1.50 Hz, CHO-11). 13C-NMR (125 
MHz, CDCl3): δ [ppm] = 14.0 (CH3, C-15), 17.3, 24.7, 25.3, 29.7, 32.7, 34.6, 41.9, 43.8 
(CH2-3/4/5/6/7/8/9/10), 61.0 (CH2, C-14), 62.5 (Cq, C-1), 172.1 (CO, C-12), 201.8 
(CO, C-11), 209.2 (CO, C-2). 
 
 
b. Ethyl (1-but-3-enyl)-2-oxo-cycloalkane carboxylates (68a-c) as starting 
materials  
 
R 16: Synthesis of ethyl 2-oxo-1-(5-oxo-pentyl)cyclopentane carboxylate (71a). 
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A solution of 2.0 g (9.5 mmol) of ethyl 1-(but-3-enyl)-2-oxo-cyclopentane carboxylate 
(68a), 297 mg (5.0 mol %) of BIPHEPHOS (29) and 49.0 mg (1.0 mol %) of 
[Rh(acac)(CO)2] (28) in anhydrous dichloromethane (20 ml) is placed in an autoclave. 
After flushing with argon the reactor is pressurized with 10 bar carbon monoxide and 
10 bar hydrogen, the mixture is magnetically stirred and heated to 60 °C for 3 days. 
Then the autoclave is allowed to cool to room temperature. After expanding the syngas, 
the remaining solution is filtered through alumina N (III) using MTBE as eluent. The 
solvent is removed and the residue is analyzed by gas chromatography. The product is 
separated by bulb-to-bulb distillation (T = 110 °C, P = 5.5 x 10-2 mbar) obtaining 2.057 
g (8.57 mmol, 61 % yield) of the linear aldehyde ethyl 2-oxo-1-(5-oxo-
pentyl)cyclopentane carboxylate (71a) (C13H20O4, 240.296 g/mol) as a colorless oil. 
Spectroscopic data of 71a: GC-MS (EI, 70 eV): m/z (%) = 241 (M++1, 4), 212 (5), 
195 (5), 166 (10), 83 (40), 55 (40). IR (KBr-film): ν  [cm-1] = 2940 (s), 2865 (s), 2721 
(w), 1724 (vs), 1720 (vs), 1712 (vs), 1446 (m), 
1450 (s), 1218 (s), 1178 (s), 1137 (s), 1097 (s), 
1022 (m). 1H-NMR (400 MHz, CDCl3): δ [ppm] = 
1.18 (t, 3H, 3J = 7.03 Hz, CH3-15), 1.55-2.46 (m, 
12H), 4.08 (q, 2H, 3J = 7.03 Hz, CH2-14), 9.69 (br 
s, 1H, CHO-10). 13C-NMR (100 MHz, CDCl3): δ 
[ppm] = 14.0 (CH3, C-15), 19.5, 22.1, 24.2, 32.7, 
33.3, 37.8, 43.4 (CH2, C-3/4/5/6/7/8/9), 60.1 (Cq, C-1), 61.2 (CH2, C-14), 170.8 (CO, 
C-12), 202.2 (CO, C-10), 214.7 (CO, C-2). 
 
 
R 17: Synthesis of ethyl 2-oxo-1-(5-oxo-pentyl)cyclohexane carboxylate (71b) 
Amounts: 2.0 g  (8.9 mmol) ethyl 1-(but-3-enyl)-2-oxo-cyclohexane
      carboxylate (68b) 
  45.9 mg (1.0 mol %) [Rh(acac)(CO)2] (28) 
  279.0 mg (5.0 mol %) BIPHEPHOS (29) 
  20 ml     dry DCM 
Procedure: Analogously to R 13; 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h. 
Work-up: The solvent is removed and the residue is analyzed by gas-
chromatography. The product is then separated by bulb-to-bulb distillation, T = 110 °C, 
P = 5.0 x 10-2 mbar, giving 0.79 g (3.0 mmol, 35 % yield) of ethyl 2-oxo-1-(5-oxo-
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pentyl)cyclohexane carboxylate (71b) as a colorless oil. Spectroscopic data: of 71b: 
GC-MS (EI, 70 eV): m/z (%) = 254 (2), 225 (30), 209 (95), 181 (70), 152 (5), 124 (40), 
96 (10), 55 (10). IR (KBr-film): ν  [cm-1] = 2940 (s), 2865 (s), 2721 (w), 1724 (vs), 
1720 (vs), 1712 (vs), 1463 (s), 1450 (s), 1307 (s), 1241 (s), 1207 (s), 1135 (s), 1097 (s), 
1022 (s). 1H-NMR (500 MHz, CDCl3): δ 
[ppm] = 1.22 (t, 3H, 3J = 7.03 Hz, CH3-16), 
1.38 (m, 1H), 1.50 (m, 1H), 1.58 (m, 3H), 
1.63-1.71 (m, 3H), 1.82 (m, 1H), 1.95 (m, 
1H), 2.38-2.46 (m, 6H), 4.15 (q, 2H, 3J = 
7.03 Hz, CH2-15), 9.7 (t, 1H, 3J = 1.75 Hz, 
CHO-11). 13C-NMR (125 MHz, CDCl3): δ 
[ppm] = 14.1 (CH3, C-16), 22.3, 22.5, 23.8, 27.5, 34.3, 36.1, 41.0, 43.5 (CH2, C-
3/4/5/6/7/8/9/10), 60.6 (Cq, C-1), 61.1 (CH2, C-15), 170.8 (CO, C-13), 202.3 (CO, C-
11), 207.9 (CO, C-2). 
 
 
R 18: Synthesis of ethyl 2-oxo-1-(5-oxo-pentyl)cycloheptane carboxylate (71c) 
Amounts: 0.40 g  (1.6 mmol) ethyl 1-(but-3-enyl)-2-oxo-cycloheptane 
      carboxylate (68c) 
  4.1 mg  (1.0 mol %) [Rh(acac)(CO)2] (28) 
  50.0 mg (5.0 mol %) BIPHEPHOS (29) 
  20 ml     dry DCM 
Procedure: Analogously to R 13, 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h. 
Work-up: The solvent is removed by rotary evaporation and the residue is analyzed 
by gas chromatography. The product is then separated by column chromatography with 
a mixture of cyclohexane-MTBE (3:1), and 0.171 g (0.6 mmol, 40 % yield) of ethyl 2-
oxo-1-(5-oxo-pentyl)cycloheptane carboxylate (71c) are obtained as a colorless oil. 
Spectroscopic data of 71c: GC-MS (EI, 70 eV): 
m/z (%) = 268 (M+, 1), 223 (6), 195 (7), 111 (8), 
55 (41). IR (KBr-film): ν  [cm-1] = 2935 (vs), 2863 
(s), 2721 (m), 1731 (vs), 1727 (vs), 1712 (vs), 
1455 (s), 1446 (s), 1417 (m), 1367 (m), 1309 (m), 
1251 (s), 1224 (s), 1176 (s), 1151 (s), 1097 (s), 
1025 (s). 1H-NMR (400 MHz, CDCl3): δ [ppm] = 
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1.21 (t, 3H, 3J = 6.27 Hz, CH3-16), 1.35 (m, 2H), 1.50-1.69 (m, 10H), 1.92 (m, 1H), 
2.08 (m, 1H), 2.39 (m, 3H), 2.58 (m, 1H), 4.11 (q, 2H, 3J = 7.03 Hz, CH2-15), 9.70 (br 
s, 1H, CHO-12). 13C-NMR (100 MHz, CDCl3): δ [ppm] = 14.0 (CH3, C-16), 22.3, 
24.1, 24.7, 25.4, 29.7, 32.8, 35.0, 42.0, 43.5 (CH2, C-3/4/5/6/7/8/9/10/11), 61.0 (CH2, 
C-15), 62.5 (Cq, C-1), 172.3 (CO, C-13), 202.3 (CO, C-12), 209.5 (CO, C-2). 
 
 
4.3.2 Second step: Step-wise intramolecular aldol addition under acidic 
conditions 
a. Ethyl 2-oxo-1-(4-oxo-butyl)cycloalkane carboxylates (70a-c) 
R 19: Synthesis of ethyl 6-formyl-2,3,4,5-tetrahydropentalene-3a(1H)-carboxylate 
(72a) 
To a solution of ethyl 2-oxo-1-(4-oxo-butyl)cyclopentane carboxylate (70a) (1.0 g, 4.4 
mmol) in 20 ml of DCM is added HCl 7N (14.0 ml) and the mixture is stirred for 18h at 
room temperature. Then, the solution is cautiously neutralized with NaHCO3 and the 
aqueous layer is extracted with ether (3 x 20 ml). The combined organic phase is dried 
with anhydrous MgSO4, filtered, and concentrated in vacuum. 905 mg (4.3 mmol, 99 % 
yield) of ethyl 6-formyl-2,3,4,5-tetrahydropentalene-3a(1H)-carboxylate (72a) 
(C12H16O3, 208.254 g/mol) are obtained as a colorless oil. 
Spectroscopic data of 72a: GC-MS (EI, 70 eV): m/z (%) = 
209 (M++1, 67), 208 (22), 179 (2), 163 (7), 135 (100), 107 
(45), 79 (68), 65 (15). IR (KBr-film): ν [cm-1] = 2938 (s), 
2868 (w), 1725 (s), 1683 (s). 1H-NMR (400 MHz, CDCl3): 
δ [ppm] = 1.20 (t, 3H, 3J = 7.03 Hz, CH3-12), 1.30 (m, 1H), 
1.44 (m, 1H), 1.65-1.73 (m, 2H), 1.88-1.93 (m, 1H), 2.19 
(m, 2H), 2.49-2.57 (m, 2H), 3.18 (m, 1H), 4.12 (q, 2H, 3J = 
7.03 Hz, CH2-11), 10.0 (s, 1H, CHO-7). 13C-NMR (100 
MHz, CDCl3): δ [ppm] = 14.1 (CH3, C-12), 23.5, 25.4, 
28.2, 35.3, 38.2 (CH2, C-1/2/3/4/5), 60.9 (CH2, C-11), 137.7 
(Cq, C-6), 163.7 (Cq, C-6a), 174.4 (CO, C-9), 188.0 (CO, C-7). 
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R 20: Synthesis of ethyl 6-formyl-2,3,4,5-tetrahydropentalene-3a(1H)-carboxylate 
(72a) 
To a solution of ethyl 2-oxo-1-(4-oxo-butyl)cyclopentane carboxylate (70a) (1.0 g, 4.4 
mmol) in 20 ml of DCM is added H2SO4 conc. (98 %) 1.05 ml (16.0 mmol) and the 
mixture is stirred for 3 hours at T = 0 °C and for other 21 hours at room temperature. 
Then, the solution is cautiously neutralized with NaHCO3 and the aqueous layer is 
extracted with ether and washed with brine. The combined organic phase is dried with 
anhydrous MgSO4, filtered, and concentrated in vacuum obtaining 906 mg (4.3 mmol, 
99 % yield) of ethyl 6-formyl-2,3,4,5-tetrahydropentalene-3a(1H)-carboxylate (72a) 
(C12H16O3, 208.254 g/mol) are obtained as a colorless oil. Spectroscopic data of 72a 
are consistent with those reported in R 19. 
 
 
R 21: Synthesis of ethyl 6-formyl-2,3,4,5-tetrahydropentalene-3a(1H)-carboxylate 
(72a) 
Amounts: 1.0 g  (4.4 mmol) ethyl 2-oxo-1-(4-oxo-butyl)cyclopentane 
      carboxylate (70a) 
  14.0 ml    HCl (7N) 
  20 ml    dioxane  
Procedure: Analogously to R 19. 
Work-up: The combined organic phase is dried with anhydrous MgSO4, filtered, 
and concentrated in vacuum. 560 mg (2.6 mmol, 61 %) of ethyl 6-formyl-2,3,4,5-
tetrahydropentalene-3a(1H)-carboxylate (72a) (C12H16O3, 208.254 g/mol) are obtained. 
Spectroscopic data of 72a are consistent with those reported in R 19. 
 
 
R 22: Synthesis of ethyl 6-formyl-2,3,4,5-tetrahydropentalene-3a(1H)-carboxylate 
(72a) 
Amounts: 1.0 g  (4.4 mmol) ethyl 2-oxo-1-(4-oxo-butyl)cyclopentane
      carboxylate (70a) 
  1.05 ml    H2SO4 conc. (98 %) 
  20 ml     dioxane  
Procedure: Analogously to R 20.  
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Work-up:  The combined organic phase is dried with anhydrous MgSO4, filtered, 
and concentrated in vacuum. 906 mg (4.3 mmol, 99 % yield) of ethyl 6-formyl-2,3,4,5-
tetrahydropentalene-3a(1H)-carboxylate (72a) (C12H16O3, 208.254 g/mol) are obtained. 
Spectroscopic data of 72a are consistent with those reported in R 19. 
 
 
R 23: Synthesis of ethyl 6-formyl-2,3,4,5-tetrahydropentalene-3a(1H)-carboxylate 
(72a) 
To a solution of ethyl 2-oxo-1-(4-oxo-butyl)cyclopentane carboxylate (70a) 1.0 g (4.4 
mmol), in 20 ml of DCM is added PTSA 42.0 mg (5.0 % mol) and the mixture is stirred 
for 72 h at reflux. Then, the solution is extracted with Et2O, the combined organic 
phases are washed with water and dried over anhydrous MgSO4. After evaporation of 
solvent under reduced pressure, the residue is analyzed by gas-chromatography. 906 
mg (4.3 mmol, 99 % yield) of ethyl 6-formyl-2,3,4,5-tetrahydropentalene-3a(1H)-
carboxylate (72a) (C12H16O3, 208.254 g/mol) are obtained. Spectroscopic data of 72a 
are consistent with those reported in R 19. 
 
 
R 24: Synthesis of ethyl 1-formyl-2,3,4,5,6,7-hexahydro-3aH-indene-3a-
carboxylate (72b) 
Amounts: 1.0 g  (4.1 mmol) ethyl 2-oxo-1-(4-oxo-butyl)cyclohexane
      carboxylate (70b) 
  13.1 ml    HCl (7N) 
  20 ml     DCM  
Procedure:  Analogously to R 19. 
Work-up:  The combined organic phase is dried with anhydrous MgSO4, filtered, 
and concentrated in vacuum. 0.891 g (4.01 mmol, 99 % yield) of ethyl 1-formyl-
2,3,4,5,6,7-hexahydro-3aH-indene-3a-carboxylate (72b) (C13H18O3, 222.280 g/mol) is 
obtained. 
Spectroscopic data of 72b: GC-MS (EI, 70 eV): m/z (%) = 222 (M+, 7), 149 (30), 121 
(28), 29 (100). High Resolution Mass: Calculated: 222.1256; Found: 222.1256. IR 
(KBr-film): ν  [cm-1] = 3307 (w), 2938 (vs), 2859 (s), 2730 (s), 1727 (vs), 1668 (vs, 
1446 (s), 1390 (m), 1224 (s), 1176 (s), 1027 (s). 1H-NMR (500 MHz, CDCl3): δ [ppm] 
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= 1.19 (t, 3H, 3J = 6.98 Hz, CH3-12), 1.29-1.43 (m, 3H), 
1.67 (m, 2H), 1.89 (m, 1H), 2.19 (m, 2H), 2.48-2.56 (m, 
3H), 3.17 (m, 1H), 4.11 (q, 2H, 3J = 6.98 Hz, CH2-11), 
9.99 (s, 1H, CHO-8). 13C-NMR (125 MHz, CDCl3): δ 
[ppm] = 14.1 (CH3, C-12), 23.5, 25.4, 26.9, 28.2, 35.3, 
38.1 (CH2, C-2/3/4/5/6/7), 60.6 (Cq, C-3a), 60.8 (CH2, 
C-11), 137.6 (Cq, C-1), 163.9 (Cq, C-7a), 174.4 (CO, 
C-9), 188.0 (CO, C-8). 
 
 
R 25: Synthesis of ethyl 1-formyl-2,3,4,5,6,7-hexahydro-3aH-indene-3a-
carboxylate (72b) 
Amounts: 0.5 g  (2.0 mmol) ethyl 2-oxo-1-(4-oxo-butyl)cyclohexane
      carboxylate (70b) 
  0.9 ml     H2SO4 conc. (98 %) 
  15 ml    DCM  
Procedure: Analogously to R 20. 
Work-up: The combined organic phase is dried with anhydrous MgSO4, filtered, 
and concentrated in vacuum obtaining 0.435 g (1.96 mmol, 98 % yield) of ethyl 1-
formyl-2,3,4,5,6,7-hexahydro-3aH-indene-3a-carboxylate (72b) (C13H18O3, 222.280 
g/mol) is obtained. Spectroscopic data of 72b are consistent with those reported in R 
24. 
 
 
R 26: Synthesis of ethyl 1-formyl-2,3,4,5,6,7-hexahydro-3aH-indene-3a-
carboxylate (72b) 
Amounts: 1.0 g  (4.1 mmol) 2-oxo-1-(4-oxo-butyl)cyclohexane 
      carboxylate (70b) 
  13.1 ml   HCl (7N) 
  20 ml    dioxane  
Procedure: Analogously to R 19. 
Work-up: The combined organic phase is dried with anhydrous MgSO4, filtered, 
and concentrated in vacuum. 473 mg (2.1 mmol, 52 % yield) of ethyl 1-formyl-
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2,3,4,5,6,7-hexahydro-3aH-indene-3a-carboxylate (72b) (C13H18O3, 222.280 g/mol) is 
obtained. 
Spectroscopic data of 72b are consistent with those reported in R 24. 
 
 
R 27: Synthesis of ethyl 1-formyl-2,3,4,5,6,7-hexahydro-3aH-indene-3a-
carboxylate (72b) 
Amounts: 0.5 g  (2.0 mmol) ethyl 2-oxo-1-(4-oxo-butyl)cyclohexane 
      carboxylate (70b) 
  0.90 ml   H2SO4 conc. (98 %) 
  20 ml    dioxane 
Procedure: Analogously to R 20. 
Work-up: The combined organic phase is dried with anhydrous MgSO4, filtered, 
and concentrated in vacuum giving 0.435 g (1.96 mmol, 98 % yield) of ethyl 1-formyl-
2,3,4,5,6,7-hexahydro-3aH-indene-3a-carboxylate (72b) (C13H18O3, 222.280 g/mol) is 
obtained. Spectroscopic data of 72b are consistent with those reported in R 24. 
 
 
R 28: Synthesis of ethyl 1-formyl-2,3,4,5,6,7-hexahydro-3aH-indene-3a-
carboxylate (72b) 
Amounts: 1.0 g  (4.1 mmol) ethyl 2-oxo-1-(4-oxo-butyl)cyclohexane
      carboxylate (70b) 
  40.0 mg  (5.0 % mol) PTSA 
  20 ml    DCM 
Procedure: Analogously to R 23. 
Work-up: Then, the solution is extracted with Et2O, the combined organic phases 
are washed with water and dried over anhydrous MgSO4.. After evaporation of solvent 
under reduced pressure, the residue is analyzed by gas-chromatography. 0.88 g (3.96 
mmol, 97 % yield) of ethyl 1-formyl-2,3,4,5,6,7-hexahydro-3aH-indene-3a-carboxylate 
(72b) (C13H18O3, 222.280 g/mol) is obtained. 
Spectroscopic data of 72b are consistent with those reported in R 24. 
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R 29: Attempt to synthesize ethyl 1-formyl-2,4,5,6,7,8,-hexahydro-azulene-3a(3H) 
carboxylate (72c) 
Amounts: 0.15 g  (0.6 mmol) ethyl 2-oxo-1-(4-oxo-butyl)cycloheptane
      carboxylate (70c) 
  2.0 ml     HCl (7N)  
  10 ml     DCM 
Procedure: Analogously to R 19. 
Work-up: The combined organic phase is dried with anhydrous MgSO4, filtered, 
and concentrated in vacuum. Starting material is recovered.  
 
 
R 30: Attempt to aldol addition of ethyl 2-oxo-1-(4-oxo-butyl)cycloheptane 
carboxylate (70c) 
Amounts: 0.15 g  (0.6 mmol) ethyl 2-oxo-1-(4-oxo-butyl)cycloheptane
      carboxylate (70c) 
  2.00 ml    HCl (7N)  
  10 ml     dioxane 
Procedure: Analogously to R 19. 
Work-up: The combined organic phase is dried with anhydrous MgSO4, filtered, 
and concentrated in vacuum. Starting material is recovered.  
 
 
b. Ethyl 2-oxo-1-(5-oxo-pentyl)cycloalkane carboxylates (71a-c) 
 
R 31: Attempted aldol addition of ethyl 2-oxo-1-(5-oxo-pentyl)cyclopentane 
carboxylate (71a) 
Amounts: 0.3 g  (0.6 mmol) ethyl 2-oxo-1-(5-oxo-pentyl)cyclopentane
      carboxylate (71a) 
  4.0 ml     HCl (7N) 
  10 ml     DCM 
Procedure: Analogously to R 19. 
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Work-up: The combined organic phase is dried with anhydrous MgSO4, filtered, 
and concentrated in vacuum. After removal of solvent, no products are obtained: 
starting material is recovered. 
 
 
R 32: Attempted aldol addition of ethyl 2-oxo-1-(5-oxo-pentyl)cyclopentane 
carboxylate (71a) 
Amounts: 0.3 g  (0.6 mmol) ethyl 2-oxo-1-(5-oxo-pentyl)cyclopentane
      carboxylate (71a) 
  0.90 ml    H2SO4 conc. (98 %) 
  10 ml     DCM 
Procedure: Analogously to R 20. 
Work-up: The combined organic phase is dried with anhydrous MgSO4, filtered, 
and concentrated in vacuum. After removal of solvent no products are obtained starting 
material is recovered.  
 
 
R 33: Attempted aldol addition of ethyl 2-oxo-1-(5-oxo-pentyl)cyclohexane 
carboxylate (71b) 
Amounts: 0.3 g  (0.6 mmol) ethyl 2-oxo-1-(5-oxo-pentyl)cyclohexane 
      carboxylate (71b) 
  4.0 ml     HCl (7N)  
  10 ml     DCM 
Procedure: Analogously to R 19. 
Work-up:  The combined organic phase is dried with anhydrous MgSO4, filtered, 
and concentrated in vacuum. After removal of the solvent, no products are obtained 
starting material is recovered. 
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R 34: Attempted aldol addition of ethyl 2-oxo-1-(5-oxo-pentyl)cyclohexane 
carboxylate (71b) 
Amounts: 0.3 g  (0.6 mmol) ethyl 2-oxo-1-(5-oxo-pentyl)cyclohexane 
      carboxylate (71b) 
    0.90 ml  H2SO4 conc. (98 %) 
    10 ml   DCM 
Procedure: Analogously to R 20.  
Work-up: The combined organic phase is dried with anhydrous MgSO4, filtered, 
and concentrated in vacuum. After removal of the solvent no products are obtained 
starting material is recovered. 
 
 
R 35: Attempted aldol addition of ethyl 2-oxo-1-(5-oxo-pentyl)cycloheptane 
carboxylate (71c) 
Amounts: 0.2 g  (0.74 mmol) ethyl 2-oxo-1-(5-oxo-pentyl)cycloheptane 
      carboxylate (71c) 
  2.0 ml     HCl (7N) 
  10 ml     DCM 
Procedure: Analogously to R 23; T = 60 °C, t = 72 h. 
Work-up: The combined organic phase is dried with anhydrous MgSO4, filtered, 
and concentrated in vacuum. After removal of the solvent no products are obtained 
starting material is recovered. 
 
 
4.3.3 Attempts of tandem hydroformylation/ aldol addition on ethyl 1-alkenyl-2-
oxo-cycloalkane carboxylates. 
a. Ethyl 1-allyl-2-oxo-cycloalkane carboxylates (4a-e)  
 
R 36: Synthesis of ethyl 6-formyl-2,3,4,5-tetrahydropentalene-3a(1H)-
carboxylate (72a) 
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A solution of ethyl 1-allyl-2-oxo-cyclopentane carboxylate (4a) (1.0 g, 5.1 mmol), 150 
mg (4.0 mol %) of BIPHEPHOS (29), 49.2 mg (5.0 mol %) of PTSA and 13.1 mg (1.0 
mol %) of [Rh(acac)(CO)2] (28) in anhydrous dichloromethane (20 ml) is placed in an 
autoclave. After flushing with argon the reactor is pressurized with 10 bar carbon 
monoxide and 10 bar hydrogen, the mixture is magnetically stirred and heated to 60 °C 
for 3 days. Then the autoclave is allowed to cool to room temperature. After expanding 
the syngas, the remaining solution is filtered through alumina N (III) using MTBE as 
eluent. The solvent is removed and the residue is analyzed by gas chromatography. The 
mixture is separated by column chromatography using a mixture of cyclohexane and 
MTBE (8:1) as eluent 698.0 mg (3.35 mmol, 65 % yield) of ethyl 6-formyl-2,3,4,5-
tetrahydropentalene-3a(1H)-carboxylate (72a) (C12H16O3, 208.254 g/mol) are obtained 
as a colorless oil. Spectroscopic data of 72a are consistent with those reported in R 19. 
 
 
R 37: Conversion of ethyl 1-allyl-2-oxo-cyclohexane carboxylate (4b) 
Amounts: 1.0 g  (4.7 mmol) ethyl 1-allyl-2-oxo-cyclohexane  
      carboxylate (4b) 
  24.0 mg (1.0 mol %) [Rh(acac)(CO)2] (28) 
  147.0 mg (4.0 mol %) BIPHEPHOS (29) 
  45.0 mg (5.0 mol %) PTSA 
  20 ml     abs. DCM 
Procedure: Analogously to R 36; 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h. 
Work-up:  After expanding the syngas, the remaining solution is filtered through 
alumina N (III) using MTBE as eluent. The solvent is removed and the residue is 
analyzed by gas chromatography. By bulb-to-bulb distillation (T = 75 °C, 7.0 x 10-2 
mbar) are obtained 0.712 g (79 % by G.C-analysis) as a colorless mixture of ethyl 1-
formyl-2,3,4,5,6,7-hexahydro-3aH-indene-3a-carboxylate (72b) (C13H18O3, 222.280 
g/mol) and ethyl 1-formyl-octahydro-3aH-indene-3a-carboxylate (76b) (C13H20O3, 
224.280 g/mol) in a ratio of 3:1 detected by 1H-NNR analysis. The ethyl 1-formyl-
octahydro-3aH-indene-3a-carboxylate (76b) is present as a mixture of 2 
diastereoisomers in a ratio of 1:1.3 calculated by 1H-NNR analysis. Spectroscopic data 
of 72b are consistent with those reported in R 24. 
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The presence of the ethyl 1-formyl-octahydro-3aH-
indene-3a-carboxylate (76b) is detected from the most 
significant peaks identified by NMR analysis: 1H-NMR 
(500 MHz, CDCl3): δ [ppm] = 9.54 (d, 1H, 3J = 2.76 Hz, 
CHO-13, DS1/DS2), 9.72 (d, 1H, 3J = 1.76 Hz, CHO-13, 
DS2/DS1). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 41.5 
(CH, C-8, DS1/DS2), 42.0 (CH, C-8, DS2/DS1), 54.3 
(CH, C-1, DS1/DS2), 54.4 (CH, C-1, DS2/DS1), 203.0 
(CO, C-13, DS-1/2), 203.5 (CO, C-13, DS-2/1).  
 
 
R 38: Synthesis of ethyl 2-oxo-1-(4-oxo-butyl)cycloheptane carboxylate (70c) 
Amounts: 812.0 mg (3.6 mmol) ethyl 1-allyl-2-oxo-cycloheptane  
      carboxylate (4c) 
  2.00 mg (1.0 mol %) [Rh(acac)(CO)2] (28) 
  111.0 mg (4.0 mol %) BIPHEPHOS (29) 
  34.0 mg (5.0 mol %) PTSA 
  20 ml     dry DCM 
Procedure: Analogously to R 36; 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h. 
Work-up: After expanding the syngas, the remaining solution is filtered through 
alumina N (III) using MTBE as eluent. The solvent is removed and the residue is 
analyzed by gas-chromatography. 0.916 g (3.6 mmol, 98 %) of ethyl 2-oxo-1-(4-oxo-
butyl)cycloheptane carboxylate (70c) (C14H22O4, 254.3221 g/mol) are isolated as a 
colorless single product without any further purification. 
Spectroscopic data of 70c are consistent with those reported in R 15. 
 
 
R 39: Synthesis of ethyl 2-oxo-1-(4-oxo-butyl)cyclooctane carboxylate (70d) 
Amounts: 1.00 g  (4.2 mmol) ethyl 1-allyl-2-oxo-cyclooctane  
      carboxylate (4d) 
  10.0 mg (1.0 % mol) [Rh(acac)(CO)2] (28) 
  132.0 mg (4.0 % mol) BIPHEPHOS (29) 
  40.0 mg (5.0 % mol) PTSA 
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  20 ml     dry DCM 
Procedure: Analogously to R 36; 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h. 
Work-up: After expanding the syngas, the remaining solution is filtered through 
alumina N (III) using MTBE as eluent. The solvent is removed and the residue is 
analyzed by gas-chromatography. 419.0 mg (3.7 mmol, 37 % yield) of ethyl 2-oxo-1-
(4-oxo-butyl)cyclo-octane carboxylate (70d) (C15H24O4 268.349 g/mol) are isolated as 
a colorless single product without any further purification. 
Spectroscopic data: IR (KBr-film): ν  [cm-1] = 
3434 (w), 2929 (s), 2873 (m), 2854 (m), 2721 (w), 
1737 (vs), 1725 (vs), 1708 (vs), 1643 (m), 1477 
(m), 1446 (s), 1232 (s), 1193 (s), 1025 (s). 1H-
NMR (500 MHz, CDCl3): δ [ppm] = 1.22 (t, 3H, 
3J = 6.98 Hz, CH3-17), 1.30-1.50 (m, 10H), 1.65 
(m, 1H), 1.86-1.91 (m, 3H), 2.20-2.44 (m, 3H), 
2.70 (m, 1H), 4.15 (q, 2H, 3J = 6.98 Hz, CH2-16), 9.7 (br s, 1H, CHO-12). 13C-NMR 
(125 MHz, CDCl3): δ [ppm] = 14.0 (CH3, C-17), 19.7, 22.7, 23.5, 23.9, 24.6, 25.2, 
28.5, 37.8, 39.3 (CH2, C-3/4/5/6/7/8/9/10/11), 61.1 (Cq, C-1), 61.4 (CH2, C-16), 170.9 
(CO, C-14), 201.2 (CO, C-12), 213.8 (CO, C-2). 
 
 
R 40: Synthesis of ethyl 2-oxo-1-(4-oxo-butyl)cyclononane carboxylate (70e) 
Amounts: 1.00 g  (4.0 mmol) ethyl 1-allyl-2-oxo-cyclononane  
      carboxylate (4e) 
  10.0 mg (1.0 % mol) [Rh(acac)(CO)2] (28) 
  120.0 mg (4.0 % mol) BIPHEPHOS (29) 
  38.0 mg (5.0 % mol) PTSA 
  20 ml     dry DCM 
Procedure: Analogously to R 36; 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h. 
Work-up:  After expanding the syngas, the remaining solution is filtered through 
alumina N (III) using MTBE as eluent. The solvent is removed and the residue is 
analyzed by gas-chromatography. 451.0 mg (1.6 mmol, 40 % yield) of ethyl 2-oxo-1-
(4-oxo-butyl)cyclononane carboxylate (70e) (C16H26O4, 282.375 g/mol) are isolated as 
a colorless single product without any further purification.  
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Spectroscopic data: 1H-NMR (400 MHz, 
CDCl3): δ [ppm] = 1.18 (t, 3H, 3J = 7.03 Hz, 
CH3-18), 1.5 (m, 10H), 1.7 (m, 2H), 1.8 (m, 2H), 
2.2 (m, 2H), 2.4 (m, 2H), 2.7 (m, 2H), 4.16 (q, 
2H, 3J = 7.03 Hz, CH2-17), 9.7 (m, 1H, CHO-
13). 13C-NMR (100 MHz, CDCl3): δ [ppm] = 
14.2 (CH3, C-18), 17.1, 19.9, 23.2, 23.8, 24.7, 
25.1, 27.5, 30.7, 37.7, 44.1 (CH2, C-
3/4/5/6/7/8/9/10/11/12), 61.3 (Cq, C-1), 63.8 (CH2, C-17), 172.1 (CO, C-15), 201.8 
(CO, C-13), 210.0 (CO, C-2). 
 
 
R 41: Conversion of ethyl 1-allyl-2-oxo-cyclohexane carboxylate (4b)  
Amounts: 1.0 g  (4.7 mmol) ethyl 1-allyl-2-oxo-cyclohexane  
      carboxylate (4b) 
  12.0 mg (1.0 % mol) [Rh(acac)(CO)2] (28) 
  147 mg (4.0 % mol) BIPHEPHOS (29) 
  36.0 mg (5.0 % mol) DBU 
  20 ml    dry DCM 
Procedure:  Analogously to R 36; 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h. 
Work-up:  After expanding the syngas, the remaining solution is filtered through 
alumina N (III) using MTBE as eluent. The solvent is removed; the residue is analyzed 
by gas-chromatography. 1.105 g of the crude products is formed of a mixture of ethyl 
1-formyl-2,3,4,5,6,7-hexahydro-3aH-indene-3a-carboxylate (72b) (C12H16O3, 208.254 
g/mol) and ethyl 2-oxo-1-(4-oxo-butyl)-cyclohexane carboxylate (70b) (C13H20O4, 
240.296 g/mol) in a ratio of 11:1 detected by 1H-NMR analysis. 
Spectroscopic data: of 72b are consistent with those reported in R 37. 
Spectroscopic data: of 70b178 are consistent with those reported in R 14. 
 
 
b. Ethyl (1-but-3-enyl)-2-oxo-cycloalkane carboxylates (68a-c,e) 
 
R 42: Synthesis of ethyl 2-oxo-1-(5-oxo-pentyl)cyclopentane carboxylate (71a)  
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Amounts:  0.2 g  (0.95 mmol) ethyl 1-(but-3-enyl)-2-oxo-cyclopentane 
      carboxylate (68a) 
  4.9 mg  (1.0 % mol) [Rh(acac)(CO)2] (28) 
  29.7 mg (4.0 % mol) BIPHEPHOS (29) 
  9.1 mg  (5.0 % mol) PTSA 
  20 ml     dry DCM 
Procedure:  Analogously to R 36, 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h. 
Work-up:  After expanding the syngas, the remaining solution is filtered through 
alumina N (III) using MTBE as eluent. The solvent is removed and the residue is 
analyzed by gas-chromatography. 131.0 mg (0.57 mmol, 78 %) as a colorless mixture 
of ethyl 2-oxo-1-(5-oxo-pentyl)cyclopentane carboxylate (71a) (C13H20O4, 240.296 
g/mol) and ethyl 2-oxo-1-(4-methyl-3-oxo-butyl)cyclopentane carboxylate (79a) in a 
ratio of 5:1 (detected by 1H-NMR analysis) are obtained without any further 
purification. 
Spectroscopic data: of 71a are consistent with those reported in R 16. 
 
The presence of the ethyl 2-oxo-1-(4-methyl-3-oxo-
butyl)cyclopentane carboxylate (79a) is detected from the most 
significant peaks identified by NMR analysis: 1H-NMR (400 
MHz, CDCl3): δ [ppm] = 9.53 (m, 1H, CHO-9); 13C-NMR (100 
MHz, CDCl3): δ [ppm] = 204.4 (CO, C-9). 
 
 
R 43: Preparation of ethyl 2-oxo-1-(5-oxo-pentyl)cyclohexane carboxylate (71b)  
Amounts: 2.0 g  (8.9 mmol) ethyl 1-(but-3-enyl)-2-oxo-cyclohexane 
      carboxylate (68b) 
  45.9 mg (1.0 % mol) [Rh(acac)(CO)2] (28) 
  279.0 mg (4.0 % mol) BIPHEPHOS (29) 
  90.1 mg (5.0 % mol) PTSA 
  20 ml    dry DCM 
Procedure: Analogously to R 36, 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h. 
Work-up: After expanding the syngas, the remaining solution is filtered through 
alumina N (III) using MTBE as eluent. The solvent is removed and the residue is 
analyzed by gas-chromatography. 0.747 g (3.11 mmol, 86 %) as a colorless mixture of 
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ethyl 2-oxo-1-(5-oxo-pentyl)cyclohexane carboxylate (71b) (C14H22O4, 254.322 g/mol) 
and its branched isomers ethyl 2-oxo-1-(4-methyl-3-oxo-butyl)cyclohexane carboxylate 
(79b) in a ratio of 33:1, detected by 1H-NMR analysis, are obtained without any further 
purification. 
Spectroscopic data: of 71b are consistent with those reported in R 17. 
 
The presence of the ethyl 2-oxo-1-(4-methyl-3-oxo-
butyl)cyclohexane carboxylate (79b) is detected from the 
most significant peaks identified by NMR analysis: 1H-
NMR (500 MHz, CDCl3): δ [ppm] = 9.58 (m, 1H, CHO-
11); 13C-NMR (125 MHz, CDCl3): δ [ppm] = 203.9 (CO, 
C-11).  
 
 
R 44: Preparation of ethyl 2-oxo-1-(5-oxo-pentyl)cycloheptane carboxylate (71c)  
Amounts: 0.4 g  (4.0 mmol) ethyl 1-(but-3-enyl)-2-oxo-cycloheptane 
      carboxylate (68c) 
  4.0 mg  (1.0 % mol) [Rh(acac)(CO)2] (28) 
  50.0 mg (4.0 % mol) BIPHEPHOS (29) 
  14.0 mg (5.0 % mol) PTSA 
  20 ml     dry DCM 
Procedure: Analogously to R 36, 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h. 
Work-up: After expanding the syngas, the remaining solution is filtered through 
alumina N (III) using MTBE as eluent. The solvent is removed and the residue is 
analyzed by gas-chromatography. 171.0 mg (0.6 mmol, 40 % yield) of the colorless 
linear aldehyde ethyl 2-oxo-1-(5-oxo-pentyl)cycloheptane carboxylate (71c) (C15H24O4, 
268.349 g/mol) are furnished without any further purification. 
Spectroscopic data: of 71c are consistent with those reported in R 18. 
 
 
R45: Preparation of ethyl 2-oxo-1-(5-oxo-pentyl)cyclononane carboxylate (71e)  
Amounts: 0.4 g  (1.5 mmol) ethyl 1-(but-3-enyl)-2-oxo-cyclononane 
      carboxylate (68e) 
O
10
11
12
13
15
8
9123
4
5
6
7
14
16
17 O
O O
18
79b
                Experimental part 
 131
  4.0 mg  (1.0 % mol) [Rh(acac)(CO)2] (28) 
  50.0 mg (4.0 % mol) BIPHEPHOS (29) 
  14.0 mg (5.0 % mol) PTSA 
  20 ml     dry DCM 
Procedure: Analogously to R 36, 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h. 
Work-up: After expanding the syngas, the remaining solution is filtered through 
alumina N (III) using MTBE as eluent. The solvent is removed and the residue is 
analyzed by gas-chromatography. 115.0 mg (0.39 mmol, 26 % yield) of the colorless 
linear aldehyde ethyl 2-oxo-1-(5-oxo-pentyl)cyclononane carboxylate (71e) (C17H28O4 
(296.402 g/mol) are obtained without any further purification. 
Spectroscopic data: 1H-NMR (400 MHz, CDCl3): δ [ppm] = 1.18 (t, 3H, 3J = 6.27 Hz, 
CH3-18), 1.37-1.69 (m, 16H), 1.92 (m, 1H), 
2.08 (m, 1H), 2.37-2.44 (m, 3H), 2.57 (m, 
1H), 4.11 (q, 2H, 3J = 7.03 Hz, CH2-17), 9.7 
(t, 1H, 3J = 1.51 Hz, CHO-14). 13C-NMR 
(100 MHz, CDCl3): δ [ppm] = 14.5 (CH3, C-
18), 22.8, 23.6, 24.5, 24.6, 25.9, 28.8, 29.7, 
30.9, 38.9, 39.0, 43.9 (CH2, C-
3/4/5/6/7/8/9/10/11/12/13), 61.6 (CH2, C-17), 
62.5 (Cq, C-1), 172.2 (CO, C-15), 202.8 (CO, C-14), 213.0 (CO, C-2). 
 
 
4.4 Study of substituent effects in the 2-oxo-2-alkenyl-cycloalkanes 
under sequential hydroformylation/ aldol addition conditions 
4.4.1 Diethyl 1-alkenyl-2-oxo-cycloalkane-1,3-dicarboxylates  
a. Preparation of starting materials 
R 46: Preparation98 of diethyl 1-allyl-2-oxo-cyclohexane-1,3-dicarboxylate (83b)  
In a 250 ml three-necked flask, equipped with a reflux condenser and dropping funnel, 
is placed a suspension of NaH (0.88 g, 22.0 mmol, 60% in mineral oil) in dry THF (60 
ml). A solution of diethyl carbonate (82) (2.12 g, 2.2 ml, 18.0 mmol) in 20 ml of dry 
THF is added dropwise under stirring. Then, a solution of ethyl 1-allyl 2-oxo-
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cyclohexane carboxylate (4b) (2.0 g, 9.5 mmol) in 15 ml dry THF is added dropwise 
with stirring under reflux over a period of 5 h. After the addition is completed, the 
reaction mixture is refluxed for an additional 1 h. Then the mixture is cooled to 0 °C. A 
solution of acetic acid and water (1:1) is added carefully. The organic layer is 
separated, and the aqueous layer is extracted with MTBE. The combined organic layers 
are washed with 40 ml of a solution of NaHCO3 and (3 x 20 ml) of brine, then dried 
over anhydrous MgSO4 and filtered. After removal of the solvent, the residual oil is 
distilled bulb-to-bulb, T = 70 °C (P = 4.5 x 10-2 mbar), to give 2.41 g (8.5 mmol, 90 % 
yield) of diethyl 1-allyl-2-oxo-cyclohexane-1,3-dicarboxylate (83b) (C15H22O5, 
282.340 g/mol) as a colorless mixture of 2 diastereoisomers in a ratio of 1:1 detected by 
NMR analysis. 
Spectroscopic data: GC-MS 
(EI, 70 eV): m/z (%) = 282 (M+, 
8), 241 (19), 237 (23), 209 (38), 
195 (100), 136 (6), 55 (22). High 
Resolution Mass: Calculated: 
282.1467, Found: 282.1467. IR 
(KBr-film): ν  [cm-1] = 3076 (w), 
2928 (vs), 2856 (s), 1737 (s), 
1725 (s), 1716 (s), 1651 (m), 1614 (m), 1448 (s), 1219 (s), 1258 (s), 1218 (s), 1023 (s). 
1H-NMR (400 MHz, CDCl3): δ [ppm] = 1.21 (m, 6H, CH3-13/17), 1.55-2.70 (approx. 
8H), 3.50 (dd, 1H, 3Jaa = 10.47 Hz, 3Jae = 5.24 Hz, CH-3), 4.07 (q, 2H, 3J = 6.48 Hz, 
CH2-12/16), 4.15 (q, 2H, 3J = 6.98 Hz, CH2-16/12), 5.03 (m, 2H, CH2-9), 5.67 (m, 1H, 
CH-8). Mixture of two diastereoisomers DS1/DS2 13C-NMR (100 MHz, CDCl3): δ 
[ppm] = 14.0 (CH3, C-13/17), 14.1 (CH3, C-17/13), 18.7, 21.3, 22.6, 30.2, 31.1, 36.0, 
39.2, 39.4 (CH2, C-4/5/6/7, DS1 and DS2), 45.0 (CH, C-3, DS1/DS2), 56.4 (CH, C-3, 
DS2/DS1), 60.0 (Cq, C-1), 60.4, 61.0, 61.1, 61.4 (CH2, C-12/16, DS1 and DS2), 118.4, 
118.5 (CH2, C-9, DS1 and DS2), 132.8, 133.8 (CH, C-8, DS1 and DS2), 169.6 (CO, C-
10/14), 172.7 (CO, C-14/10), 208.0 (CO, C-2). 
 
 
R 47: Synthesis98 of diethyl 1-allyl-2-oxo-cycloheptane-1,3-dicarboxylate (83c)  
Amounts: 4.6 g  (20.0 mmol)  ethyl 1-allyl 2-oxo-cycloheptane  
       carboxylate (4c) 
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  1.89 g  (47.0 mmol)  NaH (60 % in mineral oil) 
  4.72 g  (40.0 mmol)  diethyl carbonate (82) 
  50 ml      dry THF  
Procedure: Analogously to R 46. 
Work-up: After removal of the solvent, the residual oil is distilled bulb-to-bulb (T 
= 70 °C, P = 4.5 x 10-2 mbar) to give 4.85 g (16.0 mmol, 82 % yield) of diethyl 1-allyl-
2-oxo-cycloheptane-1,3-dicarboxylate (83c) (C16H24O5, 296.367 g/mol) as a colorless 
oil mixture of 2 diastereoisomers in a ratio of 1:1 detected by NMR analysis. 
Spectroscopic data: GC-MS (EI, 
70 eV): m/z (%) = 297 (M+ +1, 
36), 251 (84), 223 (25), 194 (96), 
178 (12), 149 (100), 55 (20). IR 
(KBr-film): ν  [cm-1] = 2954 (vs), 
2925 (vs), 2854 (vs), 1754 (m), 
1737 (s), 1644 (w), 1463 (s), 1376 
(s), 1301 (m), 1259 (m), 1178 (m), 
1153 (m). 1H-NMR (500 MHz, CDCl3): δ [ppm] = 1.19 (t, 6H, 3J = 7.48 Hz, CH3-
14/18), 1.25 (m, 2H), 1.44 (m, 3H), 1.80 (m, 2H), 2.20 (m, 2H), 2.30 (m, 1H), 3.22 (m, 
1H, CH-3), 4.05 (q, 2H, 3J = 7.48 Hz, CH2-13/17), 4.13 (q, approx. 2H, 3J = 7.23 Hz, 
CH2-17/13), 4.95 (ddd, 2H, 3J = 17.2 Hz, 3J = 10.2 Hz, 2J = 1.5 Hz, CH2-10), 5.76 (ddd, 
1H, 3J = 16.95 Hz, 3J = 10.2 Hz, 3J = 6.73 Hz, CH-9). Mixture of two diastereoisomers 
DS1/DS2 13C-NMR (125 MHz, CDCl3): δ [ppm] = 13.9 (CH3, C-14/18), 14.1 (CH3, C-
18/14), 26.7, 27.0, 28.4, 31.8, 36.3 (CH2, C-4/5/6/7/8), 45.0, 51.7 (CH, C-3, DS1/DS2), 
59.5 (CH2, C-13/17), 61.0 (CH2, C-17/13), 61.1 (Cq, C-1), 116.5 (CH2, C-10), 135.3 
(CH, C-9), 169.2 (CO, C-11/15), 175.2 (CO, C-15/11), 203.0 (CO, C-2). 
 
 
R 48: Preparation98 of diethyl 1-(but-3-enyl)-2-oxo-cycloheptane-1,3-
dicarboxylate (84)  
Amounts: 3.4 g  (14.0 mmol)  ethyl 1-(but-3-enyl)-2-oxo- 
       cycloheptane carboxylate (68c) 
  1.32 g  (32.0 mmol)  NaH (60 % in mineral oil) 
  3.30 g  (28.0 mmol)  diethyl carbonate (82) 
  50 ml      dry THF  
O
O
O
O
O
83c
1
2
3
4
5 6
7
8
9
10
11
12
13
14
15
16
17
18
19
20 21
                Experimental part 
 134
Procedure: Analogously to R 46. 
Work-up: The solvent is removed in vacuum and residue is analyzed by gas 
chromatography. The product is separated by bulb-to-bulb distillation, T = 70 °C (P = 
3.0 x 10-2 mbar) giving 3.6 g (11.0 mmol, 83 %) of diethyl 1-(but-3-enyl)-2-oxo-
cycloheptane-1,3-dicarboxylate (84) (C17H26O5, 310.394 g/mol) as a colorless oil. 
Spectroscopic data: IR (KBr-film): ν [cm-1] = 3077 (m), 2977 (s), 2929 (s), 2857 (s), 
1733 (vs), 1641 (m), 1463 (m), 
1455 (m), 1374 (m), 1261 (m), 
1176 (s), 1031 (s), 912 (m). 1H-
NMR (500 MHz, CDCl3): δ 
[ppm] = 1.17 (t, 3H, 3J = 6.98 Hz, 
CH3-15/19), 1.22 (t, 3H, 3J = 6.98 
Hz, CH3-19/15), 1.36-1.67 
(approx. 8H), 1.95 (m, 2H), 2.19 
(m, 1H), 2.26 (m, 1H), 3.35 (m, 1H, CH-3), 4.04 (q, 2H, 3J = 7.23 Hz, CH2-14/18), 4.10 
(q, 2H, 3J = 7.23 Hz, CH2-18/14), 4.90 (ddd, 2H, 3Jtrans = 17.2 Hz, 3Jcis = 10.2 Hz, 2Jgem 
= 1.5 Hz, CH2-11), 5.69 (ddd, 1H, 3Jtrans = 16.95 Hz, 3Jcis = 10.2 Hz, 3J = 6.73 Hz, CH-
10). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 14.0 (CH3, C-15/19), 14.1 (CH3, C-
19/15), 24.6, 26.8, 28.8, 31.4, 32.0, 34.0 (CH2, C-4/5/6/7/8/9), 44.7 (CH, C-3), 59.8 
(CH2, C-14/18), 59.9 (CH2, C-18/14), 63.5 (Cq, C-1), 114.8 (CH2, C-11), 137.7 (CH, 
C-10), 173.5 (CO, C-12/16), 175.9 (CO, C-16/12), 207.3 (CO, C-2). 
 
 
b. Tandem hydroformylation/ aldol addition 
 
R 49: Tandem hydroformylation/ aldol addition of diethyl 1-allyl-2-oxo-
cyclohexane-1,3-dicarboxylate (83b) 
Amounts: 2.12 g  (7.1 mmol)  diethyl 1-allyl-2-oxo-cyclohexane 
       -1,3-dicarboxylate (83b) 
  0.8  (1.0 mol %)  [Rh(acac)(CO)2] (28) 
  0.22 g  (4.0 mol %)  BIPHEPHOS (29) 
  68.0 mg (5.0 mol %)  PTSA 
  100 ml     dry THF  
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Procedure: Analogously to R 36, 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h.  
Work-up: After expanding the syn-gas, the remaining solution is filtered through 
alumina N (III) and using MTBE as eluent. The solvent is removed by rotary 
evaporation and the residue is analyzed by gas chromatography. 0.63 g (2.6 mmol, 37 
%) of ethyl 2-hydroxy-3-methyl-9-oxo-bicyclo[3.3.1]nonane carboxylate (85) 
(C13H20O4, 240.296 g/mol) are isolated as a colorless oil. 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 240 (M+, 7), 222 (46), 195 (54), 
170 (77), 167 (10), 97 (18), 55 (34). IR (KBr-film): ν  
[cm-1] = 3450 (s), 2962 (vs), 2871 (s), 1731 (s), 1714 
(s), 1413 (s), 1261 (vs), 1093 (vs), 1020 (vs). 1H-
NMR (500 MHz, CDCl3): δ [ppm] = 1.07 (d, 3H, 3J = 
6.27 Hz, CH3-14), 1.28 (t, 3H, 3J = 6.98 Hz, CH3-13), 
1.38-1.47 (m, 1H), 1.58-1.78 (m, 3H), 1.91-2.15 (m, 
3H), 2.33-2.49 (m, 3H), 3.95 (d, 1H, 3Jaa = 10.72 Hz, 
CH-2), 4.24 (m, 2H, CH2-12). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 14.1 (CH3, C-
13), 19.8 (CH3, C-14), 20.2, 29.5, 40.8, 45.0 (CH2, C-4/6/7/8), 32.8 (CH, C-3), 46.0 
(CH, C-5), 60.5 (Cq, C-1), 61.5 (CH2, C-12), 79.6 (CH, C-2), 172.7 (CO, C-10), 212.7 
(CO, C-9).  
 
 
R 50: Attempt of tandem hydroformylation/ aldol addition of diethyl 1-allyl-2-oxo-
cycloheptane-1,3-dicarboxylate (83c) 
Amounts:  2.12 g  (7.1 mmol)  diethyl 1-allyl-2-oxo-cycloheptane-
       1,3-dicarboxylate (83c) 
  0.8  (1.0 mol %)  [Rh(acac)(CO)2] (28) 
  0.22 g  (4.0 mol %)  BIPHEPHOS (29) 
  68.0 mg (5.0 mol %)  PTSA 
  100 ml     dry THF  
Procedure: Analogously to R 36, 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h.  
Work-up: The solvent is removed in vacuum and residue is analyzed by gas 
chromatography. 2.279 g (6.9 mmol, 98 % yield) as a colorless oil mixture of 
compounds 88 and 89 (C17H26O6, 326.385 g/mol) in a ratio of 5:1, calculated by 1H-
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NMR, are obtained. The branched aldehyde 89 is present as a mixture of two 
diastereoisomers in a ratio of 1:1 calculated by 1H-NMR analysis. 
Spectroscopic data of diethyl 2-oxo-1-(4-oxo-butyl)cycloheptane-1,3-dicarboxylate 
(88): GC-MS (EI, 70 eV): m/z (%) = 327 
(M++1, 5), 281 (55), 269 (20), 237 (5), 95 
(20), 81 (20), 67 (20), 55 (20). IR (KBr-
film): ν [cm-1] = 3436 (w), 2979 (s), 2937 
(vs), 2861 (s), 2721 (w), 1747 (vs), 1745 
(vs), 1735 (vs), 1731 (vs), 1592 (w), 1463 
(s), 1369 (s), 1338 (s), 1299 (s), 1259 (s), 
1234 (s), 1178 (vs), 1157 (vs), 1095 (s), 
1029 (s), 860 (m), 794 (w). 1H-NMR (500 
MHz, CDCl3): δ [ppm] = 1.18 (t, 6H, 3J = 7.48 Hz, CH3-16/20), 1.30-2.40 (approx. 
14H), 3.21 (dd, 1H, 3Jaa = 7.48 Hz, 3Jae = 2.49 Hz, CH-3), 4.05 (q, 2H, 3J = 7.23 Hz, 
CH2-15/19), 4.10 (q, 2H, 3J = 7.23 Hz, CH2-19/15), 9.66 (t, 1H, 3J = 1.25 Hz, CHO-11). 
13C-NMR (125 MHz, CDCl3): δ [ppm] = 13.9 (CH3, C-
16/20), 14.1 (CH3, C-20/16), 19.7, 26.7, 26.9, 28.3, 
31.5, 31.8, 43.4 (CH2, C-4/5/6/7/8/9/10), 51.7 (CH, C-
3), 60.0 (CH2, C-15/19), 61.1 (CH2, C-19/15), 169.2 
(CO, C-13/17), 175.6 (CO, C-17/13), 201.8 (CO, C-11).  
The presence of the diethyl 1-(2-methyl-3-oxo-propyl)-
2-oxo-cycloheptane-1,3-dicarboxylate (89), as a 
mixture of two diastereoisomers, is detected from the most significant peaks identified 
by NMR analysis: 1H-NMR (500 MHz, CDCl3): δ [ppm] 9.49 (d, 1H, 3J = 1.5 Hz, 
CHO-10, DS1/DS2), 9.52 (d, 1H, 3J = 1.5 Hz, CHO-10, DS2/DS1). 13C-NMR (125 
MHz, CDCl3): δ [ppm] = 45.1 (CH, C-9), 205.8 (CO, C-10). 
 
 
R 51: Attempt of tandem hydroformylation/ aldol addition of diethyl 1-(but-3-
enyl)-2-oxo-cycloheptane-1,3-dicarboxylate (84) 
Amounts: 2.12 g  (7.1 mmol) diethyl 1-(but-3-enyl)-2-oxo-cycloheptane-
      1,3-dicarboxylate (84) 
  0.8  (1.0 % mol) [Rh(acac)(CO)2] (28) 
  0.22 g  (4.0 % mol) BIPHEPHOS (29) 
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  68.0 mg (5.0 % mol) PTSA 
  100 ml    dry THF  
Procedure: Analogously to R 36, 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h  
Work-up: The solvent is removed in vacuum and the residue is analyzed by gas 
chromatography. 2.170 g (6.4 mmol, 90 % yield) as a colorless oil mixture of 
compounds 90 and 91 (C18H28O6, 340.411 g/mol), in a ratio of 2:1 calculated by 1H-
NMR, are obtained. 
Spectroscopic data of diethyl 2-oxo-1-(5-oxo-pentyl)cycloheptane-1,3-dicarboxylate 
(90): IR (KBr-film): ν  [cm-1] = 3436 (w), 
2979 (s), 2937 (vs), 2861 (s), 2721 (w), 
1747 (vs), 1745 (vs), 1735 (vs), 1731 
(vs), 1592 (w), 1463 (s), 1369 (s), 1338 
(s), 1299 (s), 1259 (s), 1234 (s), 1178 
(vs), 1157 (vs), 1095 (s), 1029 (s), 860 
(m), 794 (w). 1H-NMR (500 MHz, 
CDCl3): δ [ppm] = 1.16 (t, 6H, 3J = 6.75 
Hz, CH3-16/20), 1.20-1.52 (approx. 12H), 
2.17-2.35 (approx, 4H), 4.05 (m, 4H, 
CH2-15/19), 9.66 (dd, 1H, 3J = 1.25 Hz, 
CHO-12). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 13.0 (CH3, C-16/20), 14.1 (CH3, 
C-20/16), 21.7, 24.6, 26.7, 28.7, 31.9, 32.0, 34.0, 43.5 (CH2, C-4/5/6/7/8/9/10/11), 45.2 
(CH, C-3), 59.9 (CH2, C-15/19), 61.1 (CH2, C-19/15), 173.5 (CO, C-13/17), 175.6 (CO, 
C-17/13), 201.1 (CO, C-12), 215.8 (CO, C-2). 
The presence of the diethyl 1-(2-methyl-4-oxo-butyl)-2-
oxo-cycloheptane-1,3-dicarboxylate (91) is detected 
from the most significant peaks identified by NMR 
analysis: 
Spectroscopic data of diethyl 1-(2-methyl-4-oxo-
butyl)-2-oxo-cycloheptane-1,3-dicarboxylate (91): 1H-
NMR (500 MHz, CDCl3): δ [ppm] = 9.50 (m, CHO-
12), 13C-NMR (125 MHz, CDCl3): δ [ppm] = 14.6 (CH3, C-11), 47.5 (CH, C-10), 
204.3 (CO, C-12). 
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4.4.2 Tandem hydroformylation/ aldol addition of 2-allyl-2-methyl-
cyclohexanone (92) and ethyl 3-allyl-3-methyl-2-oxo-cyclohexane 
carboxylate (93) 
 
a. Preparation of starting materials 
 
R 52: Synthesis103 of 6-methyl-1-trimethylsiloxy-cyclohex-1-ene (96) 
A solution of 2-methylcyclohexanone (94) (20.0 g, 178.0 mmol) in 50 ml of dry THF is 
added to a stirred solution of lithium diisopropylamide [prepared in situ by addition of 
n-butyllithium (75.2 ml of a 2.5 molar solution in hexane, 0.188 mol) to 
diisopropylamide 29.80 ml (213.0 mmol) in dry THF at -78 °C under argon], over 10 
min. The solution is stirred for a further 1 h, then a solution of chlorotrimethylsilane 
(95) (32.68 g, 300.0 mmol) in 30 ml is added over 5 min. The solution is allowed to 
warm to room temperature and, after stirring for 1 h, the 
solvent is evaporated in vacuum. Dry pentane (30 ml) is added 
and the lithium chloride removed by filtration through a short 
pad of alumina N (III) using n-pentane as eluent. Evaporation 
in vacuum of the filtrate and distillation of the crude mixture 
gives 27.31 g (14.8 mmol, 85 % yield) of 6-methyl-1-
trimethylsiloxycyclohex-1-ene100 (96) (C10H20OSi, 184.351 
g/mol) as a colorless liquid. 
Spectroscopic data: 1H-NMR (400 MHz, CDCl3): δ [ppm] = 
0.16 (s, 9H, CH3-10/11/12), 1.02 (d, 3H, 3J = 7.03 Hz, CH3-7), 1.30-1.81 (m, 4H), 1.97 
(m, 2H), 2.09-2.14 (m, 1H), 4.78 (dd, 1H, 3J = 4.02 Hz, 3J = 1.0 Hz, CH-2). 13C-NMR 
(100 MHz, CDCl3): δ [ppm] = 0.3 (CH3, C-10/11/12), 18.6 (CH3, C-7), 20.3, 24.3, 31.6 
(CH2, C-3/4/5), 33.6 (CH, C-6), 103.4 (CH, C-2), 154.2 (Cq, C-1). 
 
 
R 53: Synthesis104 of 2-allyl-2-methyl-cyclohexanone (92) 
To a solution of 6-methyl-1-trimethylsiloxy-cyclohex-1-ene (96) (27.3 g, 148.0 mmol) 
in 40 ml dry THF under argon is added at –15 °C a solution of potassium tert-butoxide 
(16.6 g, 148.0 mmol) in 40 ml dry THF and then stirred for 45 min. Then, 17.76 g 
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(148.0 mmol) of allylbromide (66) in 35 ml of dry THF is added and stirred for 15 h at 
this temperature. The mixture is quenched with 30 ml of water at –78 °C and extracted 
(3 x 30 ml) with Et2O. The organic layers are dried over anhydrous MgSO4, filtered, 
and concentrated in vacuum. 19.91 g (13.1 mmol, 89 % yield) of 2-allyl-2-methyl-
cyclohexanone179 (92) (C10H16O, 152.233 g/mol) are isolated by bulb-to-bulb 
distillation T = 50 °C (P = 5 x 10-2 mbar) as a colorless liquid. 
Spectroscopic data: IR (KBr-film): ν  [cm-1] = 3075 (s), 2933 (vs), 2865 (vs), 1707 
(vs), 1639 (s), 1451 (s), 1376 (s), 1124 (m), 913 (s). 1H-
NMR (400 MHz, CDCl3): δ [ppm] = 0.91 (s, 3H, CH3-10), 
1.42-1.46 (m, 1H), 1.59-1.70 (m, 5H), 2.05-2.24 (m, 4H), 
4.88 (dd, 2H, 3Jtrans = 16.8 Hz, 3Jcis = 12.5 Hz, CH2-9), 5.54 
(ddd, 1H, 3Jtrans = 16.8 Hz, 3Jcis = 12.5 Hz, 3J = 7.28 Hz, 
CH-8). 13C-NMR (100 MHz, CDCl3): δ [ppm] = 22.3 
(CH3, C-10), 20.7, 27.1, 38.2, 38.4, 41.6 (CH2, C-
3/4/5/6/7), 49.5 (Cq, C-2), 117.5 (CH2, C-9), 133.4 (CH, C-8), 214.6 (CO, C-1). 
 
 
R 54: Synthesis98 of ethyl 3-allyl-3-methyl-2-oxo-cyclohexane carboxylate (93)  
Amounts: 5.0 g  (32.0 mmol)  2-allyl-2-methyl-cyclohexanone 
(92) 
  2.94 g  (736.0 mmol)  NaH (60 % in mineral oil) 
  7.55 g  (64.0 mmol)  diethylcarbonate (82) 
  50 ml     dry THF  
Procedure: Analogously to R 46. 
Work-up: The solvent is removed in vacuum and residue is analyzed by gas 
chromatography. The product is separated by bulb-to-bulb distillation (T = 70 °C, P = 
3.0 x 10-2 mbar) giving 6.04 g (27.0 mmol, 85 % yield) of ethyl 3-allyl-3-methyl-2-oxo-
cyclohexane carboxylate (93) (C13H20O3, 224.296 g/mol) as a colorless liquid. 
Spectroscopic data: GC-MS (EI, 70 eV): 
m/z (%) = 224 (M+, 2), 151 (6), 110 (6), 
97 (19), 95 (33), 83 (21), 81 (58), 69 (81), 
67 (52), 55 (77). IR (KBr-film): ν [cm-1] = 
3075 (s), 2977 (vs), 2935 (vs), 2865 (s), 
1743 (vs), 1710 (vs), 1647 (vs), 1610 (vs), 
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1452 (m), 1397 (vs), 1375 (vs), 1260 (vs), 1192 (s), 1032 (s). 1H-NMR (400 MHz, 
CDCl3): δ [ppm] = 1.12 (s, 3H, CH3-10), 1.25 (t, 3H, 3J = 7.28 Hz, CH3-14), 1.27-1.68 
(m, 5H), 2.06-2.25 (m, 3H), 3.41 (dd, 1H, 3Jae = 5.77 Hz, 3Jee = 2.26 Hz, CH-1), 4.14 (q, 
2H, 3J = 7.28 Hz, CH2-13), 4.98 (d, 2H, 3J = 12.3 Hz, CH-9), 5.70 (ddd, 1H, 3J = 17.82 
Hz, 3J = 10.30 Hz, 3J = 7.28 Hz, CH-8). 13C-NMR (100 MHz, CDCl3): δ [ppm] = 14.3 
(CH3, C-14), 18.3, 23.3, 34.2, 42.9 (CH2, C-4/5/6/7), 25.3 (CH3, C-10), 43.6 (Cq, C-3), 
57.7 (CH, C-1), 60.3 (CH2, C-13), 117.7 (CH2, C-9), 134.7 (CH, C-8), 177.0 (CO, C-
11), 210.9 (CO, C-2). 
 
 
b. Tandem hydroformylation/ aldol addition 
 
R 55: Conversion of ethyl 3-allyl-3-methyl-2-oxo-cyclohexane carboxylate (93) 
Amounts: 1.0 g  (4.4 mmol)  ethyl 3-allyl-3-methyl-2-oxo-
       cyclohexane carboxylate (93) 
  11.0 mg (1.0 % mol)  [Rh(acac)(CO)2] (28) 
  68.0 mg (4.0 % mol)  BIPHEPHOS (29) 
  42.0 mg (5.0 % mol)  PTSA 
  100 ml     dry THF  
Procedure: Analogously to R 36; 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h. 
Work-up: After expanding the syn-gas, the remaining solution is filtered through 
alumina N (III) and using MTBE as eluent. The solvent is removed by rotary 
evaporation and the residue is analyzed by gas chromatography. A mixture of ethyl 2-
hydroxy-3,5-dimethyl-9-oxo-bicyclo[3.3.1]nonane carboxylate (97), ethyl-3-formyl-7a-
methyl-2,4,5,6,7,7a-hexahydro-1H-indene-4-carboxylate (99) and ethyl-3-formyl-7a-
methyl octahydro-1H-indene-4-carboxylate (100) is obtained in a ratio of 7.2:1:5 (by 
1H-NMR analysis) respectively. After bulb-to-bulb distillation of the crude mixture (T 
= 90 °C, P = 4.0 x 10-2 mbar) 0.350 g (1.4 mmol, 32 % yield) of 97 (C14H22O4, 254.329 
g/mol) are obtained as a colorless oil. 
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Spectroscopic data: ethyl 2-hydroxy-3,5-
dimethyl-9-oxo-bicyclo[3.3.1]nonane 
carboxylate (97): GC-MS (EI, 70 eV): m/z 
(%) = 254 (M+, 1), 236 (1), 109 (5), 95 (8), 
81 (11), 67 (13), 55 (16). HRMS-FAB: 
calculated: for C14H23O4 [M+H]+: 255.1596, 
observed: 255.1596. IR (KBr-film): ν  [cm-1] 
= 3450 (s), 2964 (vs), 2857 (s), 1735 (s), 
1714 (s), 1650 (s), 1610 (m), 1450 (s), 1261 (vs), 1097 (vs), 1022 (vs), 800 (s). 1H-
NMR (500 MHz, CDCl3): δ [ppm] = 0.97 (s, 3H, CH3-15), 1.04 (d, 3H, 3J = 5.98 Hz, 
CH3-14), 1.17 (m, 1H), 1.29 (t, 3H, 3J = 6.98 Hz, CH3-13), 1.57 (m, 1H), 1.85-1.99 (m, 
3H), 2.11-2.15 (m, 1H), 2.36-2.51 (m, 3H), 3.95 (d, 1H, 3J = 10.72 Hz, CH-2), 4.24 (q, 
2H, 3J = 6.98 Hz, CH2-12). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 14.1 (CH3, C-13), 
19.8 (CH3, C-14), 20.2, 29.5, 40.8, 45.0 (CH2, C-4/6/7/8), 24.1 (CH3, C-15), 32.8 (CH, 
C-3), 46.3 (Cq, C-5), 61.5 (CH2, C-12), 79.6 (CH, C-2), 172.7 (CO, C-10), 212.8 (CO, 
C-9).  
The presence of the compounds 99 and 100 is detected from the most significant peaks 
identified by NMR analysis; the compound 100 is present as a mixture of two 
diastereoisomers in a ratio of 3:1: 1H-NMR (400 MHz, 
CDCl3): δ [ppm] = 9.98 (s, 1H, CHO-8, 99), 9.64 (d, 
1H, 3J = 1.25 Hz, CHO-8, 100, DS1/DS2), 9.48 (d, 1H, 
3J = 3.01 Hz, CHO-8, 
100, DS2/DS1). 13C-
NMR (100 MHz, 
CDCl3): δ [ppm] = 44.9, 45.0 (CH, C-4, 99/100), 47.1 
(CH, C-3a, 100), 56.7 (CH, C-3, 100), 188.8 (CO, C-8, 
99), 204.1 (CO, C-8, 100). 
 
 
R 56: Synthesis of 3a-methyl-3,3a,4,5,6,7-hexahydro-2H-indene-1-carbaldehyde 
(101) 
Amounts: 0.5 g  (6.5 mmol) 2-allyl-2-methyl-cyclohexanone (92) 
  8.3 mg  (1.0 % mol) [Rh(acac)(CO)2] (28) 
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  0.101g  (4.0 % mol) BIPHEPHOS (29) 
  31.0 mg (5.0 % mol) PTSA 
  20 ml     DCM  
Procedure: Analogously to R 36, 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h.  
Work-up: After expanding the syn-gas, the remaining solution is filtered through 
alumina N (III) and using MTBE as eluent. The solvent is removed by rotary 
evaporation and the residue is analyzed by gas chromatography. 0.498 g (3.03 mmol, 
93 % yield) of 3a-methyl-3,3a,4,5,6,7-hexahydro-2H-indene-1-carbaldehyde (101) 
(C11H16O, 164.250 g/mol) are obtained as a colorless oil. 
Spectroscopic data: 3a-methyl-3,3a,4,5,6,7-hexahydro-2H-indene-1-carbaldehyde 
(101) 
GC-MS (EI, 70 eV): m/z (%) = 164 (M+, 55), 135 (48), 93 (25), 
79 (26), 45 (100), 29 (11). HRMS-EI: calculated: 164.1201, 
observed: 164.1177. IR (KBr-film): ν  [cm-1] = 2935 (vs), 2861 
(vs), 2724 (m), 1705 (vs), 1666 (vs), 1455 (s), 1261 (s), 1095 (s), 
978 (s). 1H-NMR (500 MHz, CDCl3): δ [ppm] = 1.05 (s, 3H, 
CH3-9), 1.25-3.13 (approx. 12H), 9.99 (s, 1H, CHO-8). 13C-NMR 
(125 MHz, CDCl3): δ [ppm] = 22.6 (CH3, C-9), 22.1, 23.7, 26.9, 
27.1, 38.6, 41.2 (CH2, C-2/3/4/5/6/7), 50.8 (Cq, C-3a), 134.3 (Cq, 
C-1), 163.9 (Cq, C-7a), 188.1 (CO, C-8). 
 
 
4.4.3 Ethyl 3-alkenyl-2-oxo-cycloalkane carboxylate 
a. Preparation of starting materials 
 
R 57: Synthesis109 of ethyl 3-allyl-2-oxo-cyclohexane carboxylate (102)  
A solution of ethyl 2-oxo-cyclohexane carboxylate (65b) (5.0 g, 29.0 mmol) in 25 ml 
of dry THF is added to a stirred solution of lithium diisopropylamide [prepared in situ 
by addition of n-butyllithium 23.2 ml (58.0 mmol, a 2.5 M solution in hexane) to 
diisopropylamine 8.11 ml (58.0 mmol) in dry THF at –78 °C] under argon at –78 °C, 
over 30 min. The solution is stirred for a further 1 h, then a solution of 2.52 ml (29.0 
mmol) allyl-bromide (66) is added over 5 min. The solution is allowed to warm to room 
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temperature and, after stirring for 1 h, the reaction is neutralized with HCl (5 %) and 
extracted (3 x 30 ml) with MTBE. The organic extracts are washed with 40 ml of 
saturated aqueous NaCl, dried over anhydrous MgSO4, filtered, and concentrated in 
vacuum. The residue is distilled by bulb-to-bulb T = 50 °C (P = 5.0 x 10-2 mbar), to 
give 4.99 g (24.0 mmol, 82 %) of ethyl 3-allyl-2-oxo-cyclohexane carboxylate180 (102) 
(C12H18O3, 210.275 g/mol) as a colorless oil mixture of 2 diastereoisomers in a ratio of 
2.5:1 detected by NMR analysis. 
Spectroscopic data: IR (KBr-film): ν  [cm-1] = 3076 (w), 2979 (s), 2938 (s), 2861 (s), 
1744 (vs), 1715 (vs), 1650 (vs), 1637 (s), 
1448 (m), 1301 (s), 1253 (s), 1217 (s), 
1096 (s). 1H-NMR (400 MHz, CDCl3): δ 
[ppm] = 1.28 (t, 3H, 3J = 7.28 Hz, CH3-
13), 1.30 (m, 1H), 1.46-1.50 (m, 1H), 
1.70 (m, 2H), 1.96 (m, 1H), 2.19 (m, 2H), 
2.38 (m, 1H), 2.50 (m, 1H), 3.35-3.40 (dd, 1H, 3Jae = 5.52 Hz, 3Jee = 1.0 Hz, CH-1), 
4.18 (q, 2H, 3J = 7.28 Hz, CH2-12), 5.03 (dd, 2H, 3J = 16.81 Hz, 3J = 10.54 Hz, CH-9), 
5.75 (ddd, 1H, 3J = 16.82 Hz, 3J = 10.29 Hz, 3J = 6.53 Hz, CH-8). Mixture of two 
diastereoisomers DS1/DS2 13C-NMR (100 MHz, CDCl3): δ [ppm] = 14.1, 14.2 (CH3, 
C-13, DS1/DS2), 19.9, 27.8, 24.0, 26.6, 30.7, 33.4, 33.7, 36.2 (CH2, C-4/5/6/7, DS1 
and DS2), 48.9, 50.5 (CH, C-3, DS1/DS2), 56.2, 57.8 (CH, C-1, DS1/DS2), 60.2, 60.8 
(CH2, C-12, DS1/DS2), 116.4, 116.6 (CH2, C-9, DS1/DS2), 135.9, 136.4 (CH, C-8, 
DS1/DS2), 172.9, 173.7 (CO, C-10, DS1/DS2), 206.8, 207.4 (CO, C-2, DS1/DS2). 
 
 
R 58: Synthesis109 of ethyl 3-(but-3-enyl)-2-oxo-cyclohexane carboxylate (103)  
Amounts: 2.0 g  (11.7 mmol) ethyl 2-oxo-cyclohexane carboxylate (65b) 
  14.97 g (23.0 mmol) n-butyllithium (2.5 M in hexane) 
  2.37 g  (23.0 mmol) diisopropylamine 
  1.57 g  (23.0 mmol) 4-bromo-1-butene (67) 
  50.0 ml    dry THF  
Procedure: Analogously to R 57.  
Work-up: The reaction mixture is maintained at –78 °C for 45 min and gradually 
warmed to room temperature; neutralized with a solution of HCl (5 %) is added, and 
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the aqueous layer is extracted three times with 50 ml portions of Et2O and once with 40 
ml of brine and dried over anhydrous MgSO4. The solvent is removed in vacuum and 
residue is analyzed by gas chromatography. The product, as a colorless oil, is obtained 
by bulb-to-bulb distillation T = 50 °C (P = 4.0 x 10-2 mbar) giving 0.618 g (2.75 mmol, 
24 % yield) of ethyl 3-(but-3-enyl)-2-oxo-cyclohexane carboxylate181 (103) (C13H20O3, 
224.296 g/mol) as a mixture of 2 diastereoisomers in a ratio of 3:1 detected by NMR 
analysis. 
Spectroscopic data: mixture of two diastereoisomers 1H-NMR (400 MHz, CDCl3): δ 
[ppm] = 1.22 (t, 3H, 3J = 7.03 
Hz, CH3-14), 1.38 (m, 2H), 1.61-
2.31 (approx. 10H), 2.49 (m, 
1H), 3.37 (m, 1H, CH-1), 4.16 
(q, 2H, 3J = 7.03 Hz, CH2-13), 
5.07 (d, 2H, 3Jtrans = 17.07 Hz, 
3Jcis = 10.29 Hz, CH2-10), 5.75 
(dd, 1H, 3Jtrans = 16.82 Hz, 3Jcis = 10.29 Hz, CH-9). Mixture of two diastereoisomers 
DS1/DS2 13C-NMR (100 MHz, CDCl3): δ [ppm] = 14.0, 14.3 (CH3, C-14, DS1/DS2), 
19.9, 22.6, 24.0, 26.9, 27.9, 30.7, 31.0, 31.1, 33.5, 34.1 (CH2, C-4/5/6/7/8, DS1 and 
DS2), 48.5, 49.9 (CH, C-3, DS1/DS2), 56.0, 57.7 (CH, C-1, DS1/DS2), 60.0, 60.7 
(CH2, C-13, DS1/DS2), 114.5, 114.7 (CH2, C-10, DS1/DS2), 138.1, 138.3 (CH, C-9, 
DS1/DS2), 172.8, 174.5 (CO, C-11, DS1/DS2), 207.2, 207.8 (CO, C-2, DS1/DS2). 
 
 
b. Tandem hydroformylation/ aldol addition 
 
R 59: Synthesis of ethyl 1-hydroxy-6-oxo-spiro[4.5]decane-7-carboxylate (104) 
Amounts: 1.0 g  (4.7 mmol)  ethyl 3-allyl-2-oxo-cyclohexane 
       carboxylate (102) 
  12.0 mg (1.0 % mol)  [Rh(acac)(CO)2] (28) 
  147.0 mg (4.0 % mol)  BIPHEPHOS (29) 
  46.0 g  (5.0 % mol)  PTSA 
  100 ml     dry THF  
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Procedure: Analogously to R 36, 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h.  
Work-up: The solvent is removed in vacuum and residue is analyzed by gas 
chromatography. 0.51 g (45 % by G.C. analysis) as a colorless oil mixture of products 
ethyl 1-hydroxy-6-oxo-spiro[4.5]decane-7-carboxylate (104) (C13H20O4, 240.302 
g/mol) and the sub-products ethyl 3-formyl-2,4,5,6,7,7a-hexahydro-1H-indene-4-
carboxylate (105) and ethyl 3-formyl-octahydro-1H-indene-4-carboxylate (106) in a 
ratio of 20:3.2:1, detected by 1H-NMR, is observed. 
Spectroscopic data: ethyl 1-hydroxy-6-oxo-spiro[4.5]decane-7-carboxylate (104) 
GC-MS (EI, 70 eV): m/z (%) = 240 (M+, 
2), 222 (12), 168 (17), 98 (29), 95 (22), 83 
(17), 55 (66), 18 (59). IR (KBr-film): ν  
[cm-1] = 3467 (s), 2937 (vs), 2866 (s), 
2728 (s), 1731 (s), 1665 (s), 1611 (w), 
1574 (w), 1398 (s). 1H-NMR (400 MHz, 
CDCl3): δ [ppm] = 1.24 (m, 3H, CH3-15), 
1.39-2.66 (approx. 12H), 3.44 (dd, 1H, 3J = 7.28 Hz, 3J = 3.76 Hz, CH-7), 4.15 (m, 2H, 
CH2-14), 4.70 (dd, 1H, 3J = 9.29 Hz, 3J = 7.03 Hz, CH-1). 13C-NMR (100 MHz, 
CDCl3): δ [ppm] = 14.1 (CH3-15) 19.0, 20.1, 29.1, 33.3, 35.4, 41.4 (CH2-2/3/4/8/9/10), 
55.5 (CH, C-7), 61.0 (CH2, C-14), 86.7 (CH, C-1), 171.2 (CO, C-12), 206.2 (CO, C-6). 
The presence of the compounds 105 and 106 is detected from the most significant 
peaks identified by NMR 
analysis: Spectroscopic data of 
1H-NMR (400 MHz, CDCl3): δ 
[ppm] = 9.57 (d, 1H, 3J = 3.01 
Hz, CHO-12, 106), 9.99 (s, 1H, 
CHO-12, 105). 13C-NMR (100 
MHz, CDCl3): δ [ppm] = 188.3 (CO, C-12, 105), 201.2 (CO, C-12, 106). 
 
 
R 60: Synthesis of ethyl 7-hydroxy-1-oxo-spiro[5.5]undecane-2-carboxylate (107) 
Amounts: 0.2 g  (0.9 mmol)  ethyl 3-(but-3-enyl)-2-oxo- 
       cyclohexane carboxylate (103) 
  2.3 mg  (1.0 % mol)  [Rh(acac)(CO)2] (28) 
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  28.0 mg (4.0 % mol)  BIPHEPHOS (29) 
  8.6 g  (5.0 % mol)  PTSA 
  100 ml     dry THF  
Procedure: Analogously to R 36; 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h.  
Work-up: The solvent is removed in vacuum and the residue is analyzed by gas 
chromatography. 0.1 g (0.36 mmol, 40 %) as a colorless oil mixture of ethyl 7-hydroxy-
1-oxo-spiro[5.5]undecane-2-carboxylate (107) C14H22O4 (254.329 g/mol) and ethyl 2-
oxo-3-(5-oxo-pentyl)cyclohexane carboxylate (108) in a ratio of 1:1 calculated by 1H-
NMR.  
Spectroscopic data: ethyl 7-hydroxy-1-oxo-spiro[5.5]undecane-2-carboxylate (107). 
1H-NMR (400 MHz, CDCl3): δ [ppm] = 1.16 
(m, 3H, CH3-15), 1.50-2.50 (approx. 14H), 
2.42 (dd, 1H, 3J = 7.03 Hz, 3J = 3.51 Hz, CH-
2), 3.44 (q, 2H, 3J = 7.03 Hz, CH2-14), 3.71 
(d, 1H, 3J = 6.53 Hz, OH-16), 4.32-4.36 (dd, 
1H, 3Jaa = 12.30 Hz, 3Jae = 4.52 Hz, CH-7). 
13C-NMR (100 MHz, CDCl3): δ [ppm] = 15.2 
(CH3-15), 20.2, 21.1, 23.8, 32.4, 34.1, 37.1, 44.5 (CH2-3/4/5/8/9/10/11), 57.0 (CH, C-
2), 65.8 (CH2-14), 67.9 (Cq, C-6), 84.3 (CH, C-7), 171.0 (CO, C-12), 207.4 (CO, C-1). 
The presence of the compounds 108 is detected from 
the most significant peaks identified by NMR analysis: 
1H-NMR (400 MHz, CDCl3): δ [ppm] = 10.01 (br s, 
1H, CHO-11). 13C-NMR (100 MHz, CDCl3): δ [ppm] 
= 48.1 (CH, C-5), 57.9 (CH, C-1), 173.0 (CO, C-12), 
206.1 (CO, C-11). 
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4.5 Enolsilylation tandem hydroformylation/ aldol addition 
4.5.1 Trimethylsilyl enol ethers 
a. Preparation of starting materials (using TMSCl) 
R 61: Synthesis100 of ethyl 1-allyl-2-trimethylsilanyloxy-cyclopent-2-ene 
carboxylate (120a) 
To a a stirred solution of lithium diisopropylamide [prepared in situ by addition of n-
butyllithium (4.4 ml of a 2.5 molar solution in hexane, 11.0 mmol) to diisopropylamine, 
freshly distilled, (1.67 ml, 12.0 mmol)] in dry THF (30 ml), a solution of ethyl 1-allyl-
2-oxo-cyclopentane carboxylate (4a) (2.0 g, 10.0 mmol) in 15 ml of THF is added at –
78 °C under argon, over 10 min. The solution is stirred for a further 1 h, then 1.836 g 
(17.0 mmol) of chlorotrimethylsilane (95) in 15 ml of abs. THF is added over 5 min. 
The solution is allowed to warm to room temperature and, after stirring for 1 h, the 
solvent is evaporated in vacuum. Dry pentane (30 ml) is added and the lithium chloride 
removed by filtration through a short pad of alumina N (III). Evaporation of the solvent 
of the filtrate under reduced pressure followed by bulb-to-bulb distillation of the crude 
mixture (T = 25 °C, P = 4.0 x 10-2 mbar) gives 2.568 g (9.56 mmol, 96 % yield) of 
ethyl 1-allyl-2-trimethylsilanyloxy-cyclopent-2-ene carboxylate (120a) (C14H24O3Si, 
268.424 g/mol) as a colorless liquid. 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 269 (M++1, 20), 227 (20), 196 
(48), 167 (5), 154 (5), 73 (98), 55 (12). IR 
(KBr-film): ν  [cm-1] = 3075 (w), 2978 (s), 2961 
(s), 2906 (m), 2859 (s), 1752 (vs), 1649 (s), 
1443 (m), 1365 (w), 1266 (s), 1166 (w), 847 (s). 
1H-NMR (400 MHz, CDCl3): δ [ppm] = 0.16 (s, 
9H, CH3-15/16/17), 1.20 (t, 3H, 3J = 7.03 Hz, 
CH3-12), 1.80 (m, 1H), 2.10-2.37 (m, 4H), 2.52 
(m, 1H), 4.09 (q, 2H, 3J = 7.03 Hz, CH2-11), 
4.64 (t, 1H, 3J = 2.26 Hz, CH-3), 4.99 (dd, 1H, 
2J = 2.01 Hz, 3Jcis = 10.04 Hz, CHH-8a), 5.05 
(dd, 1H, 2J = 2.01 Hz, 3Jtrans = 16.56 Hz, CHH-
8b), 5.73 (ddd, 1H, 3Jtrans = 17.07 Hz, 3Jcis = 10.04 Hz, 3J = 6.78 Hz, CH-7). 13C-NMR 
(100 MHz, CDCl3): δ [ppm] = 0.3 (CH3, C-15/16/17), 14.1 (CH3, C-12), 26.4, 31.1, 
120a
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38.6 (CH2, C-4/5/6), 57.8 (Cq, C-1), 60.4 (CH2, C-11), 102.8 (CH, C-3), 117.5 (CH2, 
C-8), 134.7 (CH, C-7), 154.3 (Cq, C-2), 175.0 (CO, C-9). 
 
 
R 62: Synthesis100 of ethyl 1-allyl-2-trimethylsilanyloxy-cyclohex-2-ene carboxylate 
(120b) 
Amounts: 2.0 g  (95.0 mmol)  ethyl 1-allyl-2-oxo-cyclohexane 
       carboxylate (4b) 
  4.0 ml  (10.0 mmol)  n-butyllithium (2.5 M in hexane) 
  1.6 mg  (11.4 mmol)  diisopropylamine 
  1.74 g  (16.0 mmol)  chlorotrimethylsilane (TMSCl) (94) 
  50 ml     dry THF  
Procedure: Analogously to R 61.  
Work-up: Evaporation in vacuum of the filtrate and bulb-to-bulb distillation (T = 
70 °C, P = 1.7 x 10-1 mbar) gives 2.43 g (8.60 mmol, 91 % yield) of ethyl 1-allyl-2-
trimethylsilanyloxy-cyclohex-2-ene carboxylate (120b) (C15H26O3Si, 282.451 g/mol) as 
a colorless liquid. 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 282 (M+, 5), 241 (15), 209 (45), 
167 (10), 91 (75), 73 (80). 1H-NMR (400 MHz, 
CDCl3): δ [ppm] = 0.14 (s, 9H,  CH3-16/17/18), 
1.21 (t, 3H, 3J = 7.28 Hz, CH3-13), 1.51-1.65 
(m, 4H), 1.90 (m, 1H), 2.01 (m, 1H), 2.48 (m, 
2H), 4.09 (q, 2H, 3J = 7.28 Hz, CH2-12), 4.81 
(dd, 1H, 3J = 4.27 Hz, 3J = 3.76 Hz, CH-3), 4.99 
(dd, 1H, 3J = 10.29 Hz, 2J = 2.01 Hz, CHH-9a), 
5.03 (dd, 1H, 3J = 17.32 Hz, 2J = 2.01 Hz, CHH-
9b), 5.73 (ddd, 1H, 3J = 17.32 Hz, 3J = 10.29 
Hz, 3J = 7.28 Hz, CH-8). 13C-NMR (100 MHz, 
CDCl3): δ [ppm] = 0.2 (CH3, C-16/17/18), 14.2 (CH3, C-13), 19.0, 23.8, 31.6, 39.4 
(CH2, C-4/5/6/7), 50.4 (Cq, C-1), 60.4 (CH2, C-12), 104.3 (CH, C-3), 117.3 (CH2, C-9), 
135.2 (CH, C-8), 149.6 (Cq, C-2), 175.3 (CO, C-10). 
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b. Attempted of one-pot tandem hydroformylation/ aldol addition 
 
R 63: Conversion of ethyl 1-allyl-2-trimethylsilanyloxy-cyclopent-2-ene 
carboxylate (120a) 
Amounts: 1.0 g  (3.7 mmol) ethyl 1-allyl-2-trimethylsilanyloxy- 
      cyclopent-2-ene carboxylate (120a) 
  9.5 mg  (1.0 mol %) [Rh(cod)Cl]2 (41) 
  116.0 mg (4.0 mol %) BIPHEPHOS (29) 
  20 ml     dry dichloromethane 
Procedure: Analogously to R 13; 80 bar [p(CO):p(H2) = 1:1]; T = 90 °C, 48 h.  
Work-up: After expanding the syngas, the remaining solution is filtered through 
alumina N (III) using MTBE as eluent. The solvent is removed by rotary evaporation 
and the residue is analyzed by gas chromatography. 794 mg (3.5 mmol, 95 % yield) as 
a colorless oil mixture of ethyl 2-oxo-1-(4-oxo-butyl)-cyclopentane carboxylate (70a) 
(C12H18O4, 226.269 g/mol) and ethyl 1-(2-methyl-3-oxo-propyl)-2-oxo-cyclopentane 
carboxylate (77a) in a ratio of 22:1, detected by 1H-NMR, are obtained. 
Spectroscopic data of 70a are consistent with those reported in R 13. 
The presence of the compounds 77a is detected from the most significant peaks 
identified by NMR analysis: 1H-NMR (400 MHz, CDCl3): δ [ppm] = 9.68 (d, 1H, 3J = 
2.01 Hz, CHO-9). 13C-NMR (100 MHz, CDCl3): δ [ppm] = 201.7 (CO, C-9). 
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R 64: Conversion of ethyl 1-allyl-2-trimethylsilanyloxy-cyclohex-2-ene 
carboxylate  (120b) 
Amounts: 0.5 g  (1.8 mmol) ethyl 1-allyl-2-trimethylsilanyloxy- 
      cyclohex-2-ene carboxylate (120b) 
  4.6 mg  (1.0 mol %) [Rh(cod)Cl]2 (41) 
  56.0 mg (4.0 mol %) BIPHEPHOS (29) 
  20 ml     dry DCM 
Procedure: Analogously to R 13, 80 bar [p(CO):p(H2) = 1:1]; T = 90 °C, 48 h. 
Work-up: After expanding the syngas, the remaining solution is filtered through 
alumina N (III) using MTBE as eluent. The solvent is removed by rotary evaporation 
and the residue is analyzed by gas chromatography. 388 mg (1.62 mmol, 90 % yield) as 
a colorless oil mixture of ethyl 2-oxo-1-(4-oxo-butyl)cyclohexane carboxylate (70b) 
(C13H20O4, 240.296 g/mol) and ethyl 1-(2-methyl-3-oxo-propyl)-2-oxo-cyclohexane 
carboxylate (77b) in a ratio of 8:1, detected by 1H-NMR, are obtained. 
Spectroscopic data of 70b are consistent with those reported in R 14. 
The presence of the compounds 77b is detected from the most significant peaks 
identified by NMR analysis: 1H-NMR (400 MHz, CDCl3): δ [ppm] = 9.49 (d, 1H, 3J = 
2.01 Hz, CHO-10). 13C-NMR (100 MHz, CDCl3): δ [ppm] = 14.0 (CH3, C-14), 42.0 
(CH3, C-9), 55.0 (CH, C-8), 202.0 (CO, C-10). 
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4.5.2 Tert-butyl-dimethylsilyl enol ethers 
a. Preparation of starting materials 
 
R 65: Synthesis100 of ethyl 1-allyl-2-(tert-butyl-dimethylsilanyloxy)cyclopent-2-
ene-carboxylate (125a) 
Amounts:  2.0 g  (10.0 mol) ethyl 1-allyl-2-oxo-cyclopentane  
      carboxylate (4a) 
  4.4 ml  (11.0 mmol) n-butyllithium (2.5 M in hexane) 
  1.67 ml (12.0 mmol) diisopropylamine 
  2.60 g  (17.0 mmol) chloro tert-butyldimethylsilane (124) 
  50 ml     dry THF  
Procedure: Analogously to R 61. 
Work-up: Evaporation in vacuum of the filtrate and without any purification gives 
2.8 g (8.91 mmol, 90 % yield) of ethyl 1-allyl-2-(tert-butyl-
dimethylsilanyloxy)cyclopent-2-ene carboxylate (125a) (C17H30O3Si, 310.504 g/mol) as 
a colorless liquid. 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 311 (M++1, 35), 253 (98), 255 
(85), 184 (48), 179 (5), 73 (75). IR (KBr-film): 
ν  [cm-1] = 3076 (m), 2957 (s), 2931 (s), 2903 
(s), 2858 (s), 1730 (vs), 1649 (s), 1443 (s), 
1363 (s), 1253 (w), 1167 (m), 856 (w). 1H-
NMR (400 MHz, CDCl3): δ [ppm] = 0.11 (s, 
3H, CH3-16/15), 0.13 (s, 3H, CH3-15/16), 0.88 
(s, 9H, CH3-19/20/21), 1.21 (t, 3H, 3J = 7.03 
Hz, CH3-12), 1.80 (m, 1H), 2.13 (m, 1H), 2.23 
(m, 2H), 2.37 (dd, 1H, 2J = 13.80 Hz, 3J = 6.78 
Hz), 2.51 (dd, 1H, 2J = 13.80 Hz, 3J = 7.78 Hz), 
4.09 (q, 2H, 3J = 7.03 Hz, CH2-11), 4.77 (dd, 
1H, 3J = 4.77 Hz, 3J = 2.51 Hz, CH-3), 4.99 (ddd, 1H, 4J = 1.25 Hz, 3J = 10.04 Hz, 2J = 
1.0 Hz, CHH-8a), 5.06 (ddd, 1H, 4J = 1.25 Hz, 3J = 17.32 Hz, 2J = 1.0 Hz, CHH-8b), 
5.70 (ddd, 1H, 3J = 17.07 Hz, 3J = 10.04 Hz, 3J = 7.03 Hz, CH-7). 13C-NMR (100 MHz, 
CDCl3): δ [ppm] = -5.0 (CH3, C-15/16), -4.9 (CH3, C-16/15), 14.2 (CH3, C-12), 17.9 
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(Cq, C18-Si), 25.4 (CH3, C-19/20/21), 26.4, 31.0, 38.6 (CH2, C-4/5/6), 57.9 (Cq, C-1), 
60.4 (CH2, C-11), 102.2 (CH, C-3), 117.5 (CH2, C-8), 134.7 (CH, C-7), 154.0 (Cq, C-
2), 175.1 (CO, C-9). 
 
 
R 66: Synthesis100 of ethyl 1-allyl-2-(tert-butyl-dimethylsilanyloxy)cyclohex-2-ene 
carboxylate (125b) 
Amounts: 2.0 g  (95.0 mmol) ethyl 1-allyl-2-oxo-cyclohexane  
      carboxylate (4b) 
  4.0 ml  (10.0 mmol) n-butyllithium (2.5 M in hexane) 
  1.6 ml  (11.4 mmol) diisopropylamine 
  2.42 g  (16.0 mmol) chloro tert-butyldimethylsilane (124) 
  50 ml    dry THF  
Procedure: Analogously to R 61. 
Work-up: Evaporation in vacuum and without any purification gives 2.25 g (6.93 
mmol, 73 % yield) of ethyl 1-allyl-2-(tert-butyl-dimethylsilanyloxy)cyclohex-2-ene 
carboxylate (125b) (C18H32O3Si, 324.530 g/mol) as a colorless liquid. 
Spectroscopic data: GC-MS (EI, 70 eV): 
m/z (%) = 325 (M++1, 20), 279 (20), 267 
(98), 251 (10), 239 (55), 195 (5), 153 (5), 73 
(85). IR (KBr-film): ν  [cm-1] = 3075 (s), 
3049 (s), 2977 (s), 2954 (s), 2931 (w), 2899 
(s), 2886 (s), 2858 (s), 1730 (s), 1690 (s), 
1446 (m), 1362 (m), 1252 (w), 1159 (w), 862 
(w). 1H-NMR (400 MHz, CDCl3): δ [ppm] = 
0.13 (s, 3H, CH3-16/17), 0.15 (s, 3H, CH3-
17/16), 0.87 (s, 9H, CH-20/21/22), 1.23 (t, 
3H, 3J = 7.28 Hz, CH3-13), 1.53 (m, 2H), 
1.67 (m, 1H), 1.80 (m, 1H), 2.01 (m, 2H), 
2.45 (dd, 1H, 2J = 13.80 Hz, 3J = 8.03 Hz), 2.57 (dd, 1H, 2J = 13.80 Hz, 3J = 6.27 Hz), 
4.10 (q, 2H, 3J = 7.28 Hz, CH2-12), 4.81 (dd, 1H, 3J = 4.52 Hz, 3J = 3.51 Hz, CH-3), 
5.03 (dd, 1H, 3J = 10.54 Hz, 2J = 2.26 Hz, CHH-9a), 5.07 (dd, 1H, 3J = 17.07 Hz, 2J = 
2.26 Hz, CHH-9b), 5.74 (dddd, 1H, 3J = 16.82 Hz, 3J = 10.29 Hz, 3J = 6.53 Hz, 3J = 
6.27 Hz, CH-8). 13C-NMR (100 MHz, CDCl3): δ [ppm] = -4.5 (CH3, C-16/17), -4.4 
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(CH3, C-17/16), 14.2 (CH3, C-13), 18.2 (Cq, C19-Si), 25.6 (CH3, C-20/21/22), 19.0, 
23.9, 31.6, 39.4 (CH2, C-4/5/6/7), 50.5 (Cq, C-1), 60.5 (CH2, C-12), 103.9 (CH, C-3), 
117.5 (CH2, C-9), 135.1 (CH, C-8), 149.5 (Cq, C-2), 175.5 (CO, C-10). 
 
 
R 67: Synthesis100 of ethyl 1-allyl-2-(tert-butyl-dimethylsilanyloxy)cyclohept-2-ene 
carboxylate (125c) 
Amounts: 2.0 g  (8.9 mmol) ethyl 1-allyl-2-oxo-cycloheptane  
      carboxylate (4c) 
  0.64 g  (9.7 mmol) n-butyllithium (2.5 M in hexane) 
  1.07 g  (10.0 mmol) diisopropylamine 
  1.735 g (11.5 mmol) chloro tert-butyldimethylsilane (124) 
  50 ml   dry THF  
Procedure: Analogously to R 61.  
Work-up: Evaporation in vacuum and without any purification gives  2.55 g (7.56 
mmol, 85 % yield) of ethyl 1-allyl-2-(tert-butyl-dimethylsilanyloxy)cyclohept-2-ene 
carboxylate (125c) (C19H34O3Si, 338.557 g/mol) as a colorless liquid.  
Spectroscopic data: GC-MS (EI, 70 eV): m/z 
(%) = 339 (M++1, 10), 323 (98), 309 (5), 293 
(5), 265 (5), 208 (15), 73 (20). IR (KBr-film): 
ν  [cm-1] = 3075 (w), 2958 (s), 2929 (s), 2857 
(s), 1731 (s), 1652 (m), 1471 (m), 1450 (m), 
1361 (m), 1259 (vs), 1193 (s), 1172 (s), 1143 
(s), 1092 (vs), 1027 (s). 1H-NMR (400 MHz, 
CDCl3): δ [ppm] = 0.15 (s, 3H, CH3-17/18), 
0.16 (s, 3H, CH3-18/17), 0.86 (s, 9H, CH-
21/22/23), 1.25 (t, 3H, 3J = 7.03 Hz, CH3-14), 
1.59-1.67 (m, 5H), 1.85 (m, 1H), 2.04 (m, 
2H), 2.44 (m, 1H), 2.67 (m, 1H), 4.12 (q, 2H, 3J = 7.03 Hz, CH2-13), 4.95-4.98 (dd, 1H, 
3J = 7.28 Hz, 3J = 5.52 Hz, CH-3), 5.02-5.10 (dd, 1H, 3J = 10.04 Hz, 2J = 1.25 Hz, 
CHH-10a), 5.06 (dd, 1H, 3J = 17.07 Hz, 2J = 1.25 Hz, CHH-10b), 5.82 (ddd, 1H, 3J = 
17.07 Hz, 3J = 10.04 Hz, 3J = 6.27 Hz, CH-9). 13C-NMR (100 MHz, CDCl3): δ [ppm] = 
-4.4 (CH3, C-17/18), -4.5 (CH3, C-18/17), 14.1 (CH3, C-14), 22.6 (Cq, C20-Si), 25.7 
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(CH3, C-21/22/23), 22.8, 23.5, 31.9, 32.0, 41.2 (CH2, C-4/5/6/7/8), 55.8 (Cq, C-1), 60.4 
(CH2, C-13), 108.5 (CH, C-3), 117.4 (CH2, C-10), 135.3 (CH, C-9), 152.6 (Cq, C-2), 
174.9 (CO, C-11). 
 
 
R 68: Synthesis100 of ethyl 1-(3-but-4-yl)-2-(tert-butyl-
dimethylsilanyloxy)cyclopent-2-ene carboxylate (126a) 
Amounts:  5.0 g  (24.0 mmol) ethyl (1-but-3-enyl)-2-oxo-cyclopentane 
      carboxylate (68a) 
  1.53 g  (24.7 mmol) n-butyllithium (2.5 M in hexane) 
  2.90 g  (28.8 mmol) diisopropylamine 
  6.12 g  (40.8 mmol) chloro tert-butyldimethylsilane (124) 
  80 ml     dry THF  
Procedure: Analogously to R 61. 
Work-up: Evaporation in vacuum of the solvent and without any purification gives 
7.62 g (23.52 mmol, 98 % yield) of ethyl 1-(3-buten-4-yl)-2-(tert-butyl-
dimethylsilanyloxy)cyclopent-2-ene carboxylate (126a) (C18H32O3Si, 324.530 g/mol) 
as a colorless liquid.  
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 325 (M++1, 10), 267 (98), 239 
(10), 183 (30), 154 (5), 139 (10), 73 (80). IR 
(KBr-film): ν  [cm-1] = 3077 (m), 2956 (s), 2931 
(s), 2902 (s), 2858 (s), 1727 (s), 1643 (m), 1448 
(m), 1363 (m), 1252 (vs), 1162 (s), 858 (s). 1H-
NMR (400 MHz, CDCl3): [ppm] = 0.06 (s, 3H, 
CH3-16/17), 0.16 (s, 3H, CH3-17/16), 0.88 (s, 
9H, CH3-20/21/22), 1.21 (t, 3H, 3J = 7.03 Hz, 
CH3-13), 1.70 (m, 2H), 1.87-2.02 (m, 4H), 2.20 
(m, 2H), 4.10 (q, 2H, 3J = 7.03 Hz, CH2-12), 
4.62 (dd, 1H, 3J = 4.52 Hz, 3J = 2.26 Hz, CH-3), 
4.90 (dd, 1H, 3J = 10.29 Hz, 2J = 1.76 Hz, CHH-
9a), 4.98 (dd, 1H, 3J = 17.32 Hz, 2J = 1.76 Hz, 
CHH-9b), 5.79 (ddd, 1H, 3J = 16.56 Hz, 3J = 10.04 Hz, 3J = 6.27 Hz, CH-8).13C-NMR 
(100 MHz, CDCl3): [ppm] = -3.8 (CH3, C-16/17), -3.6 (CH3, C-17/16), 14.2 (CH3, C-
13), 22.8 (Cq, C19-Si), 25.4 (CH3, C-20/21/22), 26.4, 29.0, 31.7, 33.7 (CH2, C-4/5/6/7), 
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58.0 (Cq, C-1), 60.4 (CH2, C-12), 102.1 (CH, C-3), 114.1 (CH2, C-9), 138.9 (CH, C-8), 
154.1 (Cq, C-2), 175.3 (CO, C-10).  
 
 
R 69: Synthesis100 of ethyl 1-(3-buten-1-yl)-2-(tert-butyl-
dimethylsilanyloxy)cyclohex-2-ene carboxylate (126b) 
Amounts: 5.0 g  (22.3 mmol) ethyl (1-but-3-enyl)-2-oxo-cyclohexane 
      carboxylate (68b) 
  1.56 g  (24.5 mmol) n-butyllithium (2.5 M in hexane) 
  2.70 g  (26.7 mmol) diisopropylamine 
  5.68 g  (37.9 mmol) chloro tert-butyldimethylsilane (74) 
  80 ml     dry THF  
Procedure: Analogously to R 61. 
Work-up: Evaporation in vacuum of the solvent and without any purification gives 
7.28 g (21.5 mmol, 96 % yield) of ethyl 1-(3-buten-1-yl)-2-(tert-butyl-
dimethylsilanyloxy)cyclohex-2-ene carboxylate (126b) (C19H34O3Si, 338.557 g/mol) as 
a colorless liquid. 
Spectroscopic data: GC-MS (EI, 70 eV): m/z 
(%) = 339 (M++1, 30), 281 (85), 266 (15), 210 
(5), 73 (60). IR (KBr-film): ν [cm-1] = 3077 (w), 
2954 (s), 2932 (s), 2904 (s), 2858 (s), 1729 (s), 
1641 (m), 1448 (m), 1363 (m), 1257 (vs), 1157 
(s), 860 (s). 1H-NMR (400 MHz, CDCl3): [ppm] 
= 0.12 (s, 3H, CH3-17/18), 0.15 (s, 3H, CH3-
18/17), 0.86 (s, 9H, CH-21/22/23), 1.21 (t, 3H, 3J 
= 7.28 Hz, CH3-14), 1.54–2.03 (approx. 10H), 
4.09 (q, 2H, 3J = 7.28 Hz, CH2-13), 4.81-4.83 (dd, 
1H, 3J = 4.52 Hz, 3J = 3.51 Hz, CH-3), 4.89 (dd, 
1H, 3J = 10.29 Hz, 2J = 1.76 Hz, CHH-10a), 4.98 
(dd, 1H, 3J = 17.07 Hz, 2J = 1.76 Hz, CHH-10b), 5.78 (ddd, 1H, 3J = 16.82, 3J = 10.29 
Hz, 3J = 6.53 Hz, CH-9). 13C-NMR (100 MHz, CDCl3): [ppm] = -4.5 (CH3, C-17/18), -
4.4 (CH3, C-18/17), 14.2 (CH3, C-14), 25.5 (CH3, C-21/22/23), 24.0, 24.1, 28.9, 31.8, 
34.1 (CH2, C-4/5/6/7/8), 50.7 (Cq, C-1), 60.4 (CH2, C-13), 103.9 (CH, C-3), 114.0 
(CH2, C-10), 139.0 (CH, C-9), 149.6 (Cq, C-2), 175.8 (CO, C-11). 
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b. Attempted tandem hydroformylation/ aldol addition of silyl enol ethers 
 
R 70: Synthesis of ethyl 2-(tert-butyl-dimethylsilanyloxy)-1-(4-oxo-butyl)-
cyclopent-2-ene carboxylate (127a) 
Amounts: 1.00 g  (3.0 mmol) ethyl 1-allyl-2-(tert-butyl-  
      dimethylsilanyloxy)-cyclopent-2-ene 
      carboxylate (125a) 
  63.0 mg (2.0 mol %) [Rh(cod)Cl]2 (41) 
  20 ml    dry DCM 
Procedure: Analogously toR 13; 80 bar [p(CO):p(H2) = 1:1]; T = 90 °C, 48 h.  
Work-up: After expanding the syngas, the remaining solution is filtered through 
alumina N (III) using MTBE as eluent. The solvent is removed by rotary evaporation 
and the residue is analyzed by gas chromatography. 2.05 g (6.0 mmol, 94 % yield) as a 
colorless oil mixture of ethyl 2-(tert-butyl-dimethylsilanyloxy)-1-(4-oxo-butyl)-
cyclopent-2-ene carboxylate (127a) (C18H32O4Si, 340.539 g/mol) and ethyl 2-(tert-
butyl-dimethyl-silanyloxy)-1-(2-methtyl-3-oxo-propyl)cyclopent-2-ene carboxylate 
(128a) are obtained in a ratio of 1.2:1 identified by 1H-NMR analysis; the branched 
aldehyde 128a is present as mixture of two diastereoisomers in a ratio of 1:1 identified 
by 1H-NMR analysis.  
Spectroscopic data: ethyl 2-(tert-butyl-
dimethylsilanyloxy)-1-(4-oxo-butyl)cyclopent-
2-ene carboxylate (127a). GC-MS (EI, 70 eV): 
m/z (%) = 341 (M++1, 30), 340 (19), 283 (45), 
209 (75), 73 (82). IR (KBr-film): ν  [cm-1] = 
3479 (w), 2956 (s), 2931 (s), 2903 (w), 2858 (s), 
1727 (s), 1647 (s), 1447 (m), 1363 (m), 1253 
(w), 1135 (w), 938 (s). 1H-NMR (500 MHz, 
CDCl3): δ [ppm] = 0.13 (s, 6H, CH3-17/18), 
0.82 (s, 9H, CH-21/22/23), 1.21 (t, 3H, 3J = 7.03 
Hz, CH3-14), 1.50-2.50 (approx. 10H), 4.07 (q, 
2H, 3J = 7.03 Hz, CH2-13), 4.80 (dd, 1H, 3J = 
4.52 Hz, 3J = 2.01 Hz, CH-3), 9.73 (t, 1H, 3J = 1.25 Hz, CHO-9). 13C-NMR (125 MHz, 
CDCl3): δ [ppm] = -5.5 (CH3, C-17/18), -4.5 (CH3, C-18/17), 14.2 (CH3, C-14), 25.4 
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(CH3, C-21/22/23), 17.3, 26.5, 31.7, 33.8, 44.2 (CH2, C-4/5/6/7/8), 58.1 (Cq, C-1), 60.4 
(CH2, C-13), 102.3 (CH, C-3), 153.9 (Cq, C-2), 174.9 (CO, C-11), 202.5 (CO, C-9). 
The presence of the compound ethyl 2-(tert-butyldimethyl-silanyloxy)-1-(2-methtyl-3-
oxo-propyl)-cyclopent-2-ene carboxylate (128a) as mixture of two diastereoisomers in 
a ratio of 1:1 identified by 1H-NMR analysis, is detected 
from the most significant peaks identified by NMR 
analysis: 1H-NMR (500 MHz, CDCl3): δ [ppm]: 1.08 (d, 
3H, 3J = 7.28 Hz, CH3-8), 9.50 (d, 1H, 3J = 2.72 Hz, 
CHO-9, DS1), 9.55 (d, 1H, 3J = 1.76 Hz, CHO-9, DS2). 
13C-NMR (125 MHz, CDCl3): δ [ppm]: 15.8, 15.9 (CH3, 
C-8, DS1/DS2), 43.0, 43.1 (CH, C-7, DS1/DS2), 102.8, 
103.5 (CH, C-3, DS1/DS2), 204.6, 204.9 (CO, C-9, DS1/DS2). 
 
 
R 71: Synthesis of ethyl 2-(tert-butyl-dimethylsilanyloxy)-1-(4-oxo-butyl)cyclohex-
2- ene carboxylate (127b) 
Amounts: 1.00 g  (3.0 mmol) ethyl 1-allyl-2-(tert-butyl-dimethyl 
      silanyloxy)cyclohex-2-ene carboxylate 
      (125b) 
  60.0 mg (2.0 mol %) [Rh(cod)Cl]2 (9)  
  20 ml     dry dichloromethane 
Procedure: Analogously to R 13; 80 bar [p(CO):p(H2) = 1:1]; T = 90 °C, 48 h.  
Work-up: After expanding the syngas, the remaining solution is filtered through 
alumina N (III) using MTBE as eluent. The solvent is removed by rotary evaporation 
and the residue is analyzed by gas chromatography. Removal of the solvent furnishes 
1.980 g (5.6 mmol, 92 % yield ) as a colorless oil mixture of linear aldehyde ethyl 2-
(tert-butyl-dimethyl-silanyloxy)-1-(4-oxo-butyl)cyclohex-2-ene carboxylate (127b) and 
branched aldehyde ethyl 2-(tert-butyl-dimethylsilanyloxy)-1-(2-methtyl-3-oxo-
propyl)cyclohex-2-ene carboxylate (128b) (C19H34O4Si, 354.566 g/mol) in a ratio of 
(1.5:1) identified by 1H-NMR analysis; the branched aldehyde 128b is present as a 
mixture of two diastereoisomers in a ratio of 1:1.4 identified by 1H-NMR analysis.  
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Spectroscopic data: ethyl 2-(tert-
butyldimethyl silanyloxy)-1-(4-oxo-
butyl)cyclohex-2-ene-carboxylate (127b). 
GC-MS (EI, 70 eV): m/z (%) = 355 
(M++1, 25), 354 (5), 298 (10), 281 (25), 
223 (55), 73 (60), 57 (25). IR (KBr-film): 
ν  [cm-1] = 3478 (w), 2954 (s), 2931 (w), 
2903 (s), 2886 (s), 2858 (s), 1724 (s), 1662 
(s), 1447 (m), 1363 (m), 1253 (w), 1158 
(w), 934 (s). 1H-NMR (500 MHz, CDCl3): 
δ [ppm] = 0.09 (s, 6H, CH3-18/19), 0.82 (s, 
9H, CH-22/23/24), 1.19 (t, 3H, 3J = 6.98 
Hz, CH3-15), 1.53-2.42 (approx. 12H), 4.1 (q, 2H, 3J = 6.98 Hz, CH2-14), 4.80 (dd, 1H, 
3Jaa = 7.73 Hz, 3Jae = 4.24 Hz, CH-3), 9.70 (t, 1H, 3J = 1.75 Hz, CHO-10). 13C-NMR 
(125 MHz, CDCl3): δ [ppm] = -5.4 (CH3, C-18/19), -4.5 (CH3, C-19/18), 14.1 (CH3, C-
15), 25.5 (CH3, C-22/23/24), 17.2, 19.2, 23.8, 31.7, 34.4, 44.3 (CH2, C-4/5/6/7/8/9), 
50.7 (Cq, C-1), 60.4 (CH2, C-14), 104.1 (CH, C-3), 149.4 (Cq, C-2), 175.5 (CO, C-12), 
202.4 (CO, C-10). 
 
The presence of the compound ethyl 2-(tert-butyl-dimethyl-silanyloxy)-1-(2-methtyl-3-
oxo-propyl)cyclohex-2-ene carboxylate (128b) is detected 
from the most significant peaks identified by NMR 
analysis: 1H-NMR (500 MHz, CDCl3): δ [ppm] = 1.08 (d, 
3H, 3J = 7.28 Hz, CH3-9), 9.51 (d, 1H, 3J = 2.74 Hz, CHO-
10, DS1/DS2), 9.59 (d, 1H, 3J = 2.24 Hz, CHO-10, 
DS2/DS1). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 16.1, 
16.4 (CH3, C-9, DS1/DS2), 42.8, 42.9 (CH, C-8, 
DS1/DS2), 104.6, 105.4 (CH, C-3, DS1/DS2), 204.8, 204.9 (CO, C-10, DS1/DS2). 
 
 
R 72: Synthesis of ethyl 2-(tert-butyl-dimethylsilanyloxy)-1-(4-oxo-butyl)cyclohept-
2-ene carboxylate (127c) 
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Amounts: 2.0 g  (5.9 mmol) ethyl 1-allyl-2-(tert-   
      butyldimethylsilanyloxy)cyclohept-2-ene 
      carboxylate (125c) 
  14.0 mg (1.0 mol %) [Rh(cod)Cl]2 (41) 
  20 ml     dry DCM  
Procedure: Analogously toR 13; 80 bar [p(CO):p(H2) = 1:1]; T = 90 °C, 72 h.  
Work-up: After expanding the syngas, the remaining solution is filtered through 
alumina N (III) using MTBE as eluent. The solvent is removed by rotary evaporation 
and the residue is purified by bulb-to-bulb distillation (T = 125 °C, P = 5.5 x 10-2 mbar) 
to give 0.5 g (1.35 mmol, 23 % yield of ethyl 2-(tert-butyl-dimethylsilanyloxy)-1-(4-
oxo-butyl)cyclohept-2-ene carboxylate (127c) (C20H36O4Si, 368.583 g/mol) as a 
colorless liquid. 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) 
= 369 (M++1, 25), 368 (5), 295 (18), 237 (65), 73 
(80), 57 (15). 1H-NMR (500 MHz, CDCl3): δ 
[ppm] = 0.12 (s, 3H, CH3-19/20), 0.13 (s, 3H, CH3-
20/19), 0.84 (s, 9H, CH-23/24/25), 1.23 (t, 3H, 3J = 
7.03 Hz, CH3-16), 1.57-1.66 (m, 6H), 1.73 (m, 2H), 
1.82 (m, 2H), 1.91 (m, 2H), 2.40 (m, 2H), 4.16 (m, 
2H, CH2-15), 4.95 (dd, 1H, 3Jaa = 7.28 Hz, 3Jae = 
5.27 Hz, CH-3), 9.73 (t, 1H, 3J = 1.76 Hz, CHO-
11). 13C-NMR (125 MHz, CDCl3): δ [ppm] = -5.1 
(CH3, C-19/20), -4.5 (CH3, C-20/19), 14.2 (CH3, C-16), 25.6 (CH3, C-23/24/25), 17.4, 
22.8, 23.6, 26.4, 31.5, 35.9, 44.4 (CH2, C-4/5/6/7/8/9/10), 56.1 (Cq, C-1), 60.4 (CH2, C-
15), 108.7 (CH, C-3), 152.7 (Cq, C-2), 174.9 (CO, C-13), 202.7 (CO, C-11). 
 
 
R 73: Synthesis of ethyl 2-(tert-butyl-dimethylsilanyloxy)-1-(5-oxo-
pentyl)cyclopent-2-ene carboxylate (130a) 
Amounts: 2.0 g  (6.1 mmol) ethyl 1-(3-buten-4-yl)-2-(tert-butyl- 
      dimethyl-silanyloxy)cyclopent-2-ene 
      carboxylate (126a) 
  31.4 mg (1.0 mol %) [Rh(cod)Cl]2 (41) 
  20 ml    dry DCM 
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Procedure: Analogously toR 13; 80 bar [p(CO):p(H2) = 1:1]; T = 90 °C, 72 h. 
Work-up: After expanding the syngas, the remaining solution is filtered through 
alumina N (III) using MTBE as eluent. The solvent is removed by rotary evaporation 
and the residue is analyzed by gas chromatography. 1.619 g (4.6 mmol, 75 % yield) as 
a colorless oil mixture of linear aldehyde ethyl 2-(tert-butyl-dimethyl-silanyloxy)-1-(5-
oxo-pentyl)cyclopent-2-ene carboxylate (130a) and branched aldehyde ethyl 2-(tert-
butyl-dimethylsilanyloxy)-1-(methyl-oxo-butyl)cyclopent-2-ene carboxylate (131a) 
(C19H34O4Si, 354.556 g/mol) in a ratio of 7:1 identified by 1H-NMR analysis.  
Spectroscopic data of 130a: 1H-NMR (500 MHz, CDCl3): δ [ppm] = 0.05 (s, 6H, 
CH3-18/19), 0.88 (s, 9H, CH-22/23/24), 
1.21 (t, 3H, 3J = 7.23 Hz, CH3-15), 1.38-
2.50 (approx. 12H), 4.16 (m, 2H, CH2-14), 
4.95 (dd, 1H, 3Jae = 5.79 Hz, 3Jee = 5.49 Hz, 
CH-3), 9.72 (br s, 1H, CHO-10). 13C-NMR 
(125 MHz, CDCl3): δ [ppm] = -5.7 (CH3, C-
18/19), -3.7 (CH3, C-19/18), 14.0 (CH3, C-
15), 25.6 (CH3, C-22/23/24), 22.2 (Cq, C21-
Si), 19.5, 24.6, 32.1, 32.7, 33.6, 37.9 (CH2, 
C-4/5/6/7/8/9), 50.1 (Cq, C-1), 61.3 (CH2, 
C-14), 104.3 
(CH, C-3), 152.7 (Cq, C-2), 173.6 (CO, C-12), 203.8 
(CO, C-10). 
The presence of the compounds 131a is detected from the 
most significant peaks identified by NMR analysis: 1H-
NMR (500 MHz, CDCl3): δ [ppm] = 0.95 (d, 3H, 3J = 
7.28 Hz, CH3-9), 9.58 (d, 1H, 3J = 1.0 Hz, CHO-10). 13C-
NMR (125 MHz, CDCl3): δ [ppm] = 13.8 (CH3, C-9), 
25.8 (CH3, C-22/23/24), 52.6 (CH-8), 106.6 (CH, C-3), 203.8 (CO, C-10). 
 
 
R 74: Synthesis of ethyl 2-(tert-butyl-dimethylsilanyloxy)-1-(5-oxo-pentyl)cyclohex-
2-ene carboxylate (130b) 
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Amounts: 2.00 g  (5.9 mmol) ethyl 2-(3-buten-4-yl)-(2-tert-butyl- 
      dimethyl-silanyloxy)cyclohex-2-ene 
      carboxylate (126b) 
  30.0 mg (1.0 mol %) [Rh(cod)Cl]2 (41) 
  20 ml    dry dichloromethane 
Procedure: Analogously to R 13, 80 bar [p(CO):p(H2) = 1:1]; T = 90 °C, 72 h.  
Work-up: After expanding the syngas, the remaining solution is filtered through 
alumina N (III) using MTBE as eluent. The solvent is removed by rotary evaporation 
and the residue is analyzed by gas chromatography. 1.84 g (5.0 mmol, 85 % yield) as a 
mixture of linear aldehyde ethyl 2-(tert-butyl-dimethyl-silanyloxy)-1-(5-oxo-pentyl)-
cyclohex-2-ene carboxylate (130b) (C20H36O4Si, 368.583 g/mol) and branched 
aldehyde ethyl 2-(tert-butyl-dimethylsilanyloxy)-1-(methyl-oxo-butyl)cyclohex-2-ene 
carboxylate (131b) in a ratio of 4.5:1, identified by 1H-NMR analysis, are obtained. 
The branched aldehyde 131b is present as a mixture of two diastereoisomers in a ratio 
of 1:2.1 identified by 1H-NMR analysis.  
Spectroscopic data of 130b: 1H-NMR (500 MHz, CDCl3): δ [ppm] = 0.13 (s, 3H, 
CH3-19/20), 0.14 (s, 3H, CH3-20/19), 0.84 
(s, 9H, CH-23/24/25), 1.23 (t, 3H, 3J = 7.03 
Hz, CH3-16), 1.59-2.44 (approx. 14H), 
4.12 (m, 2H, CH2-15), 4.79 (dd, 1H, 3Jaa = 
7.28 Hz, 3Jae = 5.27 Hz, CH-3), 9.71 (t, 1H, 
3J = 1.75 Hz, CHO-11). 13C-NMR (125 
MHz, CDCl3): δ [ppm] = -5.0 (CH3, C-
19/20), -3.5 
(CH3, C-
20/19), 
14.2 (CH3, C-16), 25.6 (CH3, C-23/24/25), 19.0, 22.6, 
25.4, 31.5, 34.7, 38.9, 43.7 (CH2, C-4/5/6/7/8/9/10), 
59.6 (Cq, C-1), 61.4 (CH2, C-16), 103.8 (CH, C-3), 
157.9 (Cq, C-2), 175.7 (CO, C-13), 202.2 (CO, C-11). 
The presence of the compounds 131b is detected from 
the most significant peaks identified by NMR analysis: 
1H-NMR (500 MHz, CDCl3): δ [ppm] = 9.57 (d, 1H, 3J = 1.75 Hz, CHO-11, 
DS1/DS2), 9.59 (d, 1H, 3J = 1.75 Hz, CHO-11, DS2/DS1). 13C-NMR (125 MHz, 
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CDCl3): δ [ppm] = 13.8 (CH3, C-9), 25.8 (CH3, C-22/23/24), 44.6 (CH-9), 103.8 (CH, 
C-3), 202.2 (CO, C-11). 
 
 
4.5.3 Stepwise hydroformylation/ aldol addition of preformed silyl enol ethers 
 
a. Preparation of starting materials  
 
R 75: Synthesis of ethyl 2-(tert-butyl-dimethylsilanyloxy)-1-(4-oxo-
butyl)cyclohex-2-ene carboxylate (127b) 
Amounts: 1.00 g  (3.0 mmol) ethyl 1-allyl-2-(tert-butyl-  
      dimethylsilanyloxy)cyclohex-2-ene  
      carboxylate (125b) 
  7.96 mg (1.0 mol %) [Rh(acac)(CO)2] (28) 
  96.8 mg (5.0 mol %) BIPHEPHOS (29) 
  20 ml     dry DCM 
Procedure: Analogously to R 13, 20 bar [p(CO):p(H2) = 1:1]; T = 60 °C, 72 h. 
Work-up: The solvent is removed by rotary evaporation and the residue is analyzed 
by gas chromatography. 0.96 g (2.72 mmol, 88 % yield) of ethyl 2-(tert-butyl-dimethyl-
silanyloxy)-1-(4-oxo-butyl)cyclohex-2-ene carboxylate (127b) are obtained, as a 
colorless liquid, by column chromatography on alumina N (III) using as eluent a 
mixture of cyclohexane-Et2O (3:1). 
Spectroscopic data of 127b are consistent with those reported in R 71. 
 
 
b. Intramolecular aldol addition catalyzed by TiCl4 
 
R 76: Synthesis of ethyl 5-hydroxy-10-oxo-bicyclo[4.3.1]decane carboxylate (73b) 
A solution of ethyl 2-(tert-butyl-dimethylsilanyloxy)-1-(4-oxo-butyl)cyclohex-2-ene 
carboxylate (127b) (3.0 g, 8.4 mmol) is added to 1.34 ml (2.28 g, 12.0 mmol) of TiCl4 
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in 40 ml of CH2Cl2 at room temperature under an argon atmosphere. This mixture is 
stirred for 2 hours. After hydrolysis, the resulting organic layer extracted with 
diethylether is washed (3 x 30 ml) with a solution NaHCO3. The combined extracts are 
dried over anhydrous MgSO4, filtered and concentrated under vacuum. The product, as 
a colorless oil, is obtained by column chromatography on alumina N (III) using as 
eluent a mixture of cyclohexane and Et2O (3:1) giving 1.47 g (6.13 mmol, 73 % yield) 
of ethyl 5-hydroxy-10-oxo-bicyclo[4.3.1]decane carboxylate (73b) (C13H20O4, 240.296 
g/mol) as a single diastereoisomer. 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 240 (M+, 4), 222 (14), 194 (14), 
149 (63), 79 (42), 55 (25). High 
Resolution Mass: Calculated: 240.1362; 
Found: 240.1362. IR (KBr-film): ν [cm-1] 
= 3469 (s), 2934 (s), 2864 (s), 1737 (s), 
1732 (s), 1454 (s), 1367 (s), 1255 (s), 1075 
(s), 1027 (s). 1H-NMR (500 MHz, CDCl3): 
δ [ppm] = 1.26 (t, 3H, 3J = 7.23 Hz, CH3-
14), 1.51-2.18 (approx. 10H), 2.40 (m, 1H), 2.65 (m, 1H), 2.78 (m, 1H), 3.87 (m, 1H, 
CH-5), 4.20 (q, 2H, 3J = 7.23 Hz, CH2-13). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 
14.1 (CH3, C-14), 18.0, 19.6, 28.2, 31.7, 34.7, 35.1 (CH2, C-2/3/4/7/8/9), 56.3 (CH, C-
6), 61.0 (Cq, C-1), 61.4 (CH2, C-13), 71.3 (CH, C-5), 175.1 (CO, C-11), 212.5 (CO, C-
10). 
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4.6 Sequential tandem hydrofromylation/ aldol addition via 
in situ generated borane enolate  
R 77: Conversion of ethyl 1-allyl-2-oxo-cyclohexane carboxylate (4b)  
A solution of ethyl 1-allyl-2-oxo-cyclohexane carboxylate (4b) 0.5 g (2.3 mmol), 230.0 
mg (2.3 mmol) of TEA, 6.0 mg (1.0 mol %) of [Rh(acac)(CO)2] (28) in dry DCM is 
stirred for 15 min. at T = 0 °C, then 0.487 mg (2.3 mmol) of dicyclohexylchloroborane 
(cy-hex)2BCl (159) is added and stirred for 30 min. Finally, 23.0 mg (1.8 % mol) of 
XANTPHOS (160) is added, and the reaction mixture is placed in an autoclave. After 
flushing with argon the reactor is pressurized with 40 bar of carbon monoxide and 40 
bar of hydrogen; the mixture is magnetically stirred and heated to 90 °C for 1 day. 
Then, the autoclave is allowed to cool to room temperature. After expanding the 
syngas, the remaining solution is filtered through alumina N (III) using MTBE as 
eluent. The solvent is removed by rotary evaporation and the residue is dissolved in 15 
ml of methanol, buffered at pH = 7, added H2O2 and stirred at room temperature for 1 
h. Then, the mixture is extracted with MTBE (3 x 30 ml), the organic phase dried by 
MgSO4, concentrated in vacuum and analyzed by gas chromatography. 0.412 g of ethyl 
5-hydroxy-10-oxo-bicyclo[4.3.1]decane carboxylate (73b) (C13H20O4, 240.296 g/mol) 
and ethyl 1-formyl-2,4,5,6,7-hexahydro-3aH-indene-3a-carboxylate (72b) (C13H18O3, 
222.280 g/mol) areobtained as a colorless oil. The products 73b and 72b are identified 
by comparison to those spectroscopic data reported in R 76 and R 24 respectively. 
Spectroscopic data of 73b are consistent with those reported in  
R 76. 
Spectroscopic data of 72b are consistent with those reported in R 24. 
 
 
R 78: Conversion of 2-allyl-2-methyl-cyclohexanone (92) 
Amounts:  1.0 g  (6.5 mmol) 2-allyl-2-methyl-cyclohexanone (92) 
  16.7 mg (1.0 % mol) [Rh(acac)(CO)2] (28) 
  1.44 g  (1.05 % mol) (cy-hex)2BCl (159) 
  48.0 mg (1.8 % mol) XANTPHOS (160) 
  722.0 mg (7.1 mmol) TEA 
  20 ml     dry DCM 
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Procedure: Analogously to R 77; 80 bar [p(CO):p(H2) = 1:1]; T = 90 °C, 72 h.  
Work-up: 1.08 g as a colorless oil mixture of 5-hydroxy-1-methyl-
bicyclo[4.3.1]decan-10-one (164) (C11H18O2, 182.259 g/mol) and 7a-methyl-
2,4,5,6,7,7a-hexahydro-1H-indene-3-carbaldehyde (101) (C11H16O, 164.250 g/mol) in 
the ratio of 9:1 detected by NMR analysis. The presence of 164 is identified by the 
most significant peaks: 
Spectroscopic data of 164: IR (KBr-film): 
ν  [cm-1] = 3399 (s), 2935 (vs), 2861 (vs), 
1731 (vs). 1H-NMR (400 MHz, CDCl3): δ 
[ppm] = 1.16 (s, 3H, CH3-11), 1.51-2.18 
(approx. 12H), 2.32 (m, 1H), 2.50 (m, 1H), 
3.61 (m, 1H, CH-5). 13C-NMR (100 MHz, 
CDCl3): δ [ppm] = 16.4 (CH3, C-11), 19.9, 
20.9, 29.9, 32.7, 37.1, 41.4 (CH2, C-2/3/4/7/8/9), 49.3 (CH, C-6), 62.4 (Cq, C-1), 70.5 
(CH, C-5), 203.1 (CO, C-10). 
Spectroscopic data of 101 are consistent with those reported in R 56. 
 
 
R 79: Conversion of ethyl 3-allyl-3-methyl-2-oxo-cyclohexane-carboxylate (93) 
Amounts: 1.0 g  (4.4 mmol) ethyl 3-allyl-3-methyl-2-oxo-cyclohexane-
      carboxylate (93) 
  16.0 mg (1.0 % mol) [Rh(acac)(CO)2] (28) 
  0.98 g  (1.05 mmol) (cy-hex)2BCl (159) 
  46.0 mg (1.8 % mol) XANTPHOS (160) 
  488.0 mg (4.8 mmol) TEA 
  20 ml    dry DCM 
Procedure: Analogously to R 77, 80 bar [p(CO):p(H2) = 1:1]; T = 90 °C, 72 h.  
Work-up: Evaporation in vacuum of the filtrate and bulb-to-bulb distillation of the 
crude mixture (T = 90 °C, P = 4.0 x 10-2 mbar) gives 0.51 g (2.01 mmol, 46 % yield) of 
ethyl 2-hydroxy-3,5-dimethyl-9-oxo-bicyclo[3.3.1]nonane carboxylate (97) (C14H22O4, 
254.329 g/mol) as a colorless oil. 
Spectroscopic data of 97 are consistent with those reported in R 55. 
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4.7 Stepwise Michael addition and aldol cyclization 
 
a. Preparation of ethyl 2-oxo-1-(3-oxo-propyl)cycloalkane carboxylates 
 
R 80: Synthesis158 of ethyl 2-oxo-1-(3-oxo-propyl)cyclopentane carboxylate (173a)  
To a solution of 5.0 g (32.0 mmol) of ethyl 2-oxo-cyclopentane carboxylate (65a) in 50 
ml of DMF are added 0.44 ml (0.32 g, 3.2 mmol) of TEA and the mixture is stirred for 
1h at room temperature. A solution of acrolein (172) (2.16 ml, 1.79 g, 328.0 mmol) in 
15 ml of DMF is added and the solution is stirred for 18h at room temperature. Then, 
the solution is neutralized with a solution of HCl (5%) and the aqueous layer is 
extracted with Et2O (3 x 20 ml). The combined organic phases are dried over 
anhydrous MgSO4, filtered, and concentrated in vacuum. 6.10 g (28.7 mmol, 90 % 
yield) of ethyl 2-oxo-1-(3-oxo-propyl)cyclopentane carboxylate182 (173a) (C11H16O4, 
212.242 g/mol) are isolated, as a colorless liquid, by bulb-to-bulb distillation (T = 75 
°C, P = 7.2 x 10-2 mbar). 
Spectroscopic data: 1H-NMR (500 MHz, CDCl3): δ 
[ppm] = 1.20 (t, 3H, 3J = 7.23 Hz, CH3-13), 1.80-2.00 
(m, 4H), 2.09-2.15 (m, 1H), 2.20-2.29 (m, 1H), 2.35-
2.49 (m, 3H), 2.62-2.68 (m, 1H), 4.11 (q, 2H, 3J = 
7.23 Hz, CH2-12), 9.7 (br s, 1H, CHO-8). 13C-NMR 
(125 MHz, CDCl3): δ [ppm] = 13.9 (CH3, C-13), 
19.4, 25.3, 33.9, 37.8, 39.4 (CH2, C-3/4/5/6/7), 60.1 
(Cq, C-1), 61.4 (CH2, C-12), 171.0 (CO, C-10), 201.0 (CO, C-8), 214.5 (CO, C-2). 
 
 
R 81 Synthesis158 of ethyl 2-oxo-1-(3-oxo-propyl)cyclohexane carboxylate (173b)  
Amounts: 10.0 g  (58.0 mmol) ethyl 2-oxo-cyclohexane carboxylate (65b) 
  0.80 ml (5.8 mmol) triethylamine (TEA) 
  3.91 ml (58.0 mmol) acrolein (172) 
  50 ml    DMF 
Procedure: Analogously to R 80. 
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Work-up: The organic extracts are dried over anhydrous MgSO4, filtered, and 
concentrated in vacuum. 6.54 g (28.9 mmol, 50 % yield) of ethyl 2-oxo-1-(3-oxo-
propyl)cyclohexane carboxylate158 (173b) (C12H18O4, 226.269 g/mol) are isolated as a 
colorless liquid by bulb-to-bulb distillation (T = 75 °C, P = 7.2 x 10-2 mbar). 
Spectroscopic data: 1H-NMR (500 MHz, CDCl3): δ 
[ppm] = 1.18 (t, 3H, 3J = 7.23 Hz, CH3-14), 1.35-1.40 
(m, 1H), 1.52-1.57 (m, 2H), 1.67-1.69 (m, 1H) 1.76-
1.82 (m, 1H), 1.91-1.93 (m, 1H), 2.02-2.08 (m, 1H), 
2.26-2.52 (m, 5H), 4.11 (q, 2H, 3J = 7.23 Hz, CH2-13), 
9.63 (brt, 1H, 3J = 1.0 Hz, CHO-9). 13C-NMR (125 
MHz, CDCl3): δ [ppm] = 13.9 (CH3, C-14), 22.3, 26.6, 
27.3, 36.4, 39.1, 40.8 (CH2, C-3/4/5/6/7/8), 59.6 (Cq, C-1), 61.3 (CH2, C-13), 171.6 
(CO, C-11), 200.9 (CO, C-9), 207.5 (CO, C-2). 
 
 
R 82: Synthesis158 of ethyl 2-oxo-1-(3-oxo-propyl)cycloheptane carboxylate (173c)  
Amounts: 2.0 g  (10.0 mmol) ethyl 2-oxo-cycloheptane carboxylate (65c) 
  0.14 ml (1.0 mmol) TEA  
  0.73 ml (10.0 mmol) acrolein (172) 
  20 ml    DMF 
Procedure: Analogously to R 80.  
Work-up: The organic layers are dried over anhydrous MgSO4, filtered, and 
concentrated in vacuum. 1.63 g (6.79 mmol, 68 % yield) of ethyl 2-oxo-1-(3-oxo-
propyl)cycloheptane carboxylate182 (173c) (C13H20O4, 240.296 g/mol) is isolated as a 
colorless liquid by bulb-to-bulb distillation (T = 75 °C, P = 7.2 x 10-2 mbar). 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 
240 (M+, 1), 211 (2), 195 (2), 166 (38), 138 (98), 124 
(10), 110 (40), 95 (78), 67 (65), 55 (35). 1H-NMR 
(500 MHz, CDCl3): δ [ppm] = 1.18 (m, 3H, CH3-15), 
1.38-2.00 (approx. 11H), 2.03 (m, 1H), 2.40 (m, 1H), 
2.54 (m, 1H), 4.10 (m, 2H, CH2-14), 9.66 (m, 1H, 
CHO-10). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 
13.9 (CH3, C-15), 24.7, 25.3, 27.5, 29.6, 33.7, 39.6, 42.1 (CH2, C-3/4/5/6/7/8/9), 60.4 
(Cq, C-1), 60.9 (CH2, C-14), 172.1 (CO, C-12), 201.2 (CO, C-10), 209.3 (CO, C-2). 
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R 83: Synthesis158 of ethyl 2-oxo-1-(3-oxo-propyl)cyclo-octane carboxylate (173d)  
Amounts: 2.0 g  (10.0 mmol) ethyl 2-oxo-cyclo-octane carboxylate (65d) 
  0.14 ml (1.0 mmol) TEA  
  0.67 ml (10.0 mmol) acrolein (172) 
  20 ml    DMF 
Procedure: Analogously to R 80.  
Work-up: The organic phases are dried over anhydrous MgSO4, filtered, and 
concentrated in vacuum. 1.90 g (7.49 mmol, 75 % yield) of ethyl 2-oxo-1-(3-oxo-
propyl)cyclo-octane carboxylate183 (173d) (C14H22O4, 254.322 g/mol) is isolated as a 
colorless liquid by bulb-to-bulb distillation (T = 75 °C, P = 7.2 x 10-2 mbar). 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 254 (M+, 15), 180 (58), 165 (98), 
152 (80), 137 (60), 123 (22), 109 (62), 95 (43), 81 
(38), 67 (63), 55 (37). 1H-NMR (500 MHz, 
CDCl3): δ [ppm] = 1.20 (t, 3H, 3J = 6.98 Hz, CH3-
16), 1.36-1.80 (approx. 9H), 1.97 (m, 2H), 2.35 (m, 
2H), 2.50 (m, 2H), 2.69 (m, 1H), 4.13 (q, 2H, 3J = 
6.98 Hz, CH2-15), 9.71 (t, 1H, 3J = 1.0 Hz, CHO-
11). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 14.0 
(CH3, C-16), 23.1, 23.6, 24.1, 25.4, 29.1, 29.6, 38.9, 39.6 (CH2-3/4/5/6/7/8/9/10), 61.3 
(Cq, C-1), 61.4 (CH2, C-15), 171.6 (CO, C-13), 201.2 (CO, C-11), 212.3 (CO, C-2). 
 
 
b. Stepwise cyclization under acidic conditions 
 
R 84: Synthesis63 of ethyl 4-hydroxy-8-oxo-bicyclo[3.2.1]octane carboxylate (174a)  
To a solution of ethyl 2-oxo-1-(3-oxo-propyl)cyclopentane carboxylate (173a) (1.0 g, 
4.7 mmol) in 20 ml of dioxane are added 15.0 ml of HCl (7N) and the mixture is stirred 
for 18h at room temperature. Then, the solution is neutralized with a solution of 
NaHCO3 and the aqueous layer is extracted with Et2O (3 x 20 ml). The combined 
organic phases are dried over anhydrous MgSO4, filtered, and concentrated in vacuum. 
775.9 mg (3.66 mmol, 78 % yield) of ethyl 4-hydroxy-8-oxo-bicyclo[3.2.1]octane 
carboxylate184 (174a) (C11H16O4, 212.242 g/mol) are isolated as a colorless liquid by 
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bulb-to-bulb distillation (T = 75 °C, P = 7.2 x 10-2 mbar) as a mixture of two 
diastereoisomers in a ratio of 1:3.8 detected by NMR analysis. 
Spectroscopic data: GC-MS (EI, 70 eV): m/z 
(%) = 213 (M++1, 100), 212 (5), 195 (16), 184 
(10), 166 (55), 110 (30), 55 (98). IR (KBr-
Film): ν  [cm-1] = 3467 (m), 2960 (s), 2883 
(m), 1754 (vs), 1716 (vs), 1455 (m), 1368 (m), 
1271 (s), 1074 (s), 1016 (s). Major 
diastereoisomer 1H-NMR (500 MHz, CDCl3): 
δ [ppm] = 1.24 (t, 3H, 3J = 7.23 Hz, CH3-12), 1.66 (m, 1H), 1.85-2.07 (m, 6H), 2.47 (m, 
1H), 2.56 (m, 1H), 4.06 (m, 1H, CH-4), 4.11 (q, 2H, 3J = 7.23 Hz, CH2-11). 13C-NMR 
(125 MHz, CDCl3): δ [ppm] = 14.1 (CH3, C-12), 16.3, 26.5, 27.1, 31.1 (CH2, C-
2/3/6/7), 54.2 (CH, C-5), 55.7 (Cq, C-1), 61.2 (CH2, C-11), 73.6 (CH, C-4), 172.2 (CO, 
C-9), 210.9 (CO, C-8). The minor diastereoisomer is identified by the most significant 
peaks 13C-NMR (125 MHz, CDCl3): δ [ppm] = 19.4, 25.5, 25.8, 33.9 (CH2, C-2/3/6/7), 
54.0 (CH, C-5), 77.6 (CH, C-4). 
 
 
R 85: Synthesis63 of ethyl 4-hydroxy-9-oxo-bicyclo[3.3.1]nonane carboxylate 
(174b)  
Amounts: 1.0 g  (4.4 mmol) ethyl 2-oxo-1-(3-oxo-propyl)cyclohexane 
      carboxylate (173b) 
  14.0 ml   HCl (7N)  
  20 ml    Dioxane  
Procedure: Analogously to R 84.  
Work-up: The combined organic phases are dried over anhydrous MgSO4, filtered, 
and concentrated in vacuum. 872.0 mg (3.85 mmol, 87 % yield) of ethyl 4-hydroxy-9-
oxo-bicyclo[3.3.1]octane carboxylate (174b) (C12H18O4, 226.269 g/mol) are isolated as 
a colorless liquid, by bulb-to-bulb distillation (T = 75 °C, P = 7.2 x 10-2 mbar), as a 
mixture of two diastereoisomers in a ratio of 1:1.6 detected by NMR. 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 226 (M+, 10), 208 (12), 180 
(100), 135 (30), 107 (32), 79 (55), 55 (8). IR (KBr-Film): ν [cm-1] = 3469 (m), 2934 
(s), 2864 (m), 1737 (vs), 1732 (vs), 1454 (m), 1367 (m), 1255 (s), 1075 (s), 1027 (s). 
Major diastereoisomer 1H-NMR (500 MHz, CDCl3): δ [ppm] = 1.17 (t, 6H, 3J = 7.23 
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Hz, CH3-13), 1.51 (m, 1H), 1.68 (m, 1H), 1.79-
2.03 (m, 5H), 2.17-2.35 (m, 1H), 2.60 (m, 1H), 
2.73 (m, 1H), 3.95 (m, 1H, CH-4), 4.07-4.11 (q, 
2H, 3J = 7.23 Hz, CH2-12). 13C-NMR (125 
MHz, CDCl3): δ [ppm] = 13.9 (CH3, C-13), 
20.2, 28.3, 30.1, 30.7, 36.1 (CH2, C-2/3/6/7/8), 
54.3 (CH, C-5), 57.7 (Cq, C-1), 60.9 (CH2, C-
12), 75.6 (CH, C-4), 172.2 (CO, C-10), 212.8 (CO, C-9). The minor diastereoisomer is 
identified by the most significant peaks 13C-NMR (125 MHz, CDCl3): δ [ppm] = 19.1, 
26.2, 27.8, 30.0, 35.7 (CH2, C-2/3/6/7/8), 53.7 (CH, C-5), 57.6 (Cq, C-1), 72.3 (CH, C-
4), 212.1 (CO, C-9). 
 
 
R 86: Synthesis63 of ethyl 7-hydroxy-10-oxo-bicyclo[4.3.1]decane carboxylate 
(174c)  
Amounts: 2.0 g  (8.3 mmol) ethyl 2-oxo-1-(3-oxo-propyl)cycloheptane 
      carboxylate (173c) 
  26.5 ml   HCl (7N)  
  30 ml    Dioxane  
Procedure: Analogously to R 84. 
Work-up: The combined organic phases are dried over anhydrous MgSO4, filtered, 
and concentrated in vacuum. 1.72 g (7.16 mmol, 55 % yield) of ethyl 7-hydroxy-10-
oxo-bicyclo[4.3.1]nonecan carboxylate (174c) (C13H20O4, 240.296 g/mol) are isolated 
as a colorless liquid by bulb-to-bulb distillation (T = 85 °C, P = 7.2 x 10-2 mbar) as a 
mixture of 2 diastereoisomers in a ratio of 5.4:1 detected by NMR. 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 240 (M+, 1), 222 (2), 211 (2), 194 
(18), 121 (51), 84 (68), 55 (54). High Resolution 
Mass (FAB-m-NBA matrix): Calculated: for 
C13H21O4 [M+H]+: 241.1434; Found: 241.1439. 
IR (KBr-Film): ν [cm-1] = 3490 (w), 2933 (vw), 
2863 (m), 1731 (vw), 1712 (vw), 1698 (vw), 1454 
(w), 1367 (m), 1234 (w), 1180 (w), 1027 (w). 
Major diastereoisomer 1H-NMR (500 MHz, 
CDCl3): δ [ppm] = 1.21 (t, 3H, 3J = 7.23 Hz, CH3-14), 1.50-1.80 (approx. 9H), 2.05-
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2.44 (m, 3H), 2.60 (m, 1H), 2.73 (m, 1H), 4.05 (m, 1H), 4.14 (q, 2H, 3J = 7.23 Hz, CH2-
13). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 14.0 (CH3, C-14), 25.4, 23.4, 27.3, 29.6, 
32.8, 42.0 (CH2-2/3/4/5/8/9), 57.0 (CH, C-6), 61.1 (CH2, C-13), 73.1 (CH, C-7), 172.1 
(CO, C-11), 209.2 (CO, C-10). Minor diastereoisomer 13C-NMR (125 MHz, CDCl3): δ 
[ppm] = 24.7, 25.3, 27.2, 30.0, 33.4, 42.0 (CH2-2/3/4/5/8/9), 55.6 (CH, C-6), 60.5 (Cq, 
C-1), 61.4 (CH2, C-13), 70.4 (CH, C-7), 173.6 (CO, C-11), 210.0 (CO, C-10).  
 
 
R 87: Synthesis63 of ethyl 8-hydroxy-11-oxo-bicyclo[5.3.1]undecane carboxylate 
(174d)  
Amounts: 0.5 g (1.9 mmol)  ethyl 2-oxo-1-(3-oxo-propyl)cyclo-octane 
      carboxylate (173d) 
  9.89 ml   HCl (7N)  
  15 ml    Dioxane  
Procedure: Analogously to R 84.  
Work-up: The combined organic phases are dried over anhydrous MgSO4, filtered, 
and concentrated in vacuum. 299.0 mg (1.17 mmol, 62 %) as a colorless liquid mixture 
of 2 diastereoisomers in a ratio of 4:1, detected by NMR, of ethyl 8-hydroxy-11-oxo-
bicyclo[5.3.1]undecan carboxylate (174d) (C14H22O4, 254.322 g/mol) are isolated by 
bulb-to-bulb distillation (T = 85 °C, P = 7.2 x 10-2 mbar).  
Spectroscopic data: IR (KBr-Film): ν  [cm-1] = 3430 (s), 2927 (vs), 2857 (s), 1731 (s), 
1704 (vs), 1698 (vs), 1469 (s), 1446 (s), 1365 
(m), 1351 (m), 1267 (s), 1255 (s), 1226 (s), 1218 
(s), 1187 (s), 1081 (s), 1064 (s), 1025 (s). Major 
diastereoisomer 1H-NMR (500 MHz, CDCl3): δ 
[ppm] = 1.22 (t, 3H, 3J = 7.2 Hz, CH3-15), 1.63-
2.70 (approx. 14H), 2.73-2.78 (m, 1H), 3.95 (m, 
1H), 4.08 (m, 1H), 4.13 (q, 2H, 3J = 7.48 Hz, 
CH2-14). 13C-NMR (125 MHz, CDCl3): δ 
[ppm] = 14.0 (CH3, C-14), 23.1, 23.6, 24.1, 24.7, 25.6, 30.7, 31.2 (CH2, C-
2/3/4/5/6/9/10), 57.5 (CH, C-7), 61.3 (CH2, C-14), 72.5 (CH, C-8), 170.9 (CO, C-12), 
204.3 (CO, C-11). The minor diastereosomer is detected by the most significant peaks 
13C-NMR (125 MHz, CDCl3): δ [ppm] = 57.5 (CH, C-7), 71.5 (CH, C-8). 
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4.7.1 One–Pot Michael addition /aldol cyclization under basic conditions 
 
a. Acrolein chain 
 
R 88: Synthesis of ethyl 4-hydroxy-9-oxo-bicyclo[3.3.1]nonane carboxylate (174b) 
To a solution of ethyl 2-oxo-cyclohexane carboxylate (65b) (10.0 g, 58.0 mmol) in 50 
ml of EtOH is added a solution of DBU (7.66 ml, 8.36 g, 58.0 mmol) in 10 ml of EtOH, 
and the mixture is stirred for 1h at room temperature. 3.71 ml (3.08 g, 58.0 mmol) of 
acrolein (172) in EtOH (10 ml) is added, then slowly and the solution is stirred for 18h 
at room temperature. Then, the solvent is first eliminated under reduced pressure, the 
residue is dissolved in Et2O, acidified with a solution HCl and the aqueous layers are 
extracted with diethylether. The combined organic phases are washed with water and 
dried over anhydrous MgSO4. The solvent is removed under reduced pressure and the 
crude mixture is purified by column chromatography on alumina N (III), using as 
eluent cyclohexane-diethylether (1:10). 12.656 g (17.87 mmol, 96 %) of ethyl 4-
hydroxy-9-oxo-bicyclo[3.3.1]nonane carboxylate (174b) are obtained as a colorless 
liquid mixture of 2 diastereoisomers in a ratio of 1:1, detected by NMR analysis. Its 
spectroscopic data are consistent with those reported in R 85. 
 
 
R 89: Synthesis of ethyl 7-hydroxy-10-oxo-bicyclo[4.3.1]decane carboxylate (174c) 
Amounts: 2.0 g (10.0 mmol)  ethyl 2-oxo-cycloheptane carboxylate (65c) 
  0.6 g (10.0 mmol)  acrolein (172) 
  1.52 g (10.0 mmol)  DBU  
  50 ml    EtOH  
Procedure: Analogously to R 88.  
Work-up: The combined organic phases are washed with Et2O (3 x 20 ml), dried 
over anhydrous MgSO4. After evaporation of solvent under reduced pressure, the crude 
mixture is separated by a column chromatography on alumina N (III), using as eluent 
cyclohexane-Et2O (1:10). 1.872 g (7.8 mmol, 78 % yield) of ethyl 7-hydroxy-10-oxo-
bicyclo[4.3.1]decane carboxylate (174c) are obtained as a colorless liquid mixture of 2 
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diastereoisomers in a ratio of 5:1, detected by NMR analysis. Its spectroscopic data are 
consistent with those reported in R 86. 
 
 
R 90: Synthesis of ethyl 8-hydroxy-11-oxo-bicyclo[5.3.1]undecan carboxylate 
(174d) 
Amounts: 4.0 g (20.0 mmol)  ethyl 2-oxo-cyclo-octane carboxylate (65d) 
  3.04 g (20.0 mmol)  DBU 
  1.2 g (20.0 mmol)  acrolein (172) 
  30 ml    EtOH  
Procedure: Analogously to R 88.  
Work-up: The aqueous layer is extracted with Et2O (3 x 20 ml). The combined 
organic phases are dried over anhydrous MgSO4. Evaporation of solvent under reduced 
pressure yielded 3.858 g (15.17 mmol, 76 % yield) of ethyl 8-hydroxy-11-oxo-
bicyclo[5.3.1]undecan carboxylate (174d) as a colorless liquid mixture of 2 
diastereoisomers in a ratio of 4:1, detected by NMR analysis. Its spectroscopic data are 
consistent with those reported in R 87. 
 
b. Crotonic aldehyde chain 
 
R 91: Synthesis of ethyl 4-hydroxy-2-methyl-9-oxo-bicyclo[3.3.1]nonane 
carboxylate (182b) 
Amounts: 10.0 g  (58 mmol) ethyl 2-oxo-cyclohexane carboxylate (65b) 
  8.92 g  (21.0 mmol) DBU 
  4.06 g  (58.0 mmol) crotonic aldehyde (181) 
  80 ml    EtOH  
Procedure: Analogously to R 88.  
Work-up: The solvent is removed under reduced pressure, the residue is dissolved in 
Et2O, acidified with a solution of HCl and the aqueous layers are extracted with 
diethyether (3 x 20 ml). The combined organic phase is dried over anhydrous MgSO4. 
The solvent is removed under reduced pressure and the crude mixture is purified by 
column chromatography on alumina N (III), using as eluent cyclohexane-diethylether 
(1:10). 11.97 g (49.8 mmol, 86 % yield) are obtained as a colorless oil mixture of 4 
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diastereoisomers in a ratio of 8.3:3.6:1.5:1, detected by NMR, of ethyl 4-hydroxy-2-
methyl-9-oxo-bicyclo[3.3.1]nonane carboxylate (182b) (C13H20O4, 240.296 g/mol). 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 240 (M+, 5), 222 (2), 194 (8), 84 
(100), 73 (4), 55 (16). High Resolution Mass: 
Calculated: 240.1362; Found: 240.1362. IR 
(KBr-Film): ν  [cm-1] = 3482 (m), 2960 (s), 
2937 (s), 2874 (m), 1731 (vs), 1716 (vs), 1646 
(m), 1450 (m), 1367 (m), 1247 (s), 1216 (s), 
1095 (s), 1049 (s), 993 (m). Major 
diastereisomer DS-1 1H-NMR (400 MHz, 
CDCl3): δ [ppm] = 0.91 (d, 3H, 3J = 6.78 Hz, CH3-14), 1.19 (t, 3H, 3J = 7.03 Hz, CH3-
13), 1.48-2.31 (approx. 8H), 2.50 (m, 1H), 3.03 (m, 1H), 4.02 (m, 1H, CH-4), 4.14 (q, 
2H, 3J = 7.28 Hz, CH2-12). Mixture of diastereoisomers DS-1/2/3/4 13C-NMR (100 
MHz, CDCl3): δ [ppm] = 14.0 (CH3, C-13), 16.4 (CH3, C-14), 19.2, 29.6, 30.4, 36.1 
(CH2, C-3/6/7/8), 33.3, 34.2, 34.8, 36.1 (CH, C-2), 53.0, 53.3, 53.6, 56.4 (CH, C-5), 
60.9 (CH2, C-12), 69.9, 70.5, 73.9, 74.3 (CH, C-4), 171.8 (CO, C-10), 213.9 (CO, C-9). 
 
 
R 92: Synthesis of ethyl 7-hydroxy-9-methyl-10-oxo-bicyclo[4.3.1]decane 
carboxylate (182c) 
Amounts: 4.0 g  (21.0 mmol) ethyl 2-oxo-cycloheptane carboxylate (65c) 
  3.19 g  (21.0 mmol) DBU 
  1.47 g  (21.0 mmol) crotonic aldehyde (181) 
  30 ml    EtOH  
Procedure: Analogously to R 88. 
Work-up: The purification of the crude mixture by column chromatography on 
alumina N (III), using as eluent cyclohexane-Et2O (1:10), gave 4.26 g (16.75 mmol, 80 
% yield) of ethyl 7-hydroxy-9-methyl-10-oxo-bicyclo[4.3.1]decane carboxylate (182c) 
(C14H22O4, 254.322 g/mol) as a colorless oil mixture of 6 diastereoisomers in a ratio of 
9:4.7:2:2:1.7:1, detected by NMR analysis. 
Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 254 (M+, 1), 208 (3), 73 (3), 55 
(53). 45 (12), 29 (100), 18 (1). IR (KBr-Film): ν [cm-1] = 3428 (m), 2962 (s), 2933 (s), 
2869 (m), 1733 (vs), 1698 (vs), 1454 (m), 1365 (m), 1259 (s), 1238 (s), 1209 (s), 1180 
(s), 1108 (s), 1062 (s), 1025 (vs). Major diastereoisomer DS-1 1H-NMR (400 MHz, 
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CDCl3): δ [ppm] = 0.85 (d, 3H, 3J = 7.03 Hz, 
CH3-11), 1.20 (t, 3H, 3J = 7.28 Hz, CH3-15), 
1.53 (m, 2H), 1.67-1.87 (approx. 6H), 2.2 (m, 
1H), 2.4 (m, 1H), 2.6 (ddd, 1H, 3J = 6.78 Hz, 
3J = 1.51 Hz, 3J = 4.27 Hz, CH-6), 2.94 (m, 
1H), 3.99 (m, 1H, CH-7), 4.12 (q, 2H, 3J = 
7.28 Hz, CH2-14). Mixture of 
diastereoisomers DS-1/2/3/4/5/6 13C-NMR 
(100 MHz, CDCl3): δ [ppm] = 14.0 (CH3, C-15), 16.2 (CH3, C-11), 24.5, 25.4, 28.8, 
31.4, 37.1 (CH2, C-2/3/4/5/8), 28.3, 29.4, 30.2, 30.7, 31.9, 33.3 (CH2, C-9, DS-
1/2/3/4/5/6), 53.7, 55.3, 55.9, 56.5, 57.2, 57.8 (CH2, C-6, DS-1/2/3/4/5/6), 60.7 (CH2, 
C-14), 66.5, 69.5, 70.5, 72.3, 72.4, 73.3 (CH, C-7, DS-1/2/3/4/5/6), 171.8 (CO, C-12), 
212.3 (CO, C-10).  
 
 
4.7.2 Preparation of tricylic compounds 
a. Preparation of starting materials  
 
R 93: Preparation of ethyl 4,9-dioxo-bicyclo[3.3.1]nonane carboxylate (190) 
A flask equipped with a Argon inlet, dropping funnel, and mechanical stirrer is charged 
with ethyl 4-hydroxy-9-oxo-bicyclo[3.3.1]nonane carboxylate (174b) (5.0 g, 22.0 
mmol) in abs. CH2Cl2. The flask is immersed in an ice-water bath. 3.13 ml (3.45 g, 44.0 
mmol) of DMSO and 5.62 g (39.6 mmol) of phosphorus pentoxide are added 
sequentially. The reaction mixture is allowed to stir and warm to room temperature 
until disappearance of starting material controlled by TLC (30 min). The flask is 
immersed again in the ice-water bath; then, 10.7 ml (7.7 g, 77.0 mmol) of TEA is added 
dropwise over 10 min. Stirring is continued for 30 min. The reaction is quenched with 
aqueous HCl (10 %) and extracted with CH2Cl2. The organic extracts are washed with 
saturated aqueous NaCl, dried over anhydrous MgSO4, filtered, and concentrated in 
vacuum. The crude mixture is purified by bulb-to-bulb distillation (T = 130 °C, P = 3.8 
x 10-2 mbar) giving 4.329 g (18.04 mmol, 82 % yield) of ethyl 4,9-dioxo-
bicyclo[3.3.1]nonane carboxylate185 (190) (C12H16O4, 224.253 g/mol). 
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Spectroscopic data: GC-MS (EI, 70 eV): m/z (%) = 225 (M++1, 2), 207 (45), 149 
(85), 73 (100). 1H-NMR (500 MHz, CDCl3): δ 
[ppm] = 1.27 (t, 3H, 3J = 7.28 Hz, CH3-13), 2.55-
2.70 (approx. 10H), 4.00 (m, 1H), 4.22 (q, 2H, 3J 
= 7.28 Hz, CH2-12). 13C-NMR (125 MHz, 
CDCl3): δ [ppm] = 14.0 (CH3, C-13), 18.7, 25.0, 
34.7, 38.1, 39.6 (CH2, C-2/3/6/7/8), 57.6 (Cq, C-
1), 61.6 (CH2, C-12), 62.5 (CH, C-5), 171.5 (CO, C-10), 206.6 (CO, C-9), 208.8 (CO, 
C-4). 
 
 
R 94: Synthesis of ethyl 4,9-dioxo-5-(3-oxo-propyl)-bicyclo[3.3.1]nonane 
carboxylate (191) 
Amounts: 1.0 g  (4.46 mmol) ethyl 4,9-dioxo-   
      bicyclo[3.3.1]nonane-1-carboxylate (190) 
  45.0 mg (4.46 mmol) triethylamine (TEA) 
  0.68 mg (4.46 mmol) acrolein (172) 
  30 ml    DMF 
Procedure: Analogously to R 80.  
Work-up: The organic phases are dried over anhydrous MgSO4, filtered, and 
concentrated in vacuum obtaining 1.259 g (98 % GC-conv.) as a mixture  of ethyl 4,9-
dioxo-5-(3-oxo-propyl)-bicyclo[3.3.1]nonane carboxylate (191) (C15H20O5, 280.316 
g/mol) and ethyl 8-hydroxy-11,12-dioxo-tricyclo[5.3.1.1.1,5]dodecanane-5-carboxylate 
(192) (C15H20O5, 280.316 g/mol). The products could not be completely separated. The 
presence of the compound 191 is observed by 
the most significant peaks by NMR: 1H-NMR 
(500 MHz, CDCl3): δ [ppm] = 1.31 (t, 3H, 3J 
= 7.03 Hz, CH3-12), 1.50-2.98 (approx. 14H), 
4.27 (q, 2H, 3J = 7.03 Hz, CH2-12), 10.01 (bs, 
1H, CHO-15). 13C-NMR (125 MHz, CDCl3): 
δ [ppm] = 14.0 (CH3, C-12), 17.1, 22.2, 26.8, 
30.8, 33.8, 40.9, 46.6 (CH2, C-2/3/6/7/8/13/14), 61.9 (CH2, C-11), 178.0 (CO, C-10), 
203.6 (CO, C-15), 214.0 (CO, C-9). 
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Spectroscopic data of ethyl 8-hydroxy-11,12-dioxo-tricyclo[5.3.1.1.1,5]dodecanane-5-
carboxylate (192) are described in the next reaction R 95. 
 
 
a. Intramolecular aldol addition 
 
R 95: ethyl 8-hydroxy-11,12-dioxo-tricyclo[5.3.1.1.1,5]dodecanane-5-carboxylate 
(192) 
Amounts: 1.259 g (4.5 mmol) mixture of compounds 191 and 192 from R
      94 
  14.4 ml   HCl (7N)  
  40 ml    dioxane  
Procedure: Analogously to R 84.  
Work-up: The combined organic phase is dried with anhydrous MgSO4, filtered, 
and concentrated in vacuum obtaining 1.112 g (3.9 mmol, 88 % of yield) of ethyl 8-
hydroxy-11,12-dioxo-tricyclo[5.3.1.1.1,5]dodecanane-5-carboxylate (192) (C15H20O5, 
280.316 g/mol) as a mixture of 4 diastereoisomers detected by NMR.  
Spectroscopic data of 192: GC-MS (Low Resolution-FAB): m/z (%) = 281.21 (M++1, 
18), 263 (17), 136 (42), 107 (107), 77 (18), 55 (12). HRMS-FAB (m-NBA-matrix): 
calculated for C15H21O5, [M+H]+: 281.1389; observed: 
281.1362. IR (KBr-film): [cm-1] = 3419 (s), 2962 (s), 2944 
(s), 2865 (s), 1737 (vs), 1716 (vs), 1698 (vs), 1455 (s), 
1367 (s), 1259 (vs), 1211 (s), 1079 (vs), 1024 (vs), 873 (s), 
800 (s). major diastereoisomer 1H-NMR (500 MHz, 
CDCl3): δ [ppm] = 1.23 (t, 3H, 3J = 7.03 Hz, CH3-19), 
1.60-2.80 (approx. 12H), 4.04 (m, 1H, CH-7), 4.25 (q, 2H, 
3J = 7.03 Hz, CH2-18), 4.5 (m, 1H, CH-8). 13C-NMR (125 
MHz, CDCl3): δ [ppm] = 14.0 (CH3, C-19), 17.0, 19.2, 
20.3, 24.5, 26.3, 28.4, 30.1, 30.2, 31.0, 33.7, 35.8, 36.2 (CH2, C-6/9/10/13/14/15, DS-
1/2/3/4), 47.7, 48.2, 53.8, 54.4 (CH, C-8, DS-1/2/3/4), 57.3, 57.8 (Cq, C-1/5), 61.0, 
61.1, 62.0, 62.1 (CH2, C-18, DS-1/2/3/4), 72.6, 73.8, 75.9, 76.7 (CH, C-8, DS-1/2/3/4), 
172.4, 176.4, 177.8, 178.0 (CO, C-16, DS-1/2/3/4), 211.6, 213.2 (CO, C-11/12). 
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b. Attempted preparation of α,β-unsaturated bicyclic compound 
 
R 96: Attempted preparation of ethyl 4-oxo-bicyclo[3.3.1]non-4-ene carboxylate 
(193) 
To a stirred suspension of ethyl 4-hydroxy-9-oxo-bicyclo[3.3.1]nonane carboxylate 
(174b) (3.0 g, 13.0 mmol) and 7.25 g (19.5 mmol) of cerium(III) chloride heptahydrate 
in 70 ml acetonitrile are added 2.92 g (19.5 mmol) of sodium iodide, and the resulting 
mixture is stirred for 10 h at reflux.. The reaction mixture is diluted with Et2O and 
treated with HCl (0.5 N). The organic layer is separated, and the aqueous layer is 
extracted with diethylether (3 x 25 ml). The combined organic layers are washed twice 
with an aqueous saturated NaHCO3 solution and a saturated NaCl solution and dried 
over anhydrous Na2SO4. The extracts are then concentrated under reduced pressure and 
the residue gave only starting material. 
 
 
R 97: Attempted preparation of α,β-unsaturated bicyclic compound by 
cerium(III) salt 
To a solution of ethyl 2-oxo-1-(3-oxo-propyl)cyclohexane carboxylate (174b) (5.0 g, 
22.0 mmol) in 15 ml of EtOH is added a solution of DBU (3.08 ml, 3.35 g, 22.0 mmol) 
in 15 ml of EtOH, and the mixture is stirred for 48h under refluxing conditions. Then, 
the solvent is first eliminated under reduced pressure, the residue is dissolved in Et2O, 
acidified with a solution of HCl (5 %) and the aqueous layer is extracted with Et2O. 
The combined organic phases are washed with water and dried over anhydrous MgSO4. 
Evaporation of solvent under reduced pressure gives an intractable mixture. 
 
 
R 98: Attempted preparation of α,β-unsaturated bicyclic compound by BF3·OEt2 
To a solution of ethyl 2-oxo-1-(3-oxo-propyl)-cyclohexane carboxylate (173b) (5.0 g, 
22.0 mmol) in dry dichloromethane at room temperature is added a solution of boron 
trifluoride etherate (5.56 ml, 6.28 g, 44.0 mmol) and the solution is stirred at room 
temperature for 24 h. Then, the solution is neutralized with saturated aqueous sodium 
bicarbonate solution. The resulting mixture is extracted with chloroform (3 x 20 ml). 
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The combined extracts are washed with saturated aqueous sodium chloride solution; the 
organic phases are washed with water and dried over anhydrous MgSO4. The removal 
of the solvent gives 4.32 g (19 mmol, 87 % yield) of ethyl 4-hydroxy-9-oxo-
bicyclo[3.3.1]octane carboxylate (174b) (C12H18O4, 226.269 g/mol) are isolated by 
bulb-to-bulb distillation (T = 75 °C, P = 7.2 x 10-2 mbar). 
Spectroscopic data are consistent with those reported in R 85. 
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